*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1am5_c06 PEPSIN user 1 4 # 1 32 ASP A 88 ASP^? 3.30 CG MLY A 107 33 THR A 81 THR^? 4.00 CA MLY E 63 215 ASP A 86 ASP^? 4.13 CB MLY E 62 218 THR A 84 THR^? 10.57 CH1 MLY A 107 coo -7.18 8.92 145.10 -8.77 8.81 143.59 14.06 59.10 -75.34 13.56 59.34 -77.37 coo -7.95 13.74 144.22 -6.52 14.95 143.16 14.15 54.67 -70.12 13.73 52.73 -70.95 coo -8.20 12.64 138.30 -8.86 10.97 139.38 10.80 52.06 -74.41 9.44 51.94 -72.75 coo -6.03 8.73 136.74 -7.80 9.12 135.47 6.21 56.17 -75.55 4.26 56.77 -76.35 ULMN 4 1am5_c06 PEPSIN user 2 4 # 2 32 ASP C 88 ASP^? 3.98 CA MLY C 107 33 THR C 81 THR^? 3.61 O MLY D 62 215 ASP C 86 ASP^? 3.69 CB MLY D 63 218 THR C 84 THR^? 8.12 NZ MLY D 62 coo -7.18 8.92 145.10 -8.77 8.81 143.59 14.72 94.17 -28.91 13.94 94.86 -27.07 coo -7.95 13.74 144.22 -6.52 14.95 143.16 16.25 94.99 -35.24 16.65 96.87 -36.20 coo -8.20 12.64 138.30 -8.86 10.97 139.38 13.78 99.19 -34.67 12.49 98.36 -36.08 coo -6.03 8.73 136.74 -7.80 9.12 135.47 8.84 98.53 -30.42 8.20 99.73 -28.75 1am5_c06 source 1am5 PEPSIN : 2 hits 1am5_c06 naa= 4 ULMN 4 1apt_c05 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 4 # 1 E 33 ASP A 88 ASP^? 3.30 CG MLY A 107 E 34 THR A 81 THR^? 4.00 CA MLY E 63 E 213 ASP A 86 ASP^? 4.13 CB MLY E 62 E 216 THR A 84 THR^? 10.57 CH1 MLY A 107 coo 26.30 12.96 16.78 25.46 12.99 18.72 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 25.06 17.67 17.27 23.51 18.60 16.07 14.15 54.67 -70.12 13.73 52.73 -70.95 coo 20.15 16.04 19.79 21.65 14.49 19.86 10.80 52.06 -74.41 9.44 51.94 -72.75 coo 18.77 11.27 18.60 18.17 11.74 20.64 6.21 56.17 -75.55 4.26 56.77 -76.35 ULMN 4 1apt_c05 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 4 # 2 E 33 ASP C 88 ASP^? 3.98 CA MLY C 107 E 34 THR C 81 THR^? 3.61 O MLY D 62 E 213 ASP C 86 ASP^? 3.69 CB MLY D 63 E 216 THR C 84 THR^? 8.12 NZ MLY D 62 coo 26.30 12.96 16.78 25.46 12.99 18.72 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 25.06 17.67 17.27 23.51 18.60 16.07 16.25 94.99 -35.24 16.65 96.87 -36.20 coo 20.15 16.04 19.79 21.65 14.49 19.86 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 18.77 11.27 18.60 18.17 11.74 20.64 8.84 98.53 -30.42 8.20 99.73 -28.75 1apt_c05 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 2 hits 1apt_c05 naa= 4 ULMN 4 1avf_c07 GASTRICSIN user 1 4 # 1 A 32 ASP C 88 ASP^? 3.98 CA MLY C 107 A 33 THR C 81 THR^? 3.61 O MLY D 62 A 217 ASP C 86 ASP^? 3.69 CB MLY D 63 A 220 THR C 84 THR^? 8.12 NZ MLY D 62 coo -10.06 2.54 49.69 -8.83 3.73 50.96 14.72 94.17 -28.91 13.94 94.86 -27.07 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 16.25 94.99 -35.24 16.65 96.87 -36.20 coo -5.22 1.43 56.08 -5.36 2.84 54.49 13.78 99.19 -34.67 12.49 98.36 -36.08 coo -1.48 1.48 52.34 -0.65 2.04 54.29 8.84 98.53 -30.42 8.20 99.73 -28.75 1avf_c07 source 1avf GASTRICSIN : 1 hits 1avf_c07 naa= 4 ULMN 4 1avf_c08 GASTRICSIN user 1 4 # 1 J 32 ASP C 88 ASP^? 3.98 CA MLY C 107 J 33 THR C 81 THR^? 3.61 O MLY D 62 J 217 ASP C 86 ASP^? 3.69 CB MLY D 63 J 220 THR C 84 THR^? 8.12 NZ MLY D 62 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 14.72 94.17 -28.91 13.94 94.86 -27.07 coo -41.87 -15.43 20.67 -42.27 -13.53 19.66 16.25 94.99 -35.24 16.65 96.87 -36.20 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 13.78 99.19 -34.67 12.49 98.36 -36.08 coo -38.56 -16.44 11.85 -40.37 -16.72 10.69 8.84 98.53 -30.42 8.20 99.73 -28.75 1avf_c08 source 1avf GASTRICSIN : 1 hits 1avf_c08 naa= 4 ULMN 4 1bbs_c10 RENIN user 1 4 # 1 32 ASP C 86 ASP^? 3.69 CB MLY D 63 33 THR C 84 THR^? 8.12 NZ MLY D 62 215 ASP C 88 ASP^? 3.98 CA MLY C 107 218 ALA C 89 ALA^? 6.02 N MLY C 107 coo 61.19 45.85 78.73 62.86 45.48 77.48 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 62.61 41.50 79.97 61.55 39.62 79.92 8.84 98.53 -30.42 8.20 99.73 -28.75 coo 63.61 40.10 74.06 64.05 42.07 74.70 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 61.04 42.48 71.22 62.11 41.40 71.19 17.41 92.58 -31.86 18.92 92.61 -31.93 1bbs_c10 source 1bbs RENIN : 1 hits 1bbs_c10 naa= 4 ULMN 4 1bbs_c11 RENIN user 1 4 # 1 32 ASP C 86 ASP^? 3.69 CB MLY D 63 33 THR C 84 THR^? 8.12 NZ MLY D 62 215 ASP C 88 ASP^? 3.98 CA MLY C 107 218 ALA C 89 ALA^? 6.02 N MLY C 107 coo 61.19 45.85 78.73 62.86 45.48 77.48 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 62.61 41.50 79.97 61.55 39.62 79.92 8.84 98.53 -30.42 8.20 99.73 -28.75 coo 63.61 40.10 74.06 64.05 42.07 74.70 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 61.04 42.48 71.22 62.11 41.40 71.19 17.41 92.58 -31.86 18.92 92.61 -31.93 1bbs_c11 source 1bbs RENIN : 1 hits 1bbs_c11 naa= 4 ULMN 4 1cms_c06 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 4 # 1 34 ASP C 88 ASP^? 3.98 CA MLY C 107 35 THR C 81 THR^? 3.61 O MLY D 62 216 ASP C 86 ASP^? 3.69 CB MLY D 63 219 THR C 84 THR^? 8.12 NZ MLY D 62 coo 16.90 26.20 29.49 16.22 24.50 28.41 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 13.84 28.82 26.85 14.18 30.39 25.32 16.25 94.99 -35.24 16.65 96.87 -36.20 coo 13.93 25.52 22.10 14.75 24.44 23.75 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 18.26 23.14 21.54 16.59 21.96 20.68 8.84 98.53 -30.42 8.20 99.73 -28.75 1cms_c06 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 1 hits 1cms_c06 naa= 4 ULMN 4 1eag_c06 PEPTIDE INHIBITOR user 1 4 # 1 A 32 ASP C 88 ASP^? 3.98 CA MLY C 107 A 33 THR C 81 THR^? 3.61 O MLY D 62 A 218 ASP C 86 ASP^? 3.69 CB MLY D 63 A 221 THR C 84 THR^? 8.12 NZ MLY D 62 coo 47.22 22.34 8.57 45.16 22.02 9.13 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 47.36 17.58 7.81 48.27 16.18 9.23 16.25 94.99 -35.24 16.65 96.87 -36.20 coo 44.05 16.99 12.67 44.05 18.89 11.74 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 44.42 20.57 16.06 42.37 19.87 16.06 8.84 98.53 -30.42 8.20 99.73 -28.75 1eag_c06 source 1eag PEPTIDE INHIBITOR : 1 hits 1eag_c06 naa= 4 ULMN 4 1eed_c05 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 4 # 1 P 32 ASP A 88 ASP^? 3.30 CG MLY A 107 P 33 THR A 81 THR^? 4.00 CA MLY E 63 P 215 ASP A 86 ASP^? 4.13 CB MLY E 62 P 218 THR A 84 THR^? 10.57 CH1 MLY A 107 coo 10.15 33.41 11.98 7.98 33.66 12.07 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 9.02 32.64 7.26 9.13 30.80 6.21 14.15 54.67 -70.12 13.73 52.73 -70.95 coo 4.04 29.97 8.82 4.78 31.15 10.46 10.80 52.06 -74.41 9.44 51.94 -72.75 coo 4.25 27.93 13.40 2.30 28.73 12.88 6.21 56.17 -75.55 4.26 56.77 -76.35 ULMN 4 1eed_c05 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 4 # 2 P 32 ASP C 88 ASP^? 3.98 CA MLY C 107 P 33 THR C 81 THR^? 3.61 O MLY D 62 P 215 ASP C 86 ASP^? 3.69 CB MLY D 63 P 218 THR C 84 THR^? 8.12 NZ MLY D 62 coo 10.15 33.41 11.98 7.98 33.66 12.07 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 9.02 32.64 7.26 9.13 30.80 6.21 16.25 94.99 -35.24 16.65 96.87 -36.20 coo 4.04 29.97 8.82 4.78 31.15 10.46 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 4.25 27.93 13.40 2.30 28.73 12.88 8.84 98.53 -30.42 8.20 99.73 -28.75 1eed_c05 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 2 hits 1eed_c05 naa= 4 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 1 4 # 1 A 7 TYR D 66 TYR^? 6.79 CE MLY D 56 A 72 ASP D 55 ASP^? 3.95 N MLY D 56 A 92 ASP C 86 ASP^? 3.69 CB MLY D 63 A 98 GLU C 80 GLU^? 4.30 CE MLY D 63 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 15.56 92.60 -38.66 14.20 91.79 -40.09 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 2 4 # 2 A 7 TYR E 66 TYR^? -3.37 C3 PEG E4126s A 72 ASP E 55 ASP^? 3.37 N MLY E 56 A 92 ASP A 86 ASP^? 4.13 CB MLY E 62 A 98 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 10.80 52.06 -74.41 9.44 51.94 -72.75 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 13.22 55.53 -66.00 11.94 55.88 -64.34 1f8x_c00 source 1f8x NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE : 2 hits 1f8x_c00 naa= 4 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 1 4 # 1 B 207 TYR D 66 TYR^? 6.79 CE MLY D 56 B 272 ASP D 55 ASP^? 3.95 N MLY D 56 B 292 ASP C 86 ASP^? 3.69 CB MLY D 63 B 298 GLU C 80 GLU^? 4.30 CE MLY D 63 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 15.56 92.60 -38.66 14.20 91.79 -40.09 1f8x_c01 source 1f8x NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE : 1 hits 1f8x_c01 naa= 4 ULMN 4 1mpp_c06 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 4 # 1 32 ASP C 88 ASP^? 3.98 CA MLY C 107 33 THR C 81 THR^? 3.61 O MLY D 62 215 ASP C 86 ASP^? 3.69 CB MLY D 63 218 THR C 84 THR^? 8.12 NZ MLY D 62 coo 20.97 14.47 32.28 19.66 15.96 31.62 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 20.74 16.43 36.65 22.27 17.66 37.53 16.25 94.99 -35.24 16.65 96.87 -36.20 coo 20.65 22.00 33.80 20.06 20.56 32.39 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 22.99 21.66 29.34 21.36 23.06 29.40 8.84 98.53 -30.42 8.20 99.73 -28.75 1mpp_c06 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 1 hits 1mpp_c06 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 59 VAL^? 6.97 N MLY A 62 A 194 GLY A 61 GLY^? 2.44 N MLY A 62 A 417 ILE C 69 ILE^? 7.69 C3 GOL C2126 A 457 ALA C 73 ALA^? 3.70 C MLY C 72 coo 60.43 93.31 8.03 62.16 94.30 8.93 4.87 81.57 -70.08 3.89 83.33 -69.13 coo 59.34 89.99 13.88 59.24 89.18 13.73 9.20 80.72 -73.86 9.00 81.48 -73.88 coo 39.61 128.90 22.54 40.04 128.24 23.80 25.04 74.43 -32.80 23.99 75.27 -33.27 coo 43.27 124.32 20.47 43.79 125.29 21.53 26.69 73.30 -38.88 25.98 72.46 -37.78 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL A 64 VAL^? 3.14 C MLY A 63 A 194 GLY A 58 GLY^? 4.23 CG MLY A 63 A 417 ILE B 69 ILE^? 7.97 O MLY B 49 A 457 ALA B 73 ALA^? 3.65 C MLY B 72 coo 60.43 93.31 8.03 62.16 94.30 8.93 16.48 82.20 -71.11 17.86 82.13 -72.75 coo 59.34 89.99 13.88 59.24 89.18 13.73 8.59 81.71 -69.27 8.46 80.93 -69.54 coo 39.61 128.90 22.54 40.04 128.24 23.80 23.21 57.88 -37.01 22.39 58.16 -36.56 coo 43.27 124.32 20.47 43.79 125.29 21.53 26.25 62.56 -40.56 25.40 61.44 -41.11 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 151 VAL C 64 VAL^? 3.12 C MLY C 63 A 194 GLY C 61 GLY^? 2.42 N MLY C 62 A 417 ILE A 69 ILE^? 7.93 N MLY A 72 A 457 ALA A 73 ALA^? 3.70 C MLY A 72 coo 60.43 93.31 8.03 62.16 94.30 8.93 16.33 72.98 -19.82 17.78 73.92 -18.50 coo 59.34 89.99 13.88 59.24 89.18 13.73 9.13 75.85 -18.56 8.73 75.86 -17.88 coo 39.61 128.90 22.54 40.04 128.24 23.80 24.15 72.79 -61.03 23.03 71.90 -61.11 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.53 70.37 -55.18 24.94 71.71 -55.64 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 151 VAL C 112 VAL^? 6.15 O MLY C 107 A 194 GLY C 114 GLY^? 4.57 N MLY C 117 A 417 ILE E 69 ILE^? 7.87 N MLY E 72 A 457 ALA E 73 ALA^? 3.67 C MLY E 72 coo 60.43 93.31 8.03 62.16 94.30 8.93 24.25 92.00 -29.51 22.31 92.82 -30.22 coo 59.34 89.99 13.88 59.24 89.18 13.73 29.63 90.90 -29.25 28.97 90.71 -29.70 coo 39.61 128.90 22.54 40.04 128.24 23.80 22.98 56.35 -54.27 21.87 56.06 -53.48 coo 43.27 124.32 20.47 43.79 125.29 21.53 24.59 60.71 -49.83 23.98 60.79 -51.22 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 151 VAL D 112 VAL^? 5.02 O MLY D 107 A 194 GLY D 114 GLY^? 4.53 N MLY D 117 A 417 ILE B 69 ILE^? 7.97 O MLY B 49 A 457 ALA B 73 ALA^? 3.65 C MLY B 72 coo 60.43 93.31 8.03 62.16 94.30 8.93 23.73 92.76 -64.17 21.85 92.54 -65.29 coo 59.34 89.99 13.88 59.24 89.18 13.73 29.18 91.87 -63.07 28.51 91.45 -62.96 coo 39.61 128.90 22.54 40.04 128.24 23.80 23.21 57.88 -37.01 22.39 58.16 -36.56 coo 43.27 124.32 20.47 43.79 125.29 21.53 26.25 62.56 -40.56 25.40 61.44 -41.11 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 151 VAL E 40 VAL^? 5.00 CD MLY E 107 A 194 GLY E 109 GLY^? 3.43 O MLY E 107 A 417 ILE C 26 ILE^? 5.40 N MLY B 117 A 457 ALA B 120 ALA^? 3.52 O MLY B 117 coo 60.43 93.31 8.03 62.16 94.30 8.93 13.38 41.42 -54.96 11.64 41.19 -53.58 coo 59.34 89.99 13.88 59.24 89.18 13.73 16.29 34.79 -50.75 16.46 35.35 -50.19 coo 39.61 128.90 22.54 40.04 128.24 23.80 27.62 67.36 -21.22 26.39 68.07 -20.90 coo 43.27 124.32 20.47 43.79 125.29 21.53 30.33 64.86 -28.19 30.42 65.65 -26.93 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 151 VAL E 64 VAL^? 2.99 C MLY E 63 A 194 GLY E 58 GLY^? 4.59 CB MLY E 63 A 417 ILE C 69 ILE^? 7.69 C3 GOL C2126 A 457 ALA C 73 ALA^? 3.70 C MLY C 72 coo 60.43 93.31 8.03 62.16 94.30 8.93 14.80 50.45 -66.66 16.03 48.75 -67.12 coo 59.34 89.99 13.88 59.24 89.18 13.73 6.58 51.10 -65.74 6.52 50.77 -64.99 coo 39.61 128.90 22.54 40.04 128.24 23.80 25.04 74.43 -32.80 23.99 75.27 -33.27 coo 43.27 124.32 20.47 43.79 125.29 21.53 26.69 73.30 -38.88 25.98 72.46 -37.78 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 151 VAL E 64 VAL^? 2.99 C MLY E 63 A 194 GLY E 58 GLY^? 4.59 CB MLY E 63 A 417 ILE C 74 ILE^? 5.85 CH1 MLY D 72 A 457 ALA C 73 ALA^? 3.70 C MLY C 72 coo 60.43 93.31 8.03 62.16 94.30 8.93 14.80 50.45 -66.66 16.03 48.75 -67.12 coo 59.34 89.99 13.88 59.24 89.18 13.73 6.58 51.10 -65.74 6.52 50.77 -64.99 coo 39.61 128.90 22.54 40.04 128.24 23.80 26.68 78.08 -37.72 26.66 79.01 -36.61 coo 43.27 124.32 20.47 43.79 125.29 21.53 26.69 73.30 -38.88 25.98 72.46 -37.78 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 A 151 VAL E 112 VAL^? 6.27 O MLY E 107 A 194 GLY E 114 GLY^? 4.51 CB MLY E 117 A 417 ILE D 69 ILE^? 7.77 N MLY D 72 A 457 ALA D 73 ALA^? 3.72 C MLY D 72 coo 60.43 93.31 8.03 62.16 94.30 8.93 20.47 39.84 -45.28 18.74 39.43 -44.04 coo 59.34 89.99 13.88 59.24 89.18 13.73 26.06 40.68 -46.38 25.43 41.13 -46.15 coo 39.61 128.90 22.54 40.04 128.24 23.80 25.21 84.25 -47.20 24.08 84.00 -48.00 coo 43.27 124.32 20.47 43.79 125.29 21.53 26.61 78.14 -48.04 26.03 78.99 -46.87 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 9 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL A 59 VAL^? 6.97 N MLY A 62 B 194 GLY A 61 GLY^? 2.44 N MLY A 62 B 417 ILE C 69 ILE^? 7.69 C3 GOL C2126 B 457 ALA C 73 ALA^? 3.70 C MLY C 72 coo 52.95 126.71 13.21 51.34 125.24 13.19 4.87 81.57 -70.08 3.89 83.33 -69.13 coo 50.40 126.23 20.48 50.46 127.00 20.75 9.20 80.72 -73.86 9.00 81.48 -73.88 coo 68.38 85.45 19.33 67.41 85.52 20.41 25.04 74.43 -32.80 23.99 75.27 -33.27 coo 65.50 91.13 17.77 64.65 89.88 18.00 26.69 73.30 -38.88 25.98 72.46 -37.78 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL A 59 VAL^? 6.97 N MLY A 62 B 194 GLY D 83 GLY^? -3.44 O MLY A 62s B 417 ILE C 69 ILE^? 7.69 C3 GOL C2126 B 457 ALA C 73 ALA^? 3.70 C MLY C 72 coo 52.95 126.71 13.21 51.34 125.24 13.19 4.87 81.57 -70.08 3.89 83.33 -69.13 coo 50.40 126.23 20.48 50.46 127.00 20.75 11.73 87.92 -71.70 11.80 88.76 -71.59 coo 68.38 85.45 19.33 67.41 85.52 20.41 25.04 74.43 -32.80 23.99 75.27 -33.27 coo 65.50 91.13 17.77 64.65 89.88 18.00 26.69 73.30 -38.88 25.98 72.46 -37.78 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 B 151 VAL C 40 VAL^? 4.58 CH2 MLY C 107 B 194 GLY C 58 GLY^? 5.17 O MLY C 56 B 417 ILE A 69 ILE^? 7.93 N MLY A 72 B 457 ALA A 73 ALA^? 3.70 C MLY A 72 coo 52.95 126.71 13.21 51.34 125.24 13.19 17.19 86.28 -20.12 15.56 87.73 -20.27 coo 50.40 126.23 20.48 50.46 127.00 20.75 10.07 80.73 -19.95 10.07 79.97 -19.61 coo 68.38 85.45 19.33 67.41 85.52 20.41 24.15 72.79 -61.03 23.03 71.90 -61.11 coo 65.50 91.13 17.77 64.65 89.88 18.00 25.53 70.37 -55.18 24.94 71.71 -55.64 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 B 151 VAL C 40 VAL^? 4.58 CH2 MLY C 107 B 194 GLY C 58 GLY^? 5.17 O MLY C 56 B 417 ILE A 74 ILE^? 5.97 C MLY A 72 B 457 ALA A 73 ALA^? 3.70 C MLY A 72 coo 52.95 126.71 13.21 51.34 125.24 13.19 17.19 86.28 -20.12 15.56 87.73 -20.27 coo 50.40 126.23 20.48 50.46 127.00 20.75 10.07 80.73 -19.95 10.07 79.97 -19.61 coo 68.38 85.45 19.33 67.41 85.52 20.41 25.21 66.80 -58.52 25.15 66.54 -59.96 coo 65.50 91.13 17.77 64.65 89.88 18.00 25.53 70.37 -55.18 24.94 71.71 -55.64 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 B 151 VAL C 40 VAL^? 4.58 CH2 MLY C 107 B 194 GLY C 58 GLY^? 5.17 O MLY C 56 B 417 ILE E 69 ILE^? 7.87 N MLY E 72 B 457 ALA E 73 ALA^? 3.67 C MLY E 72 coo 52.95 126.71 13.21 51.34 125.24 13.19 17.19 86.28 -20.12 15.56 87.73 -20.27 coo 50.40 126.23 20.48 50.46 127.00 20.75 10.07 80.73 -19.95 10.07 79.97 -19.61 coo 68.38 85.45 19.33 67.41 85.52 20.41 22.98 56.35 -54.27 21.87 56.06 -53.48 coo 65.50 91.13 17.77 64.65 89.88 18.00 24.59 60.71 -49.83 23.98 60.79 -51.22 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 B 151 VAL E 40 VAL^? 5.00 CD MLY E 107 B 194 GLY E 109 GLY^? 3.43 O MLY E 107 B 417 ILE C 26 ILE^? 5.40 N MLY B 117 B 457 ALA B 120 ALA^? 3.52 O MLY B 117 coo 52.95 126.71 13.21 51.34 125.24 13.19 13.38 41.42 -54.96 11.64 41.19 -53.58 coo 50.40 126.23 20.48 50.46 127.00 20.75 16.29 34.79 -50.75 16.46 35.35 -50.19 coo 68.38 85.45 19.33 67.41 85.52 20.41 27.62 67.36 -21.22 26.39 68.07 -20.90 coo 65.50 91.13 17.77 64.65 89.88 18.00 30.33 64.86 -28.19 30.42 65.65 -26.93 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 B 151 VAL E 64 VAL^? 2.99 C MLY E 63 B 194 GLY E 58 GLY^? 4.59 CB MLY E 63 B 417 ILE C 69 ILE^? 7.69 C3 GOL C2126 B 457 ALA C 73 ALA^? 3.70 C MLY C 72 coo 52.95 126.71 13.21 51.34 125.24 13.19 14.80 50.45 -66.66 16.03 48.75 -67.12 coo 50.40 126.23 20.48 50.46 127.00 20.75 6.58 51.10 -65.74 6.52 50.77 -64.99 coo 68.38 85.45 19.33 67.41 85.52 20.41 25.04 74.43 -32.80 23.99 75.27 -33.27 coo 65.50 91.13 17.77 64.65 89.88 18.00 26.69 73.30 -38.88 25.98 72.46 -37.78 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 B 151 VAL E 112 VAL^? 6.27 O MLY E 107 B 194 GLY E 114 GLY^? 4.51 CB MLY E 117 B 417 ILE D 69 ILE^? 7.77 N MLY D 72 B 457 ALA D 73 ALA^? 3.72 C MLY D 72 coo 52.95 126.71 13.21 51.34 125.24 13.19 20.47 39.84 -45.28 18.74 39.43 -44.04 coo 50.40 126.23 20.48 50.46 127.00 20.75 26.06 40.68 -46.38 25.43 41.13 -46.15 coo 68.38 85.45 19.33 67.41 85.52 20.41 25.21 84.25 -47.20 24.08 84.00 -48.00 coo 65.50 91.13 17.77 64.65 89.88 18.00 26.61 78.14 -48.04 26.03 78.99 -46.87 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 8 hits 1pix_c01 naa= 4 ULMN 4 1rk2_c00 RIBOKINASE user 1 4 # 1 A 252 ALA A 89 ALA^? 4.05 O1 PEG E4126 A 253 ALA A 82 ALA^? 6.93 O MLY A 104 A 254 GLY A 83 GLY^? 7.64 CG MLY A 107 A 255 ASP A 88 ASP^? 3.30 CG MLY A 107 coo 19.22 5.40 78.99 19.00 6.90 79.25 16.00 58.61 -71.58 17.49 58.35 -71.38 coo 22.30 4.08 77.15 23.28 3.04 77.64 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 20.04 2.01 74.92 19.93 2.78 75.17 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 16.76 5.52 75.75 15.62 4.24 76.95 14.06 59.10 -75.34 13.56 59.34 -77.37 ULMN 4 1rk2_c00 RIBOKINASE user 2 4 # 2 A 252 ALA C 89 ALA^? 6.02 N MLY C 107 A 253 ALA C 82 ALA^? 5.29 NZ MLY D 63 A 254 GLY C 83 GLY^? 6.95 NZ MLY D 63 A 255 ASP C 88 ASP^? 3.98 CA MLY C 107 coo 19.22 5.40 78.99 19.00 6.90 79.25 17.41 92.58 -31.86 18.92 92.61 -31.93 coo 22.30 4.08 77.15 23.28 3.04 77.64 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 20.04 2.01 74.92 19.93 2.78 75.17 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 16.76 5.52 75.75 15.62 4.24 76.95 14.72 94.17 -28.91 13.94 94.86 -27.07 1rk2_c00 source 1rk2 RIBOKINASE : 2 hits 1rk2_c00 naa= 4 ULMN 4 1rk2_c01 RIBOKINASE user 1 4 # 1 B 252 ALA A 89 ALA^? 4.05 O1 PEG E4126 B 253 ALA A 82 ALA^? 6.93 O MLY A 104 B 254 GLY A 83 GLY^? 7.64 CG MLY A 107 B 255 ASP A 88 ASP^? 3.30 CG MLY A 107 coo 5.65 0.71 109.93 4.85 1.99 109.63 16.00 58.61 -71.58 17.49 58.35 -71.38 coo 4.16 -2.29 111.77 4.09 -3.72 111.27 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 7.20 -2.36 114.01 6.78 -1.70 113.77 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 7.39 2.43 113.17 9.13 2.23 112.02 14.06 59.10 -75.34 13.56 59.34 -77.37 1rk2_c01 source 1rk2 RIBOKINASE : 1 hits 1rk2_c01 naa= 4 ULMN 4 1rk2_c02 RIBOKINASE user 1 4 # 1 C 252 ALA A 89 ALA^? 4.05 O1 PEG E4126 C 253 ALA A 82 ALA^? 6.93 O MLY A 104 C 254 GLY A 83 GLY^? 7.64 CG MLY A 107 C 255 ASP A 88 ASP^? 3.30 CG MLY A 107 coo 11.35 5.28 194.49 12.50 6.27 194.18 16.00 58.61 -71.58 17.49 58.35 -71.38 coo 8.26 6.36 196.43 6.81 6.31 195.96 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 8.52 3.23 198.55 9.13 3.73 198.31 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 13.27 3.50 197.59 13.27 1.76 196.39 14.06 59.10 -75.34 13.56 59.34 -77.37 ULMN 4 1rk2_c02 RIBOKINASE user 2 4 # 2 C 252 ALA C 89 ALA^? 6.02 N MLY C 107 C 253 ALA C 82 ALA^? 5.29 NZ MLY D 63 C 254 GLY C 83 GLY^? 6.95 NZ MLY D 63 C 255 ASP C 88 ASP^? 3.98 CA MLY C 107 coo 11.35 5.28 194.49 12.50 6.27 194.18 17.41 92.58 -31.86 18.92 92.61 -31.93 coo 8.26 6.36 196.43 6.81 6.31 195.96 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 8.52 3.23 198.55 9.13 3.73 198.31 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 13.27 3.50 197.59 13.27 1.76 196.39 14.72 94.17 -28.91 13.94 94.86 -27.07 1rk2_c02 source 1rk2 RIBOKINASE : 2 hits 1rk2_c02 naa= 4 ULMN 4 1rk2_c03 RIBOKINASE user 1 4 # 1 D 252 ALA A 89 ALA^? 4.05 O1 PEG E4126 D 253 ALA A 82 ALA^? 6.93 O MLY A 104 D 254 GLY A 83 GLY^? 7.64 CG MLY A 107 D 255 ASP A 88 ASP^? 3.30 CG MLY A 107 coo 15.44 -6.06 163.02 16.93 -5.92 163.28 16.00 58.61 -71.58 17.49 58.35 -71.38 coo 13.90 -8.94 161.04 12.81 -9.89 161.50 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 11.98 -6.40 159.00 12.77 -6.36 159.23 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 15.72 -3.40 159.93 14.56 -2.20 161.19 14.06 59.10 -75.34 13.56 59.34 -77.37 1rk2_c03 source 1rk2 RIBOKINASE : 1 hits 1rk2_c03 naa= 4 ULMN 4 1rne_c06 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 4 # 1 32 ASP C 86 ASP^? 3.69 CB MLY D 63 33 THR C 84 THR^? 8.12 NZ MLY D 62 215 ASP C 88 ASP^? 3.98 CA MLY C 107 218 ALA C 89 ALA^? 6.02 N MLY C 107 coo 11.85 17.24 72.81 11.09 15.37 72.36 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 8.33 16.80 75.95 6.64 18.11 76.07 8.84 98.53 -30.42 8.20 99.73 -28.75 coo 5.22 15.03 71.43 7.19 14.88 70.83 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 6.97 16.73 67.05 5.86 15.77 67.41 17.41 92.58 -31.86 18.92 92.61 -31.93 1rne_c06 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 1 hits 1rne_c06 naa= 4 ULMN 4 1sme_c08 PLASMEPSIN II user 1 4 # 1 A 34 ASP C 88 ASP^? 3.98 CA MLY C 107 A 35 THR C 81 THR^? 3.61 O MLY D 62 A 214 ASP C 86 ASP^? 3.69 CB MLY D 63 A 217 THR C 84 THR^? 8.12 NZ MLY D 62 coo 51.75 60.57 19.10 52.05 60.90 21.19 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 47.08 60.98 20.23 45.92 59.29 20.80 16.25 94.99 -35.24 16.65 96.87 -36.20 coo 48.59 58.89 25.78 50.13 59.74 24.61 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 52.57 55.68 25.62 52.26 56.53 27.63 8.84 98.53 -30.42 8.20 99.73 -28.75 1sme_c08 source 1sme PLASMEPSIN II : 1 hits 1sme_c08 naa= 4 ULMN 4 1sme_c09 PLASMEPSIN II user 1 4 # 1 B 34 ASP C 88 ASP^? 3.98 CA MLY C 107 B 35 THR C 81 THR^? 3.61 O MLY D 62 B 214 ASP C 86 ASP^? 3.69 CB MLY D 63 B 217 THR C 84 THR^? 8.12 NZ MLY D 62 coo 17.69 97.58 52.73 17.33 97.19 54.77 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 15.50 101.62 53.68 13.37 101.87 53.41 16.25 94.99 -35.24 16.65 96.87 -36.20 coo 12.41 98.71 58.47 14.37 98.17 58.05 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 12.08 94.10 57.29 12.50 94.74 59.28 8.84 98.53 -30.42 8.20 99.73 -28.75 1sme_c09 source 1sme PLASMEPSIN II : 1 hits 1sme_c09 naa= 4 ULMN 4 2apr_c06 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 4 # 1 35 ASP C 88 ASP^? 3.98 CA MLY C 107 36 THR C 81 THR^? 3.61 O MLY D 62 218 ASP C 86 ASP^? 3.69 CB MLY D 63 221 THR C 84 THR^? 8.12 NZ MLY D 62 coo 41.14 58.72 105.19 42.39 59.85 103.92 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 41.22 55.69 101.49 39.49 55.36 100.22 16.25 94.99 -35.24 16.65 96.87 -36.20 coo 41.33 60.20 97.63 42.00 60.96 99.49 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 39.43 64.47 99.56 41.07 64.93 98.18 8.84 98.53 -30.42 8.20 99.73 -28.75 2apr_c06 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 1 hits 2apr_c06 naa= 4 ULMN 4 2jxr_c06 LIGAND CP-081282 user 1 4 # 1 A 32 ASP C 88 ASP^? 3.98 CA MLY C 107 A 33 THR C 81 THR^? 3.61 O MLY D 62 A 215 ASP C 86 ASP^? 3.69 CB MLY D 63 A 218 THR C 84 THR^? 8.12 NZ MLY D 62 coo -14.00 61.45 43.99 -14.19 63.14 42.84 14.72 94.17 -28.91 13.94 94.86 -27.07 coo -9.45 62.69 43.21 -8.10 61.71 41.85 16.25 94.99 -35.24 16.65 96.87 -36.20 coo -10.72 64.19 37.77 -12.20 64.43 39.15 13.78 99.19 -34.67 12.49 98.36 -36.08 coo -15.15 62.13 36.13 -14.92 64.23 35.68 8.84 98.53 -30.42 8.20 99.73 -28.75 2jxr_c06 source 2jxr LIGAND CP-081282 : 1 hits 2jxr_c06 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 42 ASP^? 3.07 NZ MLY A 104 A 100 ARG A 41 ARG^? 6.93 CH1 MLY A 107 A 116 GLN A 57 GLN^? 5.22 O MLY A 56 coo 32.24 20.09 5.34 30.38 19.04 5.27 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 26.40 25.34 6.28 26.15 22.33 7.25 12.57 70.18 -72.86 9.93 70.06 -74.53 coo 26.74 21.94 13.78 27.57 20.97 12.08 13.11 78.06 -68.28 13.58 77.51 -66.25 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 100 ARG C 41 ARG^? 4.97 CH1 MLY C 104 A 116 GLN C 57 GLN^? 3.23 O MLY C 63 coo 32.24 20.09 5.34 30.38 19.04 5.27 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 26.40 25.34 6.28 26.15 22.33 7.25 13.30 82.18 -23.38 11.50 79.88 -24.41 coo 26.74 21.94 13.78 27.57 20.97 12.08 12.75 75.84 -21.85 11.93 73.88 -21.86 12as_c00 source 12as ASPARAGINE SYNTHETASE : 2 hits 12as_c00 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 50 ARG^? 6.59 CA MLY D 117 265 HIS A 67 HIS^? 6.87 CH2 MLY A 104 274 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo -15.18 55.46 8.55 -14.82 52.98 10.38 28.95 77.70 -62.89 29.34 80.69 -63.51 coo -14.48 45.59 11.18 -14.02 47.49 10.42 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 0.94 52.26 9.16 1.95 54.78 9.91 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG B 50 ARG^? 6.45 CA MLY E 117 265 HIS B 67 HIS^? -4.73 O3 GOL B1126s 274 TYR B 37 TYR^? 5.81 N MLY B 38 coo -15.18 55.46 8.55 -14.82 52.98 10.38 27.11 51.81 -37.88 27.02 48.95 -39.10 coo -14.48 45.59 11.18 -14.02 47.49 10.42 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 0.94 52.26 9.16 1.95 54.78 9.91 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG C 50 ARG^? 6.37 CA MLY B 117 265 HIS C 67 HIS^? -4.41 O3 GOL C2126s 274 TYR C 37 TYR^? 5.94 N MLY C 38 coo -15.18 55.46 8.55 -14.82 52.98 10.38 29.38 71.17 -28.15 29.46 68.99 -25.90 coo -14.48 45.59 11.18 -14.02 47.49 10.42 20.47 72.89 -29.97 19.97 72.66 -31.99 coo 0.94 52.26 9.16 1.95 54.78 9.91 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG D 41 ARG^? 6.40 CH1 MLY D 104 265 HIS D 67 HIS^? 7.34 O MLY C 92 274 TYR D 37 TYR^? 5.94 N MLY D 38 coo -15.18 55.46 8.55 -14.82 52.98 10.38 13.18 94.01 -50.58 11.63 94.04 -47.91 coo -14.48 45.59 11.18 -14.02 47.49 10.42 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 0.94 52.26 9.16 1.95 54.78 9.91 27.03 94.32 -56.77 29.28 93.30 -58.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG D 50 ARG^? 6.49 CA MLY C 117 265 HIS C 76 HIS^? 7.27 O MLY C 92 274 TYR D 37 TYR^? 5.94 N MLY D 38 coo -15.18 55.46 8.55 -14.82 52.98 10.38 29.95 87.67 -43.01 30.32 89.04 -40.28 coo -14.48 45.59 11.18 -14.02 47.49 10.42 22.40 81.23 -44.05 20.46 80.64 -44.59 coo 0.94 52.26 9.16 1.95 54.78 9.91 27.03 94.32 -56.77 29.28 93.30 -58.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 6 3 # 6 223 ARG D 50 ARG^? 6.49 CA MLY C 117 265 HIS D 67 HIS^? 7.34 O MLY C 92 274 TYR D 37 TYR^? 5.94 N MLY D 38 coo -15.18 55.46 8.55 -14.82 52.98 10.38 29.95 87.67 -43.01 30.32 89.04 -40.28 coo -14.48 45.59 11.18 -14.02 47.49 10.42 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 0.94 52.26 9.16 1.95 54.78 9.91 27.03 94.32 -56.77 29.28 93.30 -58.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 7 3 # 7 223 ARG E 41 ARG^? 3.76 O MLY E 56 265 HIS E 67 HIS^? 7.33 CH2 MLY E 104 274 TYR E 37 TYR^? 5.92 N MLY E 38 coo -15.18 55.46 8.55 -14.82 52.98 10.38 10.72 46.92 -56.99 8.84 48.23 -59.04 coo -14.48 45.59 11.18 -14.02 47.49 10.42 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 0.94 52.26 9.16 1.95 54.78 9.91 24.28 42.38 -52.54 26.48 42.21 -50.85 ULMN 3 1a41_c01 TOPOISOMERASE I user 8 3 # 8 223 ARG E 50 ARG^? 6.44 CA MLY A 117 265 HIS E 67 HIS^? 7.33 CH2 MLY E 104 274 TYR E 37 TYR^? 5.92 N MLY E 38 coo -15.18 55.46 8.55 -14.82 52.98 10.38 27.70 55.94 -59.52 28.04 56.21 -62.59 coo -14.48 45.59 11.18 -14.02 47.49 10.42 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 0.94 52.26 9.16 1.95 54.78 9.91 24.28 42.38 -52.54 26.48 42.21 -50.85 1a41_c01 source 1a41 TOPOISOMERASE I : 8 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 13 GLU.? 5.36 C1 GOL A 127s A 60 ASP A 5 ASP~? 10.39 CH1 MLY A 117 A 175 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 46.10 28.27 19.27 45.48 26.99 20.84 30.21 69.38 -81.53 31.47 68.83 -83.15 coo 56.42 28.06 12.93 55.01 27.92 14.50 30.98 56.12 -81.35 30.72 54.26 -80.37 coo 45.02 22.04 15.38 46.16 24.00 13.76 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 80 GLU^? 4.05 CH2 MLY A 92 A 60 ASP E 42 ASP^? 3.02 NZ MLY E 104 A 175 TYR E 66 TYR^? -3.37 C3 PEG E4126s coo 46.10 28.27 19.27 45.48 26.99 20.84 13.22 55.53 -66.00 11.94 55.88 -64.34 coo 56.42 28.06 12.93 55.01 27.92 14.50 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 45.02 22.04 15.38 46.16 24.00 13.76 20.78 52.34 -65.13 20.44 50.34 -67.07 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 80 GLU^? 3.91 CD MLY C 63 A 60 ASP B 88 ASP^? 3.13 NZ MLY B 107 A 175 TYR C 66 TYR^? 7.67 C MLY C 63 coo 46.10 28.27 19.27 45.48 26.99 20.84 14.10 69.89 -23.30 12.25 70.25 -24.24 coo 56.42 28.06 12.93 55.01 27.92 14.50 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 45.02 22.04 15.38 46.16 24.00 13.76 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU B 80 GLU^? 3.91 CD MLY C 63 A 60 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 175 TYR C 66 TYR^? 7.67 C MLY C 63 coo 46.10 28.27 19.27 45.48 26.99 20.84 14.10 69.89 -23.30 12.25 70.25 -24.24 coo 56.42 28.06 12.93 55.01 27.92 14.50 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 45.02 22.04 15.38 46.16 24.00 13.76 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU D 80 GLU^? 4.08 CH1 MLY D 92 A 60 ASP A 42 ASP^? 3.07 NZ MLY A 104 A 175 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 46.10 28.27 19.27 45.48 26.99 20.84 15.29 82.50 -64.93 13.31 81.80 -64.63 coo 56.42 28.06 12.93 55.01 27.92 14.50 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 45.02 22.04 15.38 46.16 24.00 13.76 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU D 80 GLU^? 4.08 CH1 MLY D 92 A 60 ASP D 88 ASP^? 3.08 NZ MLY D 107 A 175 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 46.10 28.27 19.27 45.48 26.99 20.84 15.29 82.50 -64.93 13.31 81.80 -64.63 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.64 92.96 -63.76 13.01 94.95 -63.51 coo 45.02 22.04 15.38 46.16 24.00 13.76 22.17 81.84 -68.52 22.05 83.01 -71.05 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 6 hits 1a50_c03 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 50 ARG^? 6.59 CA MLY D 117 78 HIS A 67 HIS^? 6.87 CH2 MLY A 104 122 TYR E 66 TYR^? -3.37 C3 PEG E4126s coo 48.32 72.26 30.89 48.69 69.28 31.53 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 53.63 68.24 34.99 53.08 69.10 33.16 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 75.01 61.87 32.93 75.34 59.26 31.96 20.78 52.34 -65.13 20.44 50.34 -67.07 1ab4_c00 source 1ab4 GYRASE A : 1 hits 1ab4_c00 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 30 ASN.? 5.83 CH1 MLY A 49 63 ARG D 121 ARG^? 4.29 CG MLY D 117 255 ARG A 50 ARG^? 6.59 CA MLY D 117 coo 42.10 13.02 11.14 41.85 11.12 10.23 40.27 80.58 -61.87 41.65 82.00 -61.12 coo 44.36 11.24 3.39 41.81 12.78 4.00 36.09 87.23 -59.47 34.81 89.98 -60.22 coo 38.40 3.83 10.26 40.02 6.30 9.25 28.95 77.70 -62.89 29.34 80.69 -63.51 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN B 30 ASN^? 4.18 CH2 MLY B 49 63 ARG E 121 ARG^? 4.47 O MLY E 117 255 ARG B 50 ARG^? 6.45 CA MLY E 117 coo 42.10 13.02 11.14 41.85 11.12 10.23 37.76 48.70 -41.25 36.04 49.71 -42.04 coo 44.36 11.24 3.39 41.81 12.78 4.00 33.54 46.74 -47.77 31.94 44.02 -47.62 coo 38.40 3.83 10.26 40.02 6.30 9.25 27.11 51.81 -37.88 27.02 48.95 -39.10 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 2 hits 1aj0_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP D 86 ASP^? 8.22 CH1 MLY A 63 214 ASP D 15 ASP^? 3.63 N MLY D 18 289 ASP D 88 ASP^? 3.08 NZ MLY D 107 coo -0.62 65.95 29.97 0.31 67.47 31.05 6.01 94.81 -68.58 5.43 92.90 -69.25 coo 26.86 59.76 46.36 25.42 58.23 45.92 30.53 104.92 -50.08 32.32 105.80 -49.34 coo 9.42 68.07 30.27 7.35 68.27 30.10 13.64 92.96 -63.76 13.01 94.95 -63.51 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP C 42 ASP^? 3.04 NZ MLY C 104 227 GLU C 80 GLU^? 4.30 CE MLY D 63 289 ASP C 111 ASP^? 8.04 N MLY C 117 coo -0.62 65.95 29.97 0.31 67.47 31.05 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 3.96 55.76 41.24 4.83 57.69 41.17 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.96 91.49 -25.34 28.70 92.35 -26.18 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP C 111 ASP^? 8.04 N MLY C 117 227 GLU C 80 GLU^? 4.30 CE MLY D 63 289 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.96 91.49 -25.34 28.70 92.35 -26.18 coo 3.96 55.76 41.24 4.83 57.69 41.17 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 19.26 82.21 -24.59 17.46 81.65 -25.59 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP C 55 ASP^? 3.93 N MLY C 56 E 36 SER C 65 SER^? 5.92 CH2 MLY C 104 E 213 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo 26.30 12.96 16.78 25.46 12.99 18.72 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 28.33 15.15 21.27 28.70 13.12 19.97 17.46 72.45 -23.42 17.18 72.60 -25.76 coo 20.15 16.04 19.79 21.65 14.49 19.86 19.26 82.21 -24.59 17.46 81.65 -25.59 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 1 hits 1apt_c04 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 96 SER^? 5.92 O MLY A 72 A 292 ASP A 55 ASP^? 3.55 CH2 MLY A 104 A 322 HIS E 76 HIS^? -4.59 O1 GOL B1126s coo 36.34 32.23 39.60 36.43 34.62 39.93 21.16 70.03 -52.65 22.56 70.77 -50.83 coo 19.73 19.18 41.39 21.50 18.65 40.34 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 41.69 45.14 46.60 41.78 47.19 46.18 19.53 58.10 -41.26 17.57 58.86 -41.26 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 96 SER^? 5.92 O MLY A 72 A 292 ASP E 55 ASP^? 3.37 N MLY E 56 A 322 HIS C 76 HIS^? 7.27 O MLY C 92 coo 36.34 32.23 39.60 36.43 34.62 39.93 21.16 70.03 -52.65 22.56 70.77 -50.83 coo 19.73 19.18 41.39 21.50 18.65 40.34 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 41.69 45.14 46.60 41.78 47.19 46.18 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 68 SER^? 8.39 O MLY E 92 A 292 ASP B 15 ASP^? 3.54 CB MLY B 18 A 322 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 36.34 32.23 39.60 36.43 34.62 39.93 22.79 53.21 -37.95 23.70 50.99 -38.49 coo 19.73 19.18 41.39 21.50 18.65 40.34 27.82 41.92 -21.37 29.40 40.51 -21.49 coo 41.69 45.14 46.60 41.78 47.19 46.18 10.43 63.28 -44.90 9.66 63.00 -42.97 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER B 68 SER^? 8.39 O MLY E 92 A 292 ASP E 42 ASP^? 3.02 NZ MLY E 104 A 322 HIS B 76 HIS^? -4.78 C3 GOL C2126s coo 36.34 32.23 39.60 36.43 34.62 39.93 22.79 53.21 -37.95 23.70 50.99 -38.49 coo 19.73 19.18 41.39 21.50 18.65 40.34 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 22.13 70.54 -35.03 20.24 71.08 -35.76 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 96 SER^? 5.90 O MLY B 72 A 292 ASP B 42 ASP^? 3.93 N MLY B 56 A 322 HIS C 76 HIS^? 7.27 O MLY C 92 coo 36.34 32.23 39.60 36.43 34.62 39.93 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 19.73 19.18 41.39 21.50 18.65 40.34 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 41.69 45.14 46.60 41.78 47.19 46.18 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 96 SER^? 5.90 O MLY B 72 A 292 ASP B 42 ASP^? 3.93 N MLY B 56 A 322 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 36.34 32.23 39.60 36.43 34.62 39.93 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 19.73 19.18 41.39 21.50 18.65 40.34 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 41.69 45.14 46.60 41.78 47.19 46.18 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 96 SER^? 5.90 O MLY B 72 A 292 ASP B 55 ASP^? 2.74 NZ MLY B 104 A 322 HIS C 76 HIS^? 7.27 O MLY C 92 coo 36.34 32.23 39.60 36.43 34.62 39.93 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 19.73 19.18 41.39 21.50 18.65 40.34 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 41.69 45.14 46.60 41.78 47.19 46.18 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER B 96 SER^? 5.90 O MLY B 72 A 292 ASP C 55 ASP^? 3.93 N MLY C 56 A 322 HIS D 76 HIS^? 7.07 O MLY D 92 coo 36.34 32.23 39.60 36.43 34.62 39.93 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 19.73 19.18 41.39 21.50 18.65 40.34 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 41.69 45.14 46.60 41.78 47.19 46.18 21.19 75.42 -56.78 19.17 75.05 -56.40 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER C 96 SER^? 5.54 O MLY C 72 A 292 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 322 HIS D 76 HIS^? 7.07 O MLY D 92 coo 36.34 32.23 39.60 36.43 34.62 39.93 22.75 72.50 -41.71 24.26 71.19 -43.03 coo 19.73 19.18 41.39 21.50 18.65 40.34 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 41.69 45.14 46.60 41.78 47.19 46.18 21.19 75.42 -56.78 19.17 75.05 -56.40 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER D 96 SER^? 5.96 O MLY D 72 A 292 ASP D 55 ASP^? 3.95 N MLY D 56 A 322 HIS A 76 HIS^? 7.10 O MLY A 92 coo 36.34 32.23 39.60 36.43 34.62 39.93 22.18 75.94 -47.53 23.49 74.14 -46.77 coo 19.73 19.18 41.39 21.50 18.65 40.34 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 41.69 45.14 46.60 41.78 47.19 46.18 20.27 61.30 -55.15 18.31 61.65 -54.51 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER E 68 SER^? 8.34 C MLY E 49 A 292 ASP E 15 ASP^? 3.80 N MLY E 18 A 322 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 36.34 32.23 39.60 36.43 34.62 39.93 23.32 56.54 -58.94 24.53 56.34 -61.01 coo 19.73 19.18 41.39 21.50 18.65 40.34 27.54 37.14 -63.49 29.27 36.92 -64.69 coo 41.69 45.14 46.60 41.78 47.19 46.18 11.74 66.03 -51.26 10.97 64.13 -50.86 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 11 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 96 SER^? 5.92 O MLY A 72 B 292 ASP E 55 ASP^? 3.37 N MLY E 56 B 322 HIS C 76 HIS^? 7.27 O MLY C 92 coo 35.42 71.28 22.94 36.24 69.06 22.37 21.16 70.03 -52.65 22.56 70.77 -50.83 coo 24.74 78.07 5.59 24.32 79.03 7.46 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 48.81 64.16 26.34 49.30 62.16 26.73 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 68 SER^? 8.39 O MLY E 92 B 292 ASP B 15 ASP^? 3.54 CB MLY B 18 B 322 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 35.42 71.28 22.94 36.24 69.06 22.37 22.79 53.21 -37.95 23.70 50.99 -38.49 coo 24.74 78.07 5.59 24.32 79.03 7.46 27.82 41.92 -21.37 29.40 40.51 -21.49 coo 48.81 64.16 26.34 49.30 62.16 26.73 10.43 63.28 -44.90 9.66 63.00 -42.97 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 96 SER^? 5.90 O MLY B 72 B 292 ASP B 42 ASP^? 3.93 N MLY B 56 B 322 HIS C 76 HIS^? 7.27 O MLY C 92 coo 35.42 71.28 22.94 36.24 69.06 22.37 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 24.74 78.07 5.59 24.32 79.03 7.46 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 48.81 64.16 26.34 49.30 62.16 26.73 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER B 96 SER^? 5.90 O MLY B 72 B 292 ASP B 42 ASP^? 3.93 N MLY B 56 B 322 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 35.42 71.28 22.94 36.24 69.06 22.37 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 24.74 78.07 5.59 24.32 79.03 7.46 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 48.81 64.16 26.34 49.30 62.16 26.73 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER B 96 SER^? 5.90 O MLY B 72 B 292 ASP B 55 ASP^? 2.74 NZ MLY B 104 B 322 HIS C 76 HIS^? 7.27 O MLY C 92 coo 35.42 71.28 22.94 36.24 69.06 22.37 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 24.74 78.07 5.59 24.32 79.03 7.46 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 48.81 64.16 26.34 49.30 62.16 26.73 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER B 96 SER^? 5.90 O MLY B 72 B 292 ASP B 55 ASP^? 2.74 NZ MLY B 104 B 322 HIS D 76 HIS^? 7.07 O MLY D 92 coo 35.42 71.28 22.94 36.24 69.06 22.37 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 24.74 78.07 5.59 24.32 79.03 7.46 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 48.81 64.16 26.34 49.30 62.16 26.73 21.19 75.42 -56.78 19.17 75.05 -56.40 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER B 96 SER^? 5.90 O MLY B 72 B 292 ASP C 55 ASP^? 3.93 N MLY C 56 B 322 HIS D 76 HIS^? 7.07 O MLY D 92 coo 35.42 71.28 22.94 36.24 69.06 22.37 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 24.74 78.07 5.59 24.32 79.03 7.46 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 48.81 64.16 26.34 49.30 62.16 26.73 21.19 75.42 -56.78 19.17 75.05 -56.40 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER C 96 SER^? 5.54 O MLY C 72 B 292 ASP C 42 ASP^? 3.04 NZ MLY C 104 B 322 HIS D 76 HIS^? 7.07 O MLY D 92 coo 35.42 71.28 22.94 36.24 69.06 22.37 22.75 72.50 -41.71 24.26 71.19 -43.03 coo 24.74 78.07 5.59 24.32 79.03 7.46 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 48.81 64.16 26.34 49.30 62.16 26.73 21.19 75.42 -56.78 19.17 75.05 -56.40 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER E 68 SER^? 8.34 C MLY E 49 B 292 ASP E 15 ASP^? 3.80 N MLY E 18 B 322 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 35.42 71.28 22.94 36.24 69.06 22.37 23.32 56.54 -58.94 24.53 56.34 -61.01 coo 24.74 78.07 5.59 24.32 79.03 7.46 27.54 37.14 -63.49 29.27 36.92 -64.69 coo 48.81 64.16 26.34 49.30 62.16 26.73 11.74 66.03 -51.26 10.97 64.13 -50.86 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER E 96 SER^? 5.86 O MLY E 72 B 292 ASP B 55 ASP^? 2.74 NZ MLY B 104 B 322 HIS D 76 HIS^? 7.07 O MLY D 92 coo 35.42 71.28 22.94 36.24 69.06 22.37 20.41 63.14 -48.27 21.90 65.05 -48.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 48.81 64.16 26.34 49.30 62.16 26.73 21.19 75.42 -56.78 19.17 75.05 -56.40 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 10 hits 1aql_c03 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS C 99 HIS^? 9.14 O1 GOL C2126 A 58 GLU C 100 GLU^? -7.78 O1 GOL C2126s A 92 HIS C 76 HIS^? 7.27 O MLY C 92 coo 12.70 27.74 1.76 10.77 27.11 1.24 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 11.38 23.30 3.20 9.27 23.34 3.13 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 2.67 19.36 1.56 3.51 21.24 1.94 22.40 81.23 -44.05 20.46 80.64 -44.59 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 1 hits 1b2m_c00 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 108 ARG^? 7.18 O1 PEG E4126 A 141 THR A 81 THR^? 4.00 CA MLY E 63 A 235 ASP A 5 ASP~? 10.39 CH1 MLY A 117 coo 6.21 93.81 36.58 4.58 96.33 37.17 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 6.80 92.87 28.33 4.91 92.74 27.40 14.15 54.67 -70.12 13.73 52.73 -70.95 coo 12.98 90.36 47.57 11.26 89.62 46.62 30.98 56.12 -81.35 30.72 54.26 -80.37 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG C 41 ARG^? 4.97 CH1 MLY C 104 A 141 THR C 60 THR^? 5.68 CH2 MLY C 62 A 235 ASP C 88 ASP^? 3.98 CA MLY C 107 coo 6.21 93.81 36.58 4.58 96.33 37.17 13.30 82.18 -23.38 11.50 79.88 -24.41 coo 6.80 92.87 28.33 4.91 92.74 27.40 5.79 77.67 -18.09 4.47 78.14 -19.74 coo 12.98 90.36 47.57 11.26 89.62 46.62 14.72 94.17 -28.91 13.94 94.86 -27.07 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG D 108 ARG^? -4.43 O2 GOL D3126s A 141 THR D 84 THR^? -5.34 CD MLY A 62s A 235 ASP D 111 ASP^? 7.67 CB MLY D 117 coo 6.21 93.81 36.58 4.58 96.33 37.17 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 6.80 92.87 28.33 4.91 92.74 27.40 9.43 90.94 -72.09 7.63 90.02 -71.36 coo 12.98 90.36 47.57 11.26 89.62 46.62 27.01 96.00 -62.25 28.81 95.13 -62.96 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 108 ARG^? 7.18 O1 PEG E4126 D 141 THR A 81 THR^? 4.00 CA MLY E 63 D 235 ASP A 5 ASP~? 10.39 CH1 MLY A 117 coo -8.33 92.80 100.06 -7.71 95.33 98.44 18.06 54.88 -79.10 18.03 52.11 -77.78 coo -9.24 93.49 108.77 -7.37 94.21 109.61 14.15 54.67 -70.12 13.73 52.73 -70.95 coo -14.64 87.74 89.51 -12.89 87.43 90.65 30.98 56.12 -81.35 30.72 54.26 -80.37 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG C 41 ARG^? 4.97 CH1 MLY C 104 D 141 THR C 60 THR^? 5.68 CH2 MLY C 62 D 235 ASP C 88 ASP^? 3.98 CA MLY C 107 coo -8.33 92.80 100.06 -7.71 95.33 98.44 13.30 82.18 -23.38 11.50 79.88 -24.41 coo -9.24 93.49 108.77 -7.37 94.21 109.61 5.79 77.67 -18.09 4.47 78.14 -19.74 coo -14.64 87.74 89.51 -12.89 87.43 90.65 14.72 94.17 -28.91 13.94 94.86 -27.07 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG C 108 ARG^? 8.73 C MLY C 107 D 141 THR C 84 THR^? 8.12 NZ MLY D 62 D 235 ASP C 111 ASP^? 8.04 N MLY C 117 coo -8.33 92.80 100.06 -7.71 95.33 98.44 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -9.24 93.49 108.77 -7.37 94.21 109.61 8.84 98.53 -30.42 8.20 99.73 -28.75 coo -14.64 87.74 89.51 -12.89 87.43 90.65 26.96 91.49 -25.34 28.70 92.35 -26.18 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG D 108 ARG^? -4.43 O2 GOL D3126s D 141 THR D 84 THR^? -5.34 CD MLY A 62s D 235 ASP D 111 ASP^? 7.67 CB MLY D 117 coo -8.33 92.80 100.06 -7.71 95.33 98.44 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -9.24 93.49 108.77 -7.37 94.21 109.61 9.43 90.94 -72.09 7.63 90.02 -71.36 coo -14.64 87.74 89.51 -12.89 87.43 90.65 27.01 96.00 -62.25 28.81 95.13 -62.96 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 108 ARG^? 7.18 O1 PEG E4126 C 141 THR A 81 THR^? 4.00 CA MLY E 63 C 235 ASP A 5 ASP~? 10.39 CH1 MLY A 117 coo -5.79 67.26 36.83 -4.57 64.58 37.74 18.06 54.88 -79.10 18.03 52.11 -77.78 coo -6.81 68.31 28.28 -4.82 68.47 27.57 14.15 54.67 -70.12 13.73 52.73 -70.95 coo -13.01 70.96 47.58 -11.44 71.65 46.34 30.98 56.12 -81.35 30.72 54.26 -80.37 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG C 41 ARG^? 4.97 CH1 MLY C 104 C 141 THR C 60 THR^? 5.68 CH2 MLY C 62 C 235 ASP C 88 ASP^? 3.98 CA MLY C 107 coo -5.79 67.26 36.83 -4.57 64.58 37.74 13.30 82.18 -23.38 11.50 79.88 -24.41 coo -6.81 68.31 28.28 -4.82 68.47 27.57 5.79 77.67 -18.09 4.47 78.14 -19.74 coo -13.01 70.96 47.58 -11.44 71.65 46.34 14.72 94.17 -28.91 13.94 94.86 -27.07 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG C 108 ARG^? 8.73 C MLY C 107 C 141 THR C 84 THR^? 8.12 NZ MLY D 62 C 235 ASP C 111 ASP^? 8.04 N MLY C 117 coo -5.79 67.26 36.83 -4.57 64.58 37.74 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -6.81 68.31 28.28 -4.82 68.47 27.57 8.84 98.53 -30.42 8.20 99.73 -28.75 coo -13.01 70.96 47.58 -11.44 71.65 46.34 26.96 91.49 -25.34 28.70 92.35 -26.18 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG D 108 ARG^? -4.43 O2 GOL D3126s C 141 THR D 84 THR^? -5.34 CD MLY A 62s C 235 ASP D 111 ASP^? 7.67 CB MLY D 117 coo -5.79 67.26 36.83 -4.57 64.58 37.74 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -6.81 68.31 28.28 -4.82 68.47 27.57 9.43 90.94 -72.09 7.63 90.02 -71.36 coo -13.01 70.96 47.58 -11.44 71.65 46.34 27.01 96.00 -62.25 28.81 95.13 -62.96 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 108 ARG^? 7.18 O1 PEG E4126 B 141 THR A 81 THR^? 4.00 CA MLY E 63 B 235 ASP A 5 ASP~? 10.39 CH1 MLY A 117 coo 8.13 67.41 100.27 7.18 68.35 97.45 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 8.28 67.78 108.81 6.22 67.65 109.43 14.15 54.67 -70.12 13.73 52.73 -70.95 coo 14.55 73.52 89.47 12.81 73.95 90.56 30.98 56.12 -81.35 30.72 54.26 -80.37 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG C 41 ARG^? 4.97 CH1 MLY C 104 B 141 THR C 60 THR^? 5.68 CH2 MLY C 62 B 235 ASP C 88 ASP^? 3.98 CA MLY C 107 coo 8.13 67.41 100.27 7.18 68.35 97.45 13.30 82.18 -23.38 11.50 79.88 -24.41 coo 8.28 67.78 108.81 6.22 67.65 109.43 5.79 77.67 -18.09 4.47 78.14 -19.74 coo 14.55 73.52 89.47 12.81 73.95 90.56 14.72 94.17 -28.91 13.94 94.86 -27.07 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG D 108 ARG^? -4.43 O2 GOL D3126s B 141 THR D 84 THR^? -5.34 CD MLY A 62s B 235 ASP D 111 ASP^? 7.67 CB MLY D 117 coo 8.13 67.41 100.27 7.18 68.35 97.45 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 8.28 67.78 108.81 6.22 67.65 109.43 9.43 90.94 -72.09 7.63 90.02 -71.36 coo 14.55 73.52 89.47 12.81 73.95 90.56 27.01 96.00 -62.25 28.81 95.13 -62.96 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP B 55 ASP^? 2.74 NZ MLY B 104 16 HIS B 67 HIS^? -4.73 O3 GOL B1126s 67 GLY E 114 GLY^? 4.51 CB MLY E 117 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 14.45 50.68 -30.88 15.66 52.47 -30.45 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 26.06 40.68 -46.38 25.43 41.13 -46.15 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP D 55 ASP^? 3.95 N MLY D 56 16 HIS D 67 HIS^? 7.34 O MLY C 92 67 GLY D 114 GLY^? 4.53 N MLY D 117 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 29.18 91.87 -63.07 28.51 91.45 -62.96 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP E 55 ASP^? 3.37 N MLY E 56 16 HIS E 67 HIS^? 7.33 CH2 MLY E 104 67 GLY A 114 GLY^? 4.48 CB MLY A 117 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 14.69 49.71 -60.49 12.90 49.11 -59.47 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 28.45 60.20 -72.87 27.74 60.23 -72.48 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP E 55 ASP^? 3.37 N MLY E 56 16 HIS E 67 HIS^? 7.33 CH2 MLY E 104 67 GLY E 17 GLY^? 2.44 N MLY E 18 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 14.69 49.71 -60.49 12.90 49.11 -59.47 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 31.59 40.27 -65.70 30.82 40.45 -65.54 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP E 55 ASP^? 3.37 N MLY E 56 16 HIS E 67 HIS^? 7.33 CH2 MLY E 104 67 GLY E 114 GLY^? 4.51 CB MLY E 117 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 14.69 49.71 -60.49 12.90 49.11 -59.47 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 26.06 40.68 -46.38 25.43 41.13 -46.15 1be1_c02 source 1be1 GLUTAMATE MUTASE : 5 hits 1be1_c02 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 41 ARG^? 6.93 CH1 MLY A 107 A 451 GLU A 90 GLU^? 4.57 CE MLY A 92 A 540 GLU A 105 GLU^? 3.91 CD MLY A 107 coo 79.04 80.20 80.81 79.58 81.40 83.63 12.57 70.18 -72.86 9.93 70.06 -74.53 coo 81.34 87.29 87.22 82.36 86.09 88.61 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 79.94 80.46 88.84 81.11 81.36 87.27 13.30 64.14 -73.44 11.76 64.88 -74.71 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 41 ARG^? 6.93 CH1 MLY A 107 B 451 GLU A 90 GLU^? 4.57 CE MLY A 92 B 540 GLU A 105 GLU^? 3.91 CD MLY A 107 coo 82.21 41.07 119.14 83.95 40.66 116.59 12.57 70.18 -72.86 9.93 70.06 -74.53 coo 86.52 35.28 112.74 87.08 36.38 110.99 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 83.38 41.19 112.55 85.47 40.59 112.72 13.30 64.14 -73.44 11.76 64.88 -74.71 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 50 ARG^? 6.59 CA MLY D 117 B 451 GLU A 32 GLU.? 8.63 N MLY A 49 B 540 GLU A 31 GLU.? 4.36 CB MLY A 49 coo 82.21 41.07 119.14 83.95 40.66 116.59 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 86.52 35.28 112.74 87.08 36.38 110.99 38.81 75.22 -68.09 40.53 74.26 -68.89 coo 83.38 41.19 112.55 85.47 40.59 112.72 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG E 50 ARG^? 6.44 CA MLY A 117 B 451 GLU E 32 GLU^? 9.00 N MLY E 49 B 540 GLU E 31 GLU^? 4.40 CB MLY E 49 coo 82.21 41.07 119.14 83.95 40.66 116.59 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 86.52 35.28 112.74 87.08 36.38 110.99 36.93 48.99 -59.01 38.56 47.63 -58.62 coo 83.38 41.19 112.55 85.47 40.59 112.72 33.05 53.64 -60.92 31.27 54.73 -61.16 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c05 naa= 3 ULMN 3 1bol_c00 RIBONUCLEASE RH user 1 3 # 1 A 46 HIS A 99 HIS^? 11.42 NZ MLY A 92 A 105 GLU E 100 GLU^? 7.50 CH1 MLY E 92 A 109 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 43.60 31.12 0.44 42.42 31.86 -1.18 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 10.43 63.28 -44.90 9.66 63.00 -42.97 ULMN 3 1bol_c00 RIBONUCLEASE RH user 2 3 # 2 A 46 HIS E 99 HIS^? 5.87 C1 GOL B1126 A 105 GLU E 100 GLU^? 7.50 CH1 MLY E 92 A 109 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 43.60 31.12 0.44 42.42 31.86 -1.18 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 11.74 66.03 -51.26 10.97 64.13 -50.86 1bol_c00 source 1bol RIBONUCLEASE RH : 2 hits 1bol_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 41 ARG^? 6.93 CH1 MLY A 107 A 128 GLU A 90 GLU^? 4.57 CE MLY A 92 A 225 GLU A 105 GLU^? 3.91 CD MLY A 107 coo 38.56 19.11 14.83 37.12 21.00 16.76 12.57 70.18 -72.86 9.93 70.06 -74.53 coo 36.48 24.43 22.02 36.86 26.34 21.13 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 40.16 23.71 17.01 38.52 24.96 17.40 13.30 64.14 -73.44 11.76 64.88 -74.71 1bqc_c01 source 1bqc BETA-MANNANASE : 1 hits 1bqc_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 78 GLN^? 4.04 CH2 MLY A 92 A 91 LEU A 91 LEU^? 3.58 N MLY A 92 A 133 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 43.58 43.67 66.73 42.32 42.78 68.15 17.04 57.32 -61.85 15.23 57.01 -60.79 coo 38.58 45.09 70.44 38.28 45.21 72.59 18.78 63.20 -66.95 20.66 63.77 -66.00 coo 44.05 36.87 70.65 43.15 38.64 69.97 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 78 GLN^? 4.04 CH2 MLY A 92 A 91 LEU E 53 LEU^? 5.01 CH2 MLY E 104 A 133 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 43.58 43.67 66.73 42.32 42.78 68.15 17.04 57.32 -61.85 15.23 57.01 -60.79 coo 38.58 45.09 70.44 38.28 45.21 72.59 19.19 51.40 -57.25 19.45 51.43 -55.09 coo 44.05 36.87 70.65 43.15 38.64 69.97 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 98 GLN^? 8.94 CH2 MLY D 92 A 91 LEU A 102 LEU^? 4.62 CE MLY A 104 A 133 GLU A 100 GLU^? 8.29 NZ MLY A 92 coo 43.58 43.67 66.73 42.32 42.78 68.15 16.33 72.22 -55.12 14.93 73.71 -54.65 coo 38.58 45.09 70.44 38.28 45.21 72.59 16.70 69.27 -62.41 17.14 71.36 -62.38 coo 44.05 36.87 70.65 43.15 38.64 69.97 9.74 67.82 -56.04 9.26 65.81 -55.60 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 78 GLN^? 4.59 CD MLY B 92 A 91 LEU B 91 LEU^? 3.51 N MLY B 92 A 133 GLU B 80 GLU^? 3.91 CD MLY C 63 coo 43.58 43.67 66.73 42.32 42.78 68.15 18.44 69.85 -27.48 16.82 70.99 -28.18 coo 38.58 45.09 70.44 38.28 45.21 72.59 18.35 62.12 -27.27 20.33 61.96 -28.11 coo 44.05 36.87 70.65 43.15 38.64 69.97 14.10 69.89 -23.30 12.25 70.25 -24.24 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 78 GLN^? 4.59 CD MLY B 92 A 91 LEU C 53 LEU^? 4.82 CE MLY C 104 A 133 GLU B 80 GLU^? 3.91 CD MLY C 63 coo 43.58 43.67 66.73 42.32 42.78 68.15 18.44 69.85 -27.48 16.82 70.99 -28.18 coo 38.58 45.09 70.44 38.28 45.21 72.59 22.19 77.26 -27.92 21.25 79.12 -28.44 coo 44.05 36.87 70.65 43.15 38.64 69.97 14.10 69.89 -23.30 12.25 70.25 -24.24 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN C 98 GLN^? -3.27 O2 GOL C2126s A 91 LEU C 102 LEU^? -4.12 C1 GOL C2126s A 133 GLU C 100 GLU^? -7.78 O1 GOL C2126s coo 43.58 43.67 66.73 42.32 42.78 68.15 17.44 72.80 -39.41 16.11 71.18 -39.17 coo 38.58 45.09 70.44 38.28 45.21 72.59 17.90 78.41 -34.22 18.01 77.13 -32.55 coo 44.05 36.87 70.65 43.15 38.64 69.97 11.61 77.43 -41.88 9.59 77.35 -41.33 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN D 98 GLN^? 7.57 CH2 MLY D 104 A 91 LEU D 102 LEU^? 4.45 CH2 MLY D 104 A 133 GLU D 100 GLU^? 8.65 CH2 MLY D 92 coo 43.58 43.67 66.73 42.32 42.78 68.15 16.59 80.12 -46.90 17.21 82.12 -47.27 coo 38.58 45.09 70.44 38.28 45.21 72.59 18.13 85.04 -51.90 18.99 85.25 -49.89 coo 44.05 36.87 70.65 43.15 38.64 69.97 11.08 79.64 -49.38 10.05 78.59 -50.94 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 78 GLN^? 4.04 CH2 MLY A 92 B 591 LEU A 91 LEU^? 3.58 N MLY A 92 B 633 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 88.06 44.34 57.19 89.06 45.53 55.74 17.04 57.32 -61.85 15.23 57.01 -60.79 coo 86.70 48.66 52.61 87.15 48.69 50.51 18.78 63.20 -66.95 20.66 63.77 -66.00 coo 95.42 44.52 54.43 93.46 45.31 54.70 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 78 GLN^? 4.04 CH2 MLY A 92 B 591 LEU E 53 LEU^? 5.01 CH2 MLY E 104 B 633 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 88.06 44.34 57.19 89.06 45.53 55.74 17.04 57.32 -61.85 15.23 57.01 -60.79 coo 86.70 48.66 52.61 87.15 48.69 50.51 19.19 51.40 -57.25 19.45 51.43 -55.09 coo 95.42 44.52 54.43 93.46 45.31 54.70 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN A 98 GLN^? 8.94 CH2 MLY D 92 B 591 LEU A 102 LEU^? 4.62 CE MLY A 104 B 633 GLU A 100 GLU^? 8.29 NZ MLY A 92 coo 88.06 44.34 57.19 89.06 45.53 55.74 16.33 72.22 -55.12 14.93 73.71 -54.65 coo 86.70 48.66 52.61 87.15 48.69 50.51 16.70 69.27 -62.41 17.14 71.36 -62.38 coo 95.42 44.52 54.43 93.46 45.31 54.70 9.74 67.82 -56.04 9.26 65.81 -55.60 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 78 GLN^? 4.59 CD MLY B 92 B 591 LEU B 91 LEU^? 3.51 N MLY B 92 B 633 GLU B 80 GLU^? 3.91 CD MLY C 63 coo 88.06 44.34 57.19 89.06 45.53 55.74 18.44 69.85 -27.48 16.82 70.99 -28.18 coo 86.70 48.66 52.61 87.15 48.69 50.51 18.35 62.12 -27.27 20.33 61.96 -28.11 coo 95.42 44.52 54.43 93.46 45.31 54.70 14.10 69.89 -23.30 12.25 70.25 -24.24 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN C 98 GLN^? -3.27 O2 GOL C2126s B 591 LEU C 102 LEU^? -4.12 C1 GOL C2126s B 633 GLU C 100 GLU^? -7.78 O1 GOL C2126s coo 88.06 44.34 57.19 89.06 45.53 55.74 17.44 72.80 -39.41 16.11 71.18 -39.17 coo 86.70 48.66 52.61 87.15 48.69 50.51 17.90 78.41 -34.22 18.01 77.13 -32.55 coo 95.42 44.52 54.43 93.46 45.31 54.70 11.61 77.43 -41.88 9.59 77.35 -41.33 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN D 98 GLN^? 7.57 CH2 MLY D 104 B 591 LEU D 102 LEU^? 4.45 CH2 MLY D 104 B 633 GLU D 100 GLU^? 8.65 CH2 MLY D 92 coo 88.06 44.34 57.19 89.06 45.53 55.74 16.59 80.12 -46.90 17.21 82.12 -47.27 coo 86.70 48.66 52.61 87.15 48.69 50.51 18.13 85.04 -51.90 18.99 85.25 -49.89 coo 95.42 44.52 54.43 93.46 45.31 54.70 11.08 79.64 -49.38 10.05 78.59 -50.94 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 78 GLN^? 4.04 CH2 MLY A 92 C1091 LEU A 91 LEU^? 3.58 N MLY A 92 C1133 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 68.29 34.44 43.03 66.67 34.74 44.37 17.04 57.32 -61.85 15.23 57.01 -60.79 coo 65.83 38.95 47.05 65.46 38.90 49.20 18.78 63.20 -66.95 20.66 63.77 -66.00 coo 63.14 29.39 46.25 63.84 31.31 45.74 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 78 GLN^? 4.04 CH2 MLY A 92 C1091 LEU E 53 LEU^? 5.01 CH2 MLY E 104 C1133 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 68.29 34.44 43.03 66.67 34.74 44.37 17.04 57.32 -61.85 15.23 57.01 -60.79 coo 65.83 38.95 47.05 65.46 38.90 49.20 19.19 51.40 -57.25 19.45 51.43 -55.09 coo 63.14 29.39 46.25 63.84 31.31 45.74 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 98 GLN^? 8.94 CH2 MLY D 92 C1091 LEU A 102 LEU^? 4.62 CE MLY A 104 C1133 GLU A 100 GLU^? 8.29 NZ MLY A 92 coo 68.29 34.44 43.03 66.67 34.74 44.37 16.33 72.22 -55.12 14.93 73.71 -54.65 coo 65.83 38.95 47.05 65.46 38.90 49.20 16.70 69.27 -62.41 17.14 71.36 -62.38 coo 63.14 29.39 46.25 63.84 31.31 45.74 9.74 67.82 -56.04 9.26 65.81 -55.60 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 78 GLN^? 4.59 CD MLY B 92 C1091 LEU B 91 LEU^? 3.51 N MLY B 92 C1133 GLU B 80 GLU^? 3.91 CD MLY C 63 coo 68.29 34.44 43.03 66.67 34.74 44.37 18.44 69.85 -27.48 16.82 70.99 -28.18 coo 65.83 38.95 47.05 65.46 38.90 49.20 18.35 62.12 -27.27 20.33 61.96 -28.11 coo 63.14 29.39 46.25 63.84 31.31 45.74 14.10 69.89 -23.30 12.25 70.25 -24.24 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 78 GLN^? 4.59 CD MLY B 92 C1091 LEU C 53 LEU^? 4.82 CE MLY C 104 C1133 GLU B 80 GLU^? 3.91 CD MLY C 63 coo 68.29 34.44 43.03 66.67 34.74 44.37 18.44 69.85 -27.48 16.82 70.99 -28.18 coo 65.83 38.95 47.05 65.46 38.90 49.20 22.19 77.26 -27.92 21.25 79.12 -28.44 coo 63.14 29.39 46.25 63.84 31.31 45.74 14.10 69.89 -23.30 12.25 70.25 -24.24 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN B 98 GLN^? -4.27 O1 GOL B1126s C1091 LEU B 102 LEU^? 4.07 C3 GOL B1126 C1133 GLU B 100 GLU^? -7.17 O2 GOL B1126s coo 68.29 34.44 43.03 66.67 34.74 44.37 18.15 63.11 -42.95 16.88 62.03 -44.28 coo 65.83 38.95 47.05 65.46 38.90 49.20 16.84 60.57 -35.04 16.60 58.42 -34.76 coo 63.14 29.39 46.25 63.84 31.31 45.74 10.96 66.18 -39.67 10.01 67.63 -38.45 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN C 98 GLN^? -3.27 O2 GOL C2126s C1091 LEU C 102 LEU^? -4.12 C1 GOL C2126s C1133 GLU C 100 GLU^? -7.78 O1 GOL C2126s coo 68.29 34.44 43.03 66.67 34.74 44.37 17.44 72.80 -39.41 16.11 71.18 -39.17 coo 65.83 38.95 47.05 65.46 38.90 49.20 17.90 78.41 -34.22 18.01 77.13 -32.55 coo 63.14 29.39 46.25 63.84 31.31 45.74 11.61 77.43 -41.88 9.59 77.35 -41.33 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 8 3 # 8 C1050 GLN D 34 GLN^? 6.03 N MLY D 49 C1091 LEU D 35 LEU^? 8.79 C MLY D 117 C1133 GLU D 32 GLU^? 9.20 N MLY D 49 coo 68.29 34.44 43.03 66.67 34.74 44.37 37.38 92.19 -50.67 38.01 90.19 -50.80 coo 65.83 38.95 47.05 65.46 38.90 49.20 32.54 93.80 -54.62 33.93 93.39 -56.25 coo 63.14 29.39 46.25 63.84 31.31 45.74 40.33 93.18 -45.60 42.01 93.18 -46.89 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 9 3 # 9 C1050 GLN D 98 GLN^? 7.57 CH2 MLY D 104 C1091 LEU D 102 LEU^? 4.45 CH2 MLY D 104 C1133 GLU D 100 GLU^? 8.65 CH2 MLY D 92 coo 68.29 34.44 43.03 66.67 34.74 44.37 16.59 80.12 -46.90 17.21 82.12 -47.27 coo 65.83 38.95 47.05 65.46 38.90 49.20 18.13 85.04 -51.90 18.99 85.25 -49.89 coo 63.14 29.39 46.25 63.84 31.31 45.74 11.08 79.64 -49.38 10.05 78.59 -50.94 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 10 3 # 10 C1050 GLN E 98 GLN^? 9.14 CD MLY A 92 C1091 LEU E 102 LEU^? 4.48 CH2 MLY E 104 C1133 GLU E 100 GLU^? 7.50 CH1 MLY E 92 coo 68.29 34.44 43.03 66.67 34.74 44.37 15.60 61.89 -51.50 14.20 63.00 -52.67 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.68 53.46 -50.80 16.14 54.40 -52.67 coo 63.14 29.39 46.25 63.84 31.31 45.74 8.93 59.60 -48.26 8.00 59.34 -46.39 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 10 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 34 GLN^? 5.94 N MLY A 49 A 91 LEU A 35 LEU^? -3.93 O2 GOL A 127s A 133 GLU A 31 GLU.? 4.36 CB MLY A 49 coo 38.23 53.34 67.59 38.84 53.87 69.56 36.66 71.75 -68.75 37.27 70.94 -66.90 coo 35.40 53.22 73.30 35.37 54.87 74.74 32.17 68.49 -71.98 33.37 66.67 -72.06 coo 45.08 56.04 70.60 43.15 55.19 70.77 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 98 GLN^? 8.94 CH2 MLY D 92 A 91 LEU A 102 LEU^? 4.62 CE MLY A 104 A 133 GLU A 100 GLU^? 8.29 NZ MLY A 92 coo 38.23 53.34 67.59 38.84 53.87 69.56 16.33 72.22 -55.12 14.93 73.71 -54.65 coo 35.40 53.22 73.30 35.37 54.87 74.74 16.70 69.27 -62.41 17.14 71.36 -62.38 coo 45.08 56.04 70.60 43.15 55.19 70.77 9.74 67.82 -56.04 9.26 65.81 -55.60 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 34 GLN^? 6.20 N MLY B 49 A 91 LEU B 35 LEU^? 8.62 C MLY B 117 A 133 GLU B 31 GLU^? 4.39 CB MLY B 49 coo 38.23 53.34 67.59 38.84 53.87 69.56 35.01 51.68 -29.94 36.18 53.25 -30.71 coo 35.40 53.22 73.30 35.37 54.87 74.74 30.82 53.19 -25.38 32.42 54.28 -24.34 coo 45.08 56.04 70.60 43.15 55.19 70.77 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 34 GLN^? 6.20 N MLY B 49 A 91 LEU B 35 LEU^? 8.62 C MLY B 117 A 133 GLU B 32 GLU^? 10.10 CG MLY B 49 coo 38.23 53.34 67.59 38.84 53.87 69.56 35.01 51.68 -29.94 36.18 53.25 -30.71 coo 35.40 53.22 73.30 35.37 54.87 74.74 30.82 53.19 -25.38 32.42 54.28 -24.34 coo 45.08 56.04 70.60 43.15 55.19 70.77 37.56 47.47 -33.54 37.52 45.31 -33.22 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 78 GLN^? 4.59 CD MLY B 92 A 91 LEU B 91 LEU^? 3.51 N MLY B 92 A 133 GLU B 80 GLU^? 3.91 CD MLY C 63 coo 38.23 53.34 67.59 38.84 53.87 69.56 18.44 69.85 -27.48 16.82 70.99 -28.18 coo 35.40 53.22 73.30 35.37 54.87 74.74 18.35 62.12 -27.27 20.33 61.96 -28.11 coo 45.08 56.04 70.60 43.15 55.19 70.77 14.10 69.89 -23.30 12.25 70.25 -24.24 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 78 GLN^? 4.59 CD MLY B 92 A 91 LEU C 53 LEU^? 4.82 CE MLY C 104 A 133 GLU B 80 GLU^? 3.91 CD MLY C 63 coo 38.23 53.34 67.59 38.84 53.87 69.56 18.44 69.85 -27.48 16.82 70.99 -28.18 coo 35.40 53.22 73.30 35.37 54.87 74.74 22.19 77.26 -27.92 21.25 79.12 -28.44 coo 45.08 56.04 70.60 43.15 55.19 70.77 14.10 69.89 -23.30 12.25 70.25 -24.24 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN C 34 GLN^? 5.86 N MLY C 49 A 91 LEU C 35 LEU^? 8.51 C MLY C 117 A 133 GLU C 31 GLU^? 4.33 CB MLY C 49 coo 38.23 53.34 67.59 38.84 53.87 69.56 37.62 79.04 -26.19 38.04 78.38 -28.16 coo 35.40 53.22 73.30 35.37 54.87 74.74 33.17 83.51 -25.54 34.40 84.99 -26.52 coo 45.08 56.04 70.60 43.15 55.19 70.77 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN C 98 GLN^? -3.27 O2 GOL C2126s A 91 LEU C 102 LEU^? -4.12 C1 GOL C2126s A 133 GLU C 100 GLU^? -7.78 O1 GOL C2126s coo 38.23 53.34 67.59 38.84 53.87 69.56 17.44 72.80 -39.41 16.11 71.18 -39.17 coo 35.40 53.22 73.30 35.37 54.87 74.74 17.90 78.41 -34.22 18.01 77.13 -32.55 coo 45.08 56.04 70.60 43.15 55.19 70.77 11.61 77.43 -41.88 9.59 77.35 -41.33 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN D 98 GLN^? 7.57 CH2 MLY D 104 A 91 LEU D 102 LEU^? 4.45 CH2 MLY D 104 A 133 GLU D 100 GLU^? 8.65 CH2 MLY D 92 coo 38.23 53.34 67.59 38.84 53.87 69.56 16.59 80.12 -46.90 17.21 82.12 -47.27 coo 35.40 53.22 73.30 35.37 54.87 74.74 18.13 85.04 -51.90 18.99 85.25 -49.89 coo 45.08 56.04 70.60 43.15 55.19 70.77 11.08 79.64 -49.38 10.05 78.59 -50.94 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN E 34 GLN^? 6.12 N MLY E 49 A 91 LEU E 35 LEU^? 8.59 C MLY E 117 A 133 GLU E 31 GLU^? 4.40 CB MLY E 49 coo 38.23 53.34 67.59 38.84 53.87 69.56 34.73 47.56 -56.16 35.60 48.88 -54.79 coo 35.40 53.22 73.30 35.37 54.87 74.74 29.95 44.03 -53.94 31.15 43.08 -52.36 coo 45.08 56.04 70.60 43.15 55.19 70.77 33.05 53.64 -60.92 31.27 54.73 -61.16 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 10 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 88 ASP^? 3.30 CG MLY A 107 A 354 GLU A 105 GLU^? 3.91 CD MLY A 107 A 421 ASP A 42 ASP^? 3.07 NZ MLY A 104 coo 31.05 49.37 64.51 31.97 51.11 63.85 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 29.07 50.42 58.36 29.02 52.18 59.49 13.30 64.14 -73.44 11.76 64.88 -74.71 coo 30.82 59.76 58.47 31.12 59.02 60.40 18.51 71.25 -71.50 16.64 71.28 -70.53 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP C 86 ASP^? 3.69 CB MLY D 63 A 354 GLU C 80 GLU^? 4.30 CE MLY D 63 A 421 ASP D 55 ASP^? 3.95 N MLY D 56 coo 31.05 49.37 64.51 31.97 51.11 63.85 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 29.07 50.42 58.36 29.02 52.18 59.49 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 30.82 59.76 58.47 31.12 59.02 60.40 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP C 88 ASP^? 3.98 CA MLY C 107 A 354 GLU C 105 GLU^? 4.13 CH1 MLY C 107 A 421 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo 31.05 49.37 64.51 31.97 51.11 63.85 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 29.07 50.42 58.36 29.02 52.18 59.49 13.07 87.54 -28.77 11.38 88.10 -27.56 coo 30.82 59.76 58.47 31.12 59.02 60.40 19.26 82.21 -24.59 17.46 81.65 -25.59 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP D 55 ASP^? 3.95 N MLY D 56 A 354 GLU C 80 GLU^? 4.30 CE MLY D 63 A 421 ASP C 86 ASP^? 3.69 CB MLY D 63 coo 31.05 49.37 64.51 31.97 51.11 63.85 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 29.07 50.42 58.36 29.02 52.18 59.49 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 30.82 59.76 58.47 31.12 59.02 60.40 13.78 99.19 -34.67 12.49 98.36 -36.08 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 88 ASP^? 3.30 CG MLY A 107 B 354 GLU A 90 GLU^? 4.57 CE MLY A 92 B 421 ASP A 42 ASP^? 3.07 NZ MLY A 104 coo 25.90 8.19 53.87 25.36 6.97 52.29 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 27.87 10.66 47.95 27.82 8.60 48.27 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 26.02 1.87 43.38 25.90 1.97 45.49 18.51 71.25 -71.50 16.64 71.28 -70.53 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 88 ASP^? 3.30 CG MLY A 107 B 354 GLU A 105 GLU^? 3.91 CD MLY A 107 B 421 ASP A 42 ASP^? 3.07 NZ MLY A 104 coo 25.90 8.19 53.87 25.36 6.97 52.29 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 27.87 10.66 47.95 27.82 8.60 48.27 13.30 64.14 -73.44 11.76 64.88 -74.71 coo 26.02 1.87 43.38 25.90 1.97 45.49 18.51 71.25 -71.50 16.64 71.28 -70.53 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP C 88 ASP^? 3.98 CA MLY C 107 B 354 GLU C 90 GLU^? 4.76 CH2 MLY C 92 B 421 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo 25.90 8.19 53.87 25.36 6.97 52.29 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 27.87 10.66 47.95 27.82 8.60 48.27 14.69 87.71 -34.04 12.64 87.68 -34.52 coo 26.02 1.87 43.38 25.90 1.97 45.49 19.26 82.21 -24.59 17.46 81.65 -25.59 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP C 88 ASP^? 3.98 CA MLY C 107 B 354 GLU C 105 GLU^? 4.13 CH1 MLY C 107 B 421 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo 25.90 8.19 53.87 25.36 6.97 52.29 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 27.87 10.66 47.95 27.82 8.60 48.27 13.07 87.54 -28.77 11.38 88.10 -27.56 coo 26.02 1.87 43.38 25.90 1.97 45.49 19.26 82.21 -24.59 17.46 81.65 -25.59 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c09 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP D 55 ASP^? 3.95 N MLY D 56 264 GLU C 105 GLU^? 4.13 CH1 MLY C 107 328 ASP C 86 ASP^? 3.69 CB MLY D 63 coo 45.62 80.42 43.69 45.65 82.01 45.07 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 59.69 92.71 39.85 58.53 92.03 41.47 13.07 87.54 -28.77 11.38 88.10 -27.56 coo 45.39 90.72 40.63 45.07 89.14 41.90 13.78 99.19 -34.67 12.49 98.36 -36.08 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 1 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP C 86 ASP^? 3.69 CB MLY D 63 257 GLU C 80 GLU^? 4.30 CE MLY D 63 328 ASP D 55 ASP^? 3.95 N MLY D 56 coo 45.62 80.42 43.69 45.65 82.01 45.07 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 48.97 85.16 40.39 47.18 86.25 40.47 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 45.39 90.72 40.63 45.07 89.14 41.90 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP D 55 ASP^? 3.95 N MLY D 56 257 GLU C 80 GLU^? 4.30 CE MLY D 63 328 ASP C 86 ASP^? 3.69 CB MLY D 63 coo 45.62 80.42 43.69 45.65 82.01 45.07 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 48.97 85.16 40.39 47.18 86.25 40.47 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 45.39 90.72 40.63 45.07 89.14 41.90 13.78 99.19 -34.67 12.49 98.36 -36.08 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 2 hits 1cdg_c04 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 262 GLU D 80 GLU^? 4.08 CH1 MLY D 92 A 358 GLU D 90 GLU^? 4.45 CE MLY D 92 coo 26.19 60.87 43.98 27.48 59.27 43.30 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 27.13 54.07 50.45 26.96 54.19 48.35 15.29 82.50 -64.93 13.31 81.80 -64.63 coo 27.06 50.43 44.36 27.99 52.27 44.74 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 262 GLU E 80 GLU^? 3.80 CD MLY B 63 A 358 GLU E 90 GLU^? 4.38 CE MLY E 92 coo 26.19 60.87 43.98 27.48 59.27 43.30 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 27.13 54.07 50.45 26.96 54.19 48.35 12.20 46.96 -37.99 10.63 48.40 -38.11 coo 27.06 50.43 44.36 27.99 52.27 44.74 11.64 47.22 -44.78 9.75 48.01 -44.25 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 262 GLU B 80 GLU^? 3.91 CD MLY C 63 A 358 GLU B 90 GLU^? 4.73 CE MLY B 92 coo 26.19 60.87 43.98 27.48 59.27 43.30 20.47 72.89 -29.97 19.97 72.66 -31.99 coo 27.13 54.07 50.45 26.96 54.19 48.35 14.10 69.89 -23.30 12.25 70.25 -24.24 coo 27.06 50.43 44.36 27.99 52.27 44.74 13.18 64.24 -26.74 11.27 65.00 -27.34 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 A 232 HIS D 67 HIS^? 7.34 O MLY C 92 A 262 GLU C 80 GLU^? 4.30 CE MLY D 63 A 358 GLU C 90 GLU^? 4.76 CH2 MLY C 92 coo 26.19 60.87 43.98 27.48 59.27 43.30 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 27.13 54.07 50.45 26.96 54.19 48.35 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 27.06 50.43 44.36 27.99 52.27 44.74 14.69 87.71 -34.04 12.64 87.68 -34.52 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 A 232 HIS E 67 HIS^? 7.33 CH2 MLY E 104 A 262 GLU A 80 GLU^? 4.05 CH2 MLY A 92 A 358 GLU A 90 GLU^? 4.57 CE MLY A 92 coo 26.19 60.87 43.98 27.48 59.27 43.30 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 27.13 54.07 50.45 26.96 54.19 48.35 13.22 55.53 -66.00 11.94 55.88 -64.34 coo 27.06 50.43 44.36 27.99 52.27 44.74 13.22 61.52 -67.04 11.19 61.45 -66.51 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 5 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 67 HIS^? 6.87 CH2 MLY A 104 B 262 GLU D 80 GLU^? 4.08 CH1 MLY D 92 B 358 GLU D 90 GLU^? 4.45 CE MLY D 92 coo 44.98 77.01 48.39 44.42 78.67 47.18 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 41.60 83.57 54.16 42.46 83.24 52.25 15.29 82.50 -64.93 13.31 81.80 -64.63 coo 44.05 87.61 48.73 43.15 85.67 48.52 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS B 67 HIS^? -4.73 O3 GOL B1126s B 262 GLU E 80 GLU^? 3.80 CD MLY B 63 B 358 GLU E 90 GLU^? 4.38 CE MLY E 92 coo 44.98 77.01 48.39 44.42 78.67 47.18 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 41.60 83.57 54.16 42.46 83.24 52.25 12.20 46.96 -37.99 10.63 48.40 -38.11 coo 44.05 87.61 48.73 43.15 85.67 48.52 11.64 47.22 -44.78 9.75 48.01 -44.25 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS C 67 HIS^? -4.41 O3 GOL C2126s B 262 GLU B 80 GLU^? 3.91 CD MLY C 63 B 358 GLU B 90 GLU^? 4.73 CE MLY B 92 coo 44.98 77.01 48.39 44.42 78.67 47.18 20.47 72.89 -29.97 19.97 72.66 -31.99 coo 41.60 83.57 54.16 42.46 83.24 52.25 14.10 69.89 -23.30 12.25 70.25 -24.24 coo 44.05 87.61 48.73 43.15 85.67 48.52 13.18 64.24 -26.74 11.27 65.00 -27.34 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS D 67 HIS^? 7.34 O MLY C 92 B 262 GLU C 80 GLU^? 4.30 CE MLY D 63 B 358 GLU C 90 GLU^? 4.76 CH2 MLY C 92 coo 44.98 77.01 48.39 44.42 78.67 47.18 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 41.60 83.57 54.16 42.46 83.24 52.25 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 44.05 87.61 48.73 43.15 85.67 48.52 14.69 87.71 -34.04 12.64 87.68 -34.52 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 B 232 HIS E 67 HIS^? 7.33 CH2 MLY E 104 B 262 GLU A 80 GLU^? 4.05 CH2 MLY A 92 B 358 GLU A 90 GLU^? 4.57 CE MLY A 92 coo 44.98 77.01 48.39 44.42 78.67 47.18 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 41.60 83.57 54.16 42.46 83.24 52.25 13.22 55.53 -66.00 11.94 55.88 -64.34 coo 44.05 87.61 48.73 43.15 85.67 48.52 13.22 61.52 -67.04 11.19 61.45 -66.51 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 5 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 109 GLY^? 4.13 O MLY A 107 A 228 SER A 12 SER~? -2.76 O1 GOL A 126s A 549 ASP A 111 ASP^? -3.93 O2 GOL A 126s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 20.61 59.91 -81.48 20.88 60.03 -80.67 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 24.82 67.01 -79.36 25.16 64.95 -78.05 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 26.79 62.16 -76.74 28.45 60.97 -76.09 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 1 hits 1cjy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 66 TYR^? -4.01 O2 PEG D3127s A 173 ASP A 55 ASP^? 3.55 CH2 MLY A 104 C 48 ARG A 50 ARG^? 6.59 CA MLY D 117 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 24.35 4.55 25.11 25.94 3.23 25.53 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 28.95 77.70 -62.89 29.34 80.69 -63.51 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 66 TYR^? 7.57 CH2 MLY B 56 A 173 ASP B 55 ASP^? 2.74 NZ MLY B 104 C 48 ARG B 50 ARG^? 6.45 CA MLY E 117 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 24.35 4.55 25.11 25.94 3.23 25.53 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 27.11 51.81 -37.88 27.02 48.95 -39.10 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR C 66 TYR^? 7.67 C MLY C 63 A 173 ASP C 55 ASP^? 3.93 N MLY C 56 C 48 ARG C 50 ARG^? 6.37 CA MLY B 117 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 24.35 4.55 25.11 25.94 3.23 25.53 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 29.38 71.17 -28.15 29.46 68.99 -25.90 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR D 66 TYR^? 6.79 CE MLY D 56 A 173 ASP D 55 ASP^? 3.95 N MLY D 56 C 48 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 24.35 4.55 25.11 25.94 3.23 25.53 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR E 66 TYR^? -3.37 C3 PEG E4126s A 173 ASP E 55 ASP^? 3.37 N MLY E 56 C 48 ARG E 50 ARG^? 6.44 CA MLY A 117 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 24.35 4.55 25.11 25.94 3.23 25.53 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 27.70 55.94 -59.52 28.04 56.21 -62.59 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 50 ARG^? 6.59 CA MLY D 117 C 101 TYR A 66 TYR^? -4.01 O2 PEG D3127s C 173 ASP A 55 ASP^? 3.55 CH2 MLY A 104 coo 32.27 5.62 48.15 31.93 6.48 51.06 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 29.64 3.64 57.39 31.22 5.14 55.65 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 16.41 75.18 -70.84 15.40 75.53 -68.95 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 50 ARG^? 6.45 CA MLY E 117 C 101 TYR B 66 TYR^? 7.57 CH2 MLY B 56 C 173 ASP B 55 ASP^? 2.74 NZ MLY B 104 coo 32.27 5.62 48.15 31.93 6.48 51.06 27.11 51.81 -37.88 27.02 48.95 -39.10 coo 29.64 3.64 57.39 31.22 5.14 55.65 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 14.45 50.68 -30.88 15.66 52.47 -30.45 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG C 50 ARG^? 6.37 CA MLY B 117 C 101 TYR C 66 TYR^? 7.67 C MLY C 63 C 173 ASP C 55 ASP^? 3.93 N MLY C 56 coo 32.27 5.62 48.15 31.93 6.48 51.06 29.38 71.17 -28.15 29.46 68.99 -25.90 coo 29.64 3.64 57.39 31.22 5.14 55.65 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 16.82 77.26 -24.21 14.93 78.15 -24.18 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG D 50 ARG^? 6.49 CA MLY C 117 C 101 TYR D 66 TYR^? 6.79 CE MLY D 56 C 173 ASP D 55 ASP^? 3.95 N MLY D 56 coo 32.27 5.62 48.15 31.93 6.48 51.06 29.95 87.67 -43.01 30.32 89.04 -40.28 coo 29.64 3.64 57.39 31.22 5.14 55.65 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG E 50 ARG^? 6.44 CA MLY A 117 C 101 TYR E 66 TYR^? -3.37 C3 PEG E4126s C 173 ASP E 55 ASP^? 3.37 N MLY E 56 coo 32.27 5.62 48.15 31.93 6.48 51.06 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 29.64 3.64 57.39 31.22 5.14 55.65 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 14.69 49.71 -60.49 12.90 49.11 -59.47 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG E 121 ARG^? 4.47 O MLY E 117 C 101 TYR E 37 TYR^? 5.92 N MLY E 38 C 173 ASP E 111 ASP^? 7.83 CB MLY E 117 coo 32.27 5.62 48.15 31.93 6.48 51.06 33.54 46.74 -47.77 31.94 44.02 -47.62 coo 29.64 3.64 57.39 31.22 5.14 55.65 24.28 42.38 -52.54 26.48 42.21 -50.85 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 23.18 38.18 -49.05 24.84 37.79 -47.79 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 50 ARG^? 6.59 CA MLY D 117 D 101 TYR A 66 TYR^? -4.01 O2 PEG D3127s D 173 ASP A 55 ASP^? 3.55 CH2 MLY A 104 coo 69.08 8.58 32.60 69.70 10.81 30.58 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 71.77 11.86 24.26 70.23 12.22 26.56 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 71.60 6.14 19.25 70.26 6.87 20.69 16.41 75.18 -70.84 15.40 75.53 -68.95 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 50 ARG^? 6.45 CA MLY E 117 D 101 TYR B 66 TYR^? 7.57 CH2 MLY B 56 D 173 ASP B 55 ASP^? 2.74 NZ MLY B 104 coo 69.08 8.58 32.60 69.70 10.81 30.58 27.11 51.81 -37.88 27.02 48.95 -39.10 coo 71.77 11.86 24.26 70.23 12.22 26.56 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 71.60 6.14 19.25 70.26 6.87 20.69 14.45 50.68 -30.88 15.66 52.47 -30.45 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG C 50 ARG^? 6.37 CA MLY B 117 D 101 TYR C 66 TYR^? 7.67 C MLY C 63 D 173 ASP C 55 ASP^? 3.93 N MLY C 56 coo 69.08 8.58 32.60 69.70 10.81 30.58 29.38 71.17 -28.15 29.46 68.99 -25.90 coo 71.77 11.86 24.26 70.23 12.22 26.56 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 71.60 6.14 19.25 70.26 6.87 20.69 16.82 77.26 -24.21 14.93 78.15 -24.18 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG D 50 ARG^? 6.49 CA MLY C 117 D 101 TYR D 66 TYR^? 6.79 CE MLY D 56 D 173 ASP D 55 ASP^? 3.95 N MLY D 56 coo 69.08 8.58 32.60 69.70 10.81 30.58 29.95 87.67 -43.01 30.32 89.04 -40.28 coo 71.77 11.86 24.26 70.23 12.22 26.56 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 71.60 6.14 19.25 70.26 6.87 20.69 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG E 50 ARG^? 6.44 CA MLY A 117 D 101 TYR E 66 TYR^? -3.37 C3 PEG E4126s D 173 ASP E 55 ASP^? 3.37 N MLY E 56 coo 69.08 8.58 32.60 69.70 10.81 30.58 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 71.77 11.86 24.26 70.23 12.22 26.56 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 71.60 6.14 19.25 70.26 6.87 20.69 14.69 49.71 -60.49 12.90 49.11 -59.47 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 66 TYR^? -4.01 O2 PEG D3127s B 173 ASP A 55 ASP^? 3.55 CH2 MLY A 104 D 48 ARG A 50 ARG^? 6.59 CA MLY D 117 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 28.95 77.70 -62.89 29.34 80.69 -63.51 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 66 TYR^? 7.57 CH2 MLY B 56 B 173 ASP B 55 ASP^? 2.74 NZ MLY B 104 D 48 ARG B 50 ARG^? 6.45 CA MLY E 117 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 27.11 51.81 -37.88 27.02 48.95 -39.10 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR C 66 TYR^? 7.67 C MLY C 63 B 173 ASP C 55 ASP^? 3.93 N MLY C 56 D 48 ARG C 50 ARG^? 6.37 CA MLY B 117 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 29.38 71.17 -28.15 29.46 68.99 -25.90 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR D 37 TYR^? 5.94 N MLY D 38 B 173 ASP D 111 ASP^? 7.67 CB MLY D 117 D 48 ARG D 121 ARG^? 4.29 CG MLY D 117 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 27.03 94.32 -56.77 29.28 93.30 -58.07 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 27.01 96.00 -62.25 28.81 95.13 -62.96 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 36.09 87.23 -59.47 34.81 89.98 -60.22 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR D 66 TYR^? 6.79 CE MLY D 56 B 173 ASP D 55 ASP^? 3.95 N MLY D 56 D 48 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR E 66 TYR^? -3.37 C3 PEG E4126s B 173 ASP E 55 ASP^? 3.37 N MLY E 56 D 48 ARG E 50 ARG^? 6.44 CA MLY A 117 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 27.70 55.94 -59.52 28.04 56.21 -62.59 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 15 ASP~? -3.42 O1 GOL A 128s 315 GLU A 13 GLU.? 5.36 C1 GOL A 127s 390 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 32.46 99.13 19.34 30.94 100.38 20.07 31.25 75.86 -81.75 33.13 76.66 -82.26 coo 32.04 94.22 18.23 30.57 94.75 16.88 30.21 69.38 -81.53 31.47 68.83 -83.15 coo 21.10 94.74 18.36 23.09 96.71 18.59 26.61 66.73 -73.48 28.75 65.06 -72.74 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 1 hits 1ctn_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 42 ASP^? 3.07 NZ MLY A 104 A 56 ILE A 52 ILE^? 8.64 C MLY A 49 A 82 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 26.16 76.79 -67.03 26.63 78.15 -67.00 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 42 ASP^? 3.07 NZ MLY A 104 A 56 ILE A 115 ILE^? 6.25 N MLY A 117 A 82 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 25.24 63.47 -71.22 23.99 64.22 -70.90 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP A 55 ASP^? 3.55 CH2 MLY A 104 A 56 ILE A 52 ILE^? 8.64 C MLY A 49 A 82 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 26.16 76.79 -67.03 26.63 78.15 -67.00 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP B 42 ASP^? 3.93 N MLY B 56 A 56 ILE B 52 ILE^? 8.68 C MLY B 49 A 82 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 24.15 50.67 -33.93 24.45 49.48 -34.78 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 19.82 45.97 -35.59 19.43 43.56 -34.25 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP B 42 ASP^? 3.93 N MLY B 56 A 56 ILE B 115 ILE^? 6.51 N MLY B 117 A 82 TYR B 37 TYR^? 5.81 N MLY B 38 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 23.80 59.10 -23.84 22.67 58.35 -24.32 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 56 ILE C 52 ILE^? 8.64 C MLY C 49 A 82 TYR C 66 TYR^? 7.67 C MLY C 63 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 26.66 74.31 -25.34 27.00 73.11 -24.54 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 56 ILE C 115 ILE^? 6.44 N MLY C 117 A 82 TYR C 37 TYR^? 5.94 N MLY C 38 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 26.05 87.64 -29.63 24.93 86.74 -29.05 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP D 29 ASP^? 3.57 CH2 MLY C 117 A 56 ILE C 119 ILE^? 5.89 C MLY C 117 A 82 TYR C 122 TYR^? 7.12 N MLY C 49 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 40.24 89.57 -36.29 39.39 89.61 -34.38 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 28.12 84.21 -34.63 26.76 83.93 -34.68 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 33.60 80.42 -32.80 34.88 80.54 -30.34 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 9 3 # 9 A 37 ASP D 42 ASP^? 3.03 NZ MLY D 104 A 56 ILE D 52 ILE^? 8.45 C MLY D 49 A 82 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 27.12 91.23 -45.30 27.60 91.67 -43.97 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 10 3 # 10 A 37 ASP D 42 ASP^? 3.03 NZ MLY D 104 A 56 ILE D 115 ILE^? 6.22 N MLY D 117 A 82 TYR D 37 TYR^? 5.94 N MLY D 38 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 25.87 91.05 -59.50 24.68 90.93 -58.79 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 27.03 94.32 -56.77 29.28 93.30 -58.07 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 11 3 # 11 A 37 ASP E 42 ASP^? 3.02 NZ MLY E 104 A 56 ILE E 52 ILE^? 8.61 C MLY E 49 A 82 TYR E 66 TYR^? -3.37 C3 PEG E4126s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 24.58 51.82 -59.95 25.09 52.27 -61.24 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 20.78 52.34 -65.13 20.44 50.34 -67.07 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 12 3 # 12 A 37 ASP E 42 ASP^? 3.02 NZ MLY E 104 A 56 ILE E 115 ILE^? 5.98 N MLY E 117 A 82 TYR E 37 TYR^? 5.92 N MLY E 38 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 22.75 43.66 -48.35 22.42 44.24 -48.86 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 24.28 42.38 -52.54 26.48 42.21 -50.85 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 12 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 42 ASP^? 3.07 NZ MLY A 104 B 56 ILE A 52 ILE^? 8.64 C MLY A 49 B 82 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 26.16 76.79 -67.03 26.63 78.15 -67.00 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 42 ASP^? 3.07 NZ MLY A 104 B 56 ILE A 115 ILE^? 6.25 N MLY A 117 B 82 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 25.24 63.47 -71.22 23.99 64.22 -70.90 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP A 55 ASP^? 3.55 CH2 MLY A 104 B 56 ILE A 52 ILE^? 8.64 C MLY A 49 B 82 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 26.16 76.79 -67.03 26.63 78.15 -67.00 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP B 42 ASP^? 3.93 N MLY B 56 B 56 ILE B 52 ILE^? 8.68 C MLY B 49 B 82 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 24.15 50.67 -33.93 24.45 49.48 -34.78 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 19.82 45.97 -35.59 19.43 43.56 -34.25 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP B 42 ASP^? 3.93 N MLY B 56 B 56 ILE B 115 ILE^? 6.51 N MLY B 117 B 82 TYR B 37 TYR^? 5.81 N MLY B 38 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 23.80 59.10 -23.84 22.67 58.35 -24.32 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP B 55 ASP^? 2.74 NZ MLY B 104 B 56 ILE B 52 ILE^? 8.68 C MLY B 49 B 82 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 24.15 50.67 -33.93 24.45 49.48 -34.78 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 19.82 45.97 -35.59 19.43 43.56 -34.25 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP C 42 ASP^? 3.04 NZ MLY C 104 B 56 ILE C 52 ILE^? 8.64 C MLY C 49 B 82 TYR C 66 TYR^? 7.67 C MLY C 63 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 26.66 74.31 -25.34 27.00 73.11 -24.54 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP C 42 ASP^? 3.04 NZ MLY C 104 B 56 ILE C 115 ILE^? 6.44 N MLY C 117 B 82 TYR C 37 TYR^? 5.94 N MLY C 38 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 26.05 87.64 -29.63 24.93 86.74 -29.05 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 9 3 # 9 B 37 ASP D 29 ASP^? 3.57 CH2 MLY C 117 B 56 ILE C 119 ILE^? 5.89 C MLY C 117 B 82 TYR C 122 TYR^? 7.12 N MLY C 49 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 40.24 89.57 -36.29 39.39 89.61 -34.38 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 28.12 84.21 -34.63 26.76 83.93 -34.68 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 33.60 80.42 -32.80 34.88 80.54 -30.34 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 10 3 # 10 B 37 ASP D 42 ASP^? 3.03 NZ MLY D 104 B 56 ILE D 52 ILE^? 8.45 C MLY D 49 B 82 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 27.12 91.23 -45.30 27.60 91.67 -43.97 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 11 3 # 11 B 37 ASP D 42 ASP^? 3.03 NZ MLY D 104 B 56 ILE D 115 ILE^? 6.22 N MLY D 117 B 82 TYR D 37 TYR^? 5.94 N MLY D 38 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 25.87 91.05 -59.50 24.68 90.93 -58.79 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 27.03 94.32 -56.77 29.28 93.30 -58.07 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 12 3 # 12 B 37 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 56 ILE E 52 ILE^? 8.61 C MLY E 49 B 82 TYR E 66 TYR^? -3.37 C3 PEG E4126s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 24.58 51.82 -59.95 25.09 52.27 -61.24 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 20.78 52.34 -65.13 20.44 50.34 -67.07 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 13 3 # 13 B 37 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 56 ILE E 115 ILE^? 5.98 N MLY E 117 B 82 TYR E 37 TYR^? 5.92 N MLY E 38 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 22.75 43.66 -48.35 22.42 44.24 -48.86 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 24.28 42.38 -52.54 26.48 42.21 -50.85 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 13 hits 1d6o_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 63 HIS E 76 HIS^? -4.59 O1 GOL B1126s A 89 ASP B 55 ASP^? 2.74 NZ MLY B 104 coo 49.66 36.74 42.37 48.88 35.30 43.64 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 49.93 35.76 35.94 51.58 36.96 35.47 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 46.15 35.33 47.12 47.46 33.99 46.29 14.45 50.68 -30.88 15.66 52.47 -30.45 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 63 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 89 ASP C 55 ASP^? 3.93 N MLY C 56 coo 49.66 36.74 42.37 48.88 35.30 43.64 20.47 72.89 -29.97 19.97 72.66 -31.99 coo 49.93 35.76 35.94 51.58 36.96 35.47 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 46.15 35.33 47.12 47.46 33.99 46.29 16.82 77.26 -24.21 14.93 78.15 -24.18 1dco_c00 source 1dco DCOH : 2 hits 1dco_c00 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS E 99 HIS^? 5.87 C1 GOL B1126 A 96 GLU B 100 GLU^? -7.17 O2 GOL B1126s A 137 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 1.83 2.95 4.76 1.26 0.98 4.81 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 10.96 66.18 -39.67 10.01 67.63 -38.45 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 12.99 72.79 -44.62 12.72 70.82 -45.29 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 1 hits 1de3_c00 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS B 99 HIS^? 8.19 O2 GOL C2126 B 43 HIS C 99 HIS^? 9.14 O1 GOL C2126 B 65 GLU D 100 GLU^? 8.65 CH2 MLY D 92 coo 20.15 22.08 34.36 20.84 20.10 34.21 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 19.55 18.91 30.27 18.21 18.65 31.84 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 10.90 21.31 28.81 12.14 22.15 30.31 11.08 79.64 -49.38 10.05 78.59 -50.94 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS D 76 HIS^? 7.07 O MLY D 92 B 43 HIS A 67 HIS^? 6.87 CH2 MLY A 104 B 65 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo 20.15 22.08 34.36 20.84 20.10 34.21 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 19.55 18.91 30.27 18.21 18.65 31.84 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 10.90 21.31 28.81 12.14 22.15 30.31 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS D 99 HIS^? 11.73 CH2 MLY D 92 B 43 HIS C 99 HIS^? 9.14 O1 GOL C2126 B 65 GLU B 100 GLU^? -7.17 O2 GOL B1126s coo 20.15 22.08 34.36 20.84 20.10 34.21 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 19.55 18.91 30.27 18.21 18.65 31.84 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 10.90 21.31 28.81 12.14 22.15 30.31 10.96 66.18 -39.67 10.01 67.63 -38.45 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 3 hits 1e7l_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP C 55 ASP^? 3.93 N MLY C 56 A 35 SER C 65 SER^? 5.92 CH2 MLY C 104 A 218 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo 47.22 22.34 8.57 45.16 22.02 9.13 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 43.58 20.85 5.15 44.62 23.01 5.76 17.46 72.45 -23.42 17.18 72.60 -25.76 coo 44.05 16.99 12.67 44.05 18.89 11.74 19.26 82.21 -24.59 17.46 81.65 -25.59 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP E 55 ASP^? 3.37 N MLY E 56 A 35 SER E 65 SER^? 4.83 N MLY E 56 A 218 ASP E 42 ASP^? 3.02 NZ MLY E 104 coo 47.22 22.34 8.57 45.16 22.02 9.13 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 43.58 20.85 5.15 44.62 23.01 5.76 16.26 52.91 -64.19 14.97 52.38 -62.27 coo 44.05 16.99 12.67 44.05 18.89 11.74 16.27 46.44 -56.46 15.46 48.32 -56.74 1eag_c04 source 1eag PEPTIDE INHIBITOR : 2 hits 1eag_c04 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 20 ALA~? 5.28 C MLY A 18 A 257 ALA A 21 ALA~? 3.62 O MLY A 18 A 328 ASP A 15 ASP~? -3.42 O1 GOL A 128s coo 39.84 24.12 8.44 38.50 24.23 9.11 33.08 80.55 -74.34 34.47 79.99 -74.38 coo 43.22 26.73 5.37 41.81 27.09 5.79 33.14 83.88 -76.14 33.28 84.11 -77.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 31.25 75.86 -81.75 33.13 76.66 -82.26 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 21 ALA~? 3.62 O MLY A 18 A 257 ALA A 20 ALA~? 5.28 C MLY A 18 A 328 ASP A 15 ASP~? -3.42 O1 GOL A 128s coo 39.84 24.12 8.44 38.50 24.23 9.11 33.14 83.88 -76.14 33.28 84.11 -77.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 33.08 80.55 -74.34 34.47 79.99 -74.38 coo 38.17 34.10 6.67 37.72 32.06 6.84 31.25 75.86 -81.75 33.13 76.66 -82.26 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA B 6 ALA^? 8.19 CH2 MLY B 38 A 257 ALA B 11 ALA^? 10.90 CH1 MLY B 38 A 328 ASP B 15 ASP^? 3.54 CB MLY B 18 coo 39.84 24.12 8.44 38.50 24.23 9.11 28.77 49.31 -13.16 27.47 49.42 -13.96 coo 43.22 26.73 5.37 41.81 27.09 5.79 32.37 48.86 -15.64 31.95 47.90 -14.52 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.82 41.92 -21.37 29.40 40.51 -21.49 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA B 11 ALA^? 10.90 CH1 MLY B 38 A 257 ALA B 6 ALA^? 8.19 CH2 MLY B 38 A 328 ASP B 111 ASP^? 8.02 CB MLY B 117 coo 39.84 24.12 8.44 38.50 24.23 9.11 32.37 48.86 -15.64 31.95 47.90 -14.52 coo 43.22 26.73 5.37 41.81 27.09 5.79 28.77 49.31 -13.16 27.47 49.42 -13.96 coo 38.17 34.10 6.67 37.72 32.06 6.84 24.09 56.67 -18.17 25.86 57.71 -17.69 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA B 20 ALA^? 5.21 C MLY B 18 A 257 ALA B 21 ALA^? 3.61 O MLY B 18 A 328 ASP B 15 ASP^? 3.54 CB MLY B 18 coo 39.84 24.12 8.44 38.50 24.23 9.11 30.49 42.57 -29.95 31.97 42.76 -29.59 coo 43.22 26.73 5.37 41.81 27.09 5.79 30.15 38.85 -30.68 30.22 37.72 -29.66 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.82 41.92 -21.37 29.40 40.51 -21.49 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA B 21 ALA^? 3.61 O MLY B 18 A 257 ALA B 20 ALA^? 5.21 C MLY B 18 A 328 ASP B 15 ASP^? 3.54 CB MLY B 18 coo 39.84 24.12 8.44 38.50 24.23 9.11 30.15 38.85 -30.68 30.22 37.72 -29.66 coo 43.22 26.73 5.37 41.81 27.09 5.79 30.49 42.57 -29.95 31.97 42.76 -29.59 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.82 41.92 -21.37 29.40 40.51 -21.49 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA B 82 ALA^? 3.37 O MLY C 62 A 257 ALA B 89 ALA^? 5.31 CH1 MLY C 63 A 328 ASP B 86 ASP^? 8.21 CH2 MLY B 107 coo 39.84 24.12 8.44 38.50 24.23 9.11 14.39 68.30 -16.11 12.90 67.96 -15.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 14.54 63.64 -20.90 16.02 63.63 -20.57 coo 38.17 34.10 6.67 37.72 32.06 6.84 8.64 63.45 -11.70 8.10 61.49 -11.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 89 ALA^? 5.31 CH1 MLY C 63 A 257 ALA B 82 ALA^? 3.37 O MLY C 62 A 328 ASP B 86 ASP^? 8.21 CH2 MLY B 107 coo 39.84 24.12 8.44 38.50 24.23 9.11 14.54 63.64 -20.90 16.02 63.63 -20.57 coo 43.22 26.73 5.37 41.81 27.09 5.79 14.39 68.30 -16.11 12.90 67.96 -15.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 8.64 63.45 -11.70 8.10 61.49 -11.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA C 20 ALA^? 5.18 C MLY C 18 A 257 ALA C 21 ALA^? 3.79 O MLY C 18 A 328 ASP C 15 ASP^? 3.79 N MLY C 18 coo 39.84 24.12 8.44 38.50 24.23 9.11 33.43 75.29 -17.34 34.87 75.67 -17.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 33.42 73.21 -14.14 33.91 73.66 -12.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 32.23 83.07 -12.97 34.08 82.39 -12.17 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA C 21 ALA^? 3.79 O MLY C 18 A 257 ALA C 20 ALA^? 5.18 C MLY C 18 A 328 ASP C 15 ASP^? 3.79 N MLY C 18 coo 39.84 24.12 8.44 38.50 24.23 9.11 33.42 73.21 -14.14 33.91 73.66 -12.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 33.43 75.29 -17.34 34.87 75.67 -17.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 32.23 83.07 -12.97 34.08 82.39 -12.17 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA D 20 ALA^? 5.21 C MLY D 18 A 257 ALA D 21 ALA^? 3.49 O MLY D 18 A 328 ASP D 15 ASP^? 3.63 N MLY D 18 coo 39.84 24.12 8.44 38.50 24.23 9.11 33.26 99.65 -43.41 34.75 99.88 -43.89 coo 43.22 26.73 5.37 41.81 27.09 5.79 32.44 102.33 -40.78 32.19 103.84 -41.05 coo 38.17 34.10 6.67 37.72 32.06 6.84 30.53 104.92 -50.08 32.32 105.80 -49.34 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA D 21 ALA^? 3.49 O MLY D 18 A 257 ALA D 20 ALA^? 5.21 C MLY D 18 A 328 ASP D 15 ASP^? 3.63 N MLY D 18 coo 39.84 24.12 8.44 38.50 24.23 9.11 32.44 102.33 -40.78 32.19 103.84 -41.05 coo 43.22 26.73 5.37 41.81 27.09 5.79 33.26 99.65 -43.41 34.75 99.88 -43.89 coo 38.17 34.10 6.67 37.72 32.06 6.84 30.53 104.92 -50.08 32.32 105.80 -49.34 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA D 89 ALA^? 4.53 O4 PEG D3127 A 257 ALA D 82 ALA^? 3.97 O2 GOL D3126 A 328 ASP D 86 ASP^? 8.22 CH1 MLY A 63 coo 39.84 24.12 8.44 38.50 24.23 9.11 16.01 89.77 -65.40 17.43 89.97 -65.89 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.50 89.35 -68.66 13.62 90.83 -69.06 coo 38.17 34.10 6.67 37.72 32.06 6.84 6.01 94.81 -68.58 5.43 92.90 -69.25 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA E 20 ALA^? 5.54 C MLY E 18 A 257 ALA E 21 ALA^? 3.52 O MLY E 18 A 328 ASP E 15 ASP^? 3.80 N MLY E 18 coo 39.84 24.12 8.44 38.50 24.23 9.11 30.89 45.45 -65.97 32.28 45.00 -65.60 coo 43.22 26.73 5.37 41.81 27.09 5.79 30.43 44.95 -69.73 30.29 43.58 -70.42 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.54 37.14 -63.49 29.27 36.92 -64.69 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA E 21 ALA^? 3.52 O MLY E 18 A 257 ALA E 20 ALA^? 5.54 C MLY E 18 A 328 ASP E 15 ASP^? 3.80 N MLY E 18 coo 39.84 24.12 8.44 38.50 24.23 9.11 30.43 44.95 -69.73 30.29 43.58 -70.42 coo 43.22 26.73 5.37 41.81 27.09 5.79 30.89 45.45 -65.97 32.28 45.00 -65.60 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.54 37.14 -63.49 29.27 36.92 -64.69 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA E 82 ALA^? 4.40 CG MLY B 63 A 257 ALA E 89 ALA^? 6.15 N MLY E 107 A 328 ASP E 86 ASP^? 8.77 C MLY E 107 coo 39.84 24.12 8.44 38.50 24.23 9.11 9.76 41.30 -37.24 8.58 41.90 -37.96 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.32 41.94 -42.69 14.68 41.23 -42.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.40 32.25 -40.91 9.16 32.31 -43.02 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA E 89 ALA^? 6.15 N MLY E 107 A 257 ALA E 82 ALA^? 4.40 CG MLY B 63 A 328 ASP E 86 ASP^? 8.77 C MLY E 107 coo 39.84 24.12 8.44 38.50 24.23 9.11 13.32 41.94 -42.69 14.68 41.23 -42.73 coo 43.22 26.73 5.37 41.81 27.09 5.79 9.76 41.30 -37.24 8.58 41.90 -37.96 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.40 32.25 -40.91 9.16 32.31 -43.02 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 17 hits 1eo7_c00 naa= 3 ULMN 3 1esc_c00 ESTERASE user 1 3 # 1 14 SER A 65 SER^? 6.25 CH2 MLY A 104 280 TRP D 94 TRP^? 4.97 CB MLY D 92 283 HIS A 67 HIS^? 6.87 CH2 MLY A 104 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 17.55 80.47 -67.90 17.09 78.92 -66.03 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 16.97 77.28 -53.85 17.05 78.22 -57.65 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 19.88 76.04 -62.54 19.35 75.17 -60.71 ULMN 3 1esc_c00 ESTERASE user 2 3 # 2 14 SER A 68 SER^? 8.30 O MLY D 92 280 TRP D 94 TRP^? 4.97 CB MLY D 92 283 HIS A 67 HIS^? 6.87 CH2 MLY A 104 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 24.61 77.27 -62.31 25.74 79.33 -62.97 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 16.97 77.28 -53.85 17.05 78.22 -57.65 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 19.88 76.04 -62.54 19.35 75.17 -60.71 ULMN 3 1esc_c00 ESTERASE user 3 3 # 3 14 SER B 65 SER^? 5.68 N MLY B 56 280 TRP E 94 TRP^? 4.89 O3 GOL B1126 283 HIS B 67 HIS^? -4.73 O3 GOL B1126s coo 48.81 15.65 -14.70 47.48 13.77 -15.39 15.33 47.83 -35.47 14.54 49.92 -34.62 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 15.33 58.47 -44.21 15.55 55.34 -41.88 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 18.03 54.22 -37.13 17.47 55.93 -38.18 ULMN 3 1esc_c00 ESTERASE user 4 3 # 4 14 SER C 65 SER^? 5.92 CH2 MLY C 104 280 TRP B 94 TRP^? -4.25 C3 GOL C2126s 283 HIS C 67 HIS^? -4.41 O3 GOL C2126s coo 48.81 15.65 -14.70 47.48 13.77 -15.39 17.46 72.45 -23.42 17.18 72.60 -25.76 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 17.48 68.50 -36.66 17.68 69.39 -32.84 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 20.47 72.89 -29.97 19.97 72.66 -31.99 ULMN 3 1esc_c00 ESTERASE user 5 3 # 5 14 SER E 65 SER^? 4.83 N MLY E 56 280 TRP A 94 TRP^? 5.02 CB MLY A 92 283 HIS E 67 HIS^? 7.33 CH2 MLY E 104 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 16.26 52.91 -64.19 14.97 52.38 -62.27 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 16.06 64.44 -55.83 16.24 61.26 -58.13 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 18.54 56.25 -57.78 18.20 57.67 -56.27 1esc_c00 source 1esc ESTERASE : 5 hits 1esc_c00 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 55 ASP^? 3.55 CH2 MLY A 104 260 GLU D 80 GLU^? 4.08 CH1 MLY D 92 370 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 15.29 82.50 -64.93 13.31 81.80 -64.63 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 15 ASP^? 3.54 CB MLY B 18 260 GLU B 13 GLU^? 4.19 CD MLY B 38 370 TYR B 37 TYR^? 5.81 N MLY B 38 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 27.82 41.92 -21.37 29.40 40.51 -21.49 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 23.91 48.46 -16.95 22.31 49.84 -16.69 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP B 42 ASP^? 3.93 N MLY B 56 260 GLU B 13 GLU^? 4.19 CD MLY B 38 370 TYR B 37 TYR^? 5.81 N MLY B 38 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 23.91 48.46 -16.95 22.31 49.84 -16.69 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP D 42 ASP^? 3.03 NZ MLY D 104 260 GLU C 80 GLU^? 4.30 CE MLY D 63 370 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 23.81 93.85 -40.58 24.25 96.59 -40.12 1euu_c00 source 1euu SIALIDASE : 4 hits 1euu_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 88 ASP^? 3.30 CG MLY A 107 C 117 GLU A 80 GLU^? 4.05 CH2 MLY A 92 C 131 GLU A 105 GLU^? 3.91 CD MLY A 107 coo 68.01 56.37 72.57 68.42 56.10 70.51 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 66.59 62.50 67.44 67.57 60.64 67.12 13.22 55.53 -66.00 11.94 55.88 -64.34 coo 69.24 52.27 71.96 69.91 50.26 71.89 13.30 64.14 -73.44 11.76 64.88 -74.71 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 1 hits 1f6d_c02 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 41 ARG^? 6.93 CH1 MLY A 107 A 136 GLU A 90 GLU^? 4.57 CE MLY A 92 A 246 GLU A 105 GLU^? 3.91 CD MLY A 107 coo 13.48 30.30 107.06 11.75 30.99 109.44 12.57 70.18 -72.86 9.93 70.06 -74.53 coo 9.46 32.37 115.82 8.50 34.20 115.47 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 11.99 34.33 109.92 10.08 34.19 110.77 13.30 64.14 -73.44 11.76 64.88 -74.71 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 50 ARG^? 6.59 CA MLY D 117 A 136 GLU A 32 GLU.? 8.63 N MLY A 49 A 246 GLU A 31 GLU.? 4.36 CB MLY A 49 coo 13.48 30.30 107.06 11.75 30.99 109.44 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 9.46 32.37 115.82 8.50 34.20 115.47 38.81 75.22 -68.09 40.53 74.26 -68.89 coo 11.99 34.33 109.92 10.08 34.19 110.77 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG E 50 ARG^? 6.44 CA MLY A 117 A 136 GLU E 32 GLU^? 9.00 N MLY E 49 A 246 GLU E 31 GLU^? 4.40 CB MLY E 49 coo 13.48 30.30 107.06 11.75 30.99 109.44 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 9.46 32.37 115.82 8.50 34.20 115.47 36.93 48.99 -59.01 38.56 47.63 -58.62 coo 11.99 34.33 109.92 10.08 34.19 110.77 33.05 53.64 -60.92 31.27 54.73 -61.16 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 3 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 41 ARG^? 6.93 CH1 MLY A 107 A 136 GLU A 90 GLU^? 4.57 CE MLY A 92 A 246 GLU A 105 GLU^? 3.91 CD MLY A 107 coo 13.94 29.84 106.80 11.67 30.40 108.79 12.57 70.18 -72.86 9.93 70.06 -74.53 coo 9.52 31.97 115.23 8.45 33.74 114.72 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 11.92 33.82 109.35 10.10 33.50 110.39 13.30 64.14 -73.44 11.76 64.88 -74.71 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 50 ARG^? 6.59 CA MLY D 117 A 136 GLU A 32 GLU.? 8.63 N MLY A 49 A 246 GLU A 31 GLU.? 4.36 CB MLY A 49 coo 13.94 29.84 106.80 11.67 30.40 108.79 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 9.52 31.97 115.23 8.45 33.74 114.72 38.81 75.22 -68.09 40.53 74.26 -68.89 coo 11.92 33.82 109.35 10.10 33.50 110.39 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG E 50 ARG^? 6.44 CA MLY A 117 A 136 GLU E 32 GLU^? 9.00 N MLY E 49 A 246 GLU E 31 GLU^? 4.40 CB MLY E 49 coo 13.94 29.84 106.80 11.67 30.40 108.79 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 9.52 31.97 115.23 8.45 33.74 114.72 36.93 48.99 -59.01 38.56 47.63 -58.62 coo 11.92 33.82 109.35 10.10 33.50 110.39 33.05 53.64 -60.92 31.27 54.73 -61.16 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 3 hits 1fob_c00 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 80 GLU^? 4.05 CH2 MLY A 92 A 319 ASP E 55 ASP^? 3.37 N MLY E 56 A 359 ARG E 41 ARG^? 3.76 O MLY E 56 coo 14.41 12.40 16.42 12.92 13.74 15.71 13.22 55.53 -66.00 11.94 55.88 -64.34 coo 12.25 13.04 23.85 11.56 15.02 23.93 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 10.89 14.95 28.28 12.39 12.53 29.31 10.72 46.92 -56.99 8.84 48.23 -59.04 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU A 90 GLU^? 4.57 CE MLY A 92 A 319 ASP A 88 ASP^? 3.30 CG MLY A 107 A 359 ARG A 108 ARG^? 7.18 O1 PEG E4126 coo 14.41 12.40 16.42 12.92 13.74 15.71 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 12.25 13.04 23.85 11.56 15.02 23.93 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 10.89 14.95 28.28 12.39 12.53 29.31 18.06 54.88 -79.10 18.03 52.11 -77.78 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU B 80 GLU^? 3.91 CD MLY C 63 A 319 ASP C 55 ASP^? 3.93 N MLY C 56 A 359 ARG C 41 ARG^? 4.97 CH1 MLY C 104 coo 14.41 12.40 16.42 12.92 13.74 15.71 14.10 69.89 -23.30 12.25 70.25 -24.24 coo 12.25 13.04 23.85 11.56 15.02 23.93 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 10.89 14.95 28.28 12.39 12.53 29.31 13.30 82.18 -23.38 11.50 79.88 -24.41 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU B 90 GLU^? 4.73 CE MLY B 92 A 319 ASP B 88 ASP^? 3.13 NZ MLY B 107 A 359 ARG B 108 ARG^? 7.66 C MLY B 107s coo 14.41 12.40 16.42 12.92 13.74 15.71 13.18 64.24 -26.74 11.27 65.00 -27.34 coo 12.25 13.04 23.85 11.56 15.02 23.93 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 10.89 14.95 28.28 12.39 12.53 29.31 14.28 61.53 -14.52 14.41 61.31 -11.40 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 A 317 GLU C 80 GLU^? 4.30 CE MLY D 63 A 319 ASP D 55 ASP^? 3.95 N MLY D 56 A 359 ARG D 41 ARG^? 6.40 CH1 MLY D 104 coo 14.41 12.40 16.42 12.92 13.74 15.71 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 12.25 13.04 23.85 11.56 15.02 23.93 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 10.89 14.95 28.28 12.39 12.53 29.31 13.18 94.01 -50.58 11.63 94.04 -47.91 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 A 317 GLU D 90 GLU^? 4.45 CE MLY D 92 A 319 ASP D 88 ASP^? 3.08 NZ MLY D 107 A 359 ARG D 108 ARG^? -4.43 O2 GOL D3126s coo 14.41 12.40 16.42 12.92 13.74 15.71 14.28 86.95 -60.58 12.27 86.36 -60.48 coo 12.25 13.04 23.85 11.56 15.02 23.93 13.64 92.96 -63.76 13.01 94.95 -63.51 coo 10.89 14.95 28.28 12.39 12.53 29.31 15.31 96.96 -69.15 13.25 94.66 -68.95 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 A 317 GLU E 31 GLU^? 4.40 CB MLY E 49 A 319 ASP E 29 ASP^? 3.75 CH1 MLY A 117 A 359 ARG A 121 ARG^? 4.33 CG MLY A 117 coo 14.41 12.40 16.42 12.92 13.74 15.71 33.05 53.64 -60.92 31.27 54.73 -61.16 coo 12.25 13.04 23.85 11.56 15.02 23.93 38.39 56.86 -66.83 37.88 57.50 -68.78 coo 10.89 14.95 28.28 12.39 12.53 29.31 35.71 63.07 -66.37 34.42 61.95 -68.98 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 7 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 80 GLU^? 4.05 CH2 MLY A 92 B 319 ASP E 55 ASP^? 3.37 N MLY E 56 B 359 ARG E 41 ARG^? 3.76 O MLY E 56 coo 10.77 13.13 40.94 11.03 14.73 39.51 13.22 55.53 -66.00 11.94 55.88 -64.34 coo 3.77 12.64 38.21 3.35 14.53 37.39 14.69 49.71 -60.49 12.90 49.11 -59.47 coo -1.16 15.32 35.60 -3.32 13.56 36.98 10.72 46.92 -56.99 8.84 48.23 -59.04 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 90 GLU^? 4.57 CE MLY A 92 B 319 ASP A 88 ASP^? 3.30 CG MLY A 107 B 359 ARG A 108 ARG^? 7.18 O1 PEG E4126 coo 10.77 13.13 40.94 11.03 14.73 39.51 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 3.77 12.64 38.21 3.35 14.53 37.39 14.06 59.10 -75.34 13.56 59.34 -77.37 coo -1.16 15.32 35.60 -3.32 13.56 36.98 18.06 54.88 -79.10 18.03 52.11 -77.78 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU B 32 GLU^? 10.10 CG MLY B 49 B 319 ASP B 29 ASP^? 3.03 NZ MLY E 117 B 359 ARG E 121 ARG^? 4.47 O MLY E 117 coo 10.77 13.13 40.94 11.03 14.73 39.51 37.56 47.47 -33.54 37.52 45.31 -33.22 coo 3.77 12.64 38.21 3.35 14.53 37.39 36.54 43.66 -42.10 35.37 42.05 -42.81 coo -1.16 15.32 35.60 -3.32 13.56 36.98 33.54 46.74 -47.77 31.94 44.02 -47.62 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU B 80 GLU^? 3.91 CD MLY C 63 B 319 ASP C 55 ASP^? 3.93 N MLY C 56 B 359 ARG C 41 ARG^? 4.97 CH1 MLY C 104 coo 10.77 13.13 40.94 11.03 14.73 39.51 14.10 69.89 -23.30 12.25 70.25 -24.24 coo 3.77 12.64 38.21 3.35 14.53 37.39 16.82 77.26 -24.21 14.93 78.15 -24.18 coo -1.16 15.32 35.60 -3.32 13.56 36.98 13.30 82.18 -23.38 11.50 79.88 -24.41 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU B 90 GLU^? 4.73 CE MLY B 92 B 319 ASP B 88 ASP^? 3.13 NZ MLY B 107 B 359 ARG B 108 ARG^? 7.66 C MLY B 107s coo 10.77 13.13 40.94 11.03 14.73 39.51 13.18 64.24 -26.74 11.27 65.00 -27.34 coo 3.77 12.64 38.21 3.35 14.53 37.39 11.27 60.93 -19.56 10.57 59.24 -18.48 coo -1.16 15.32 35.60 -3.32 13.56 36.98 14.28 61.53 -14.52 14.41 61.31 -11.40 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 B 317 GLU C 80 GLU^? 4.30 CE MLY D 63 B 319 ASP D 55 ASP^? 3.95 N MLY D 56 B 359 ARG D 41 ARG^? 6.40 CH1 MLY D 104 coo 10.77 13.13 40.94 11.03 14.73 39.51 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 3.77 12.64 38.21 3.35 14.53 37.39 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -1.16 15.32 35.60 -3.32 13.56 36.98 13.18 94.01 -50.58 11.63 94.04 -47.91 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 B 317 GLU C 90 GLU^? 4.76 CH2 MLY C 92 B 319 ASP C 88 ASP^? 3.98 CA MLY C 107 B 359 ARG C 108 ARG^? 8.73 C MLY C 107 coo 10.77 13.13 40.94 11.03 14.73 39.51 14.69 87.71 -34.04 12.64 87.68 -34.52 coo 3.77 12.64 38.21 3.35 14.53 37.39 14.72 94.17 -28.91 13.94 94.86 -27.07 coo -1.16 15.32 35.60 -3.32 13.56 36.98 18.68 99.59 -26.36 18.80 102.03 -24.43 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 B 317 GLU C 105 GLU^? 4.13 CH1 MLY C 107 B 319 ASP C 88 ASP^? 3.98 CA MLY C 107 B 359 ARG C 108 ARG^? 8.73 C MLY C 107 coo 10.77 13.13 40.94 11.03 14.73 39.51 13.07 87.54 -28.77 11.38 88.10 -27.56 coo 3.77 12.64 38.21 3.35 14.53 37.39 14.72 94.17 -28.91 13.94 94.86 -27.07 coo -1.16 15.32 35.60 -3.32 13.56 36.98 18.68 99.59 -26.36 18.80 102.03 -24.43 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 9 3 # 9 B 317 GLU D 80 GLU^? 4.08 CH1 MLY D 92 B 319 ASP A 55 ASP^? 3.55 CH2 MLY A 104 B 359 ARG A 41 ARG^? 6.93 CH1 MLY A 107 coo 10.77 13.13 40.94 11.03 14.73 39.51 15.29 82.50 -64.93 13.31 81.80 -64.63 coo 3.77 12.64 38.21 3.35 14.53 37.39 16.41 75.18 -70.84 15.40 75.53 -68.95 coo -1.16 15.32 35.60 -3.32 13.56 36.98 12.57 70.18 -72.86 9.93 70.06 -74.53 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 10 3 # 10 B 317 GLU D 90 GLU^? 4.45 CE MLY D 92 B 319 ASP D 88 ASP^? 3.08 NZ MLY D 107 B 359 ARG D 108 ARG^? -4.43 O2 GOL D3126s coo 10.77 13.13 40.94 11.03 14.73 39.51 14.28 86.95 -60.58 12.27 86.36 -60.48 coo 3.77 12.64 38.21 3.35 14.53 37.39 13.64 92.96 -63.76 13.01 94.95 -63.51 coo -1.16 15.32 35.60 -3.32 13.56 36.98 15.31 96.96 -69.15 13.25 94.66 -68.95 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 11 3 # 11 B 317 GLU E 90 GLU^? 4.38 CE MLY E 92 B 319 ASP E 88 ASP^? 7.64 NZ MLY E 107 B 359 ARG E 108 ARG^? 5.63 NZ MLY E 107 coo 10.77 13.13 40.94 11.03 14.73 39.51 11.64 47.22 -44.78 9.75 48.01 -44.25 coo 3.77 12.64 38.21 3.35 14.53 37.39 9.12 40.44 -42.05 7.36 39.34 -42.35 coo -1.16 15.32 35.60 -3.32 13.56 36.98 10.12 34.27 -46.51 9.14 36.36 -44.43 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 11 hits 1fr8_c01 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 100 GLU^? 8.29 NZ MLY A 92 516 HIS E 99 HIS^? 5.87 C1 GOL B1126 559 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 49.01 14.50 52.53 46.99 14.61 52.78 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 41.59 7.83 54.15 41.16 9.87 53.87 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 42.22 14.55 52.50 43.91 14.87 53.60 11.74 66.03 -51.26 10.97 64.13 -50.86 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU B 100 GLU^? -7.17 O2 GOL B1126s 516 HIS A 99 HIS^? 11.42 NZ MLY A 92 559 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 49.01 14.50 52.53 46.99 14.61 52.78 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 41.59 7.83 54.15 41.16 9.87 53.87 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 42.22 14.55 52.50 43.91 14.87 53.60 10.43 63.28 -44.90 9.66 63.00 -42.97 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU C 100 GLU^? -7.78 O1 GOL C2126s 516 HIS B 99 HIS^? 8.19 O2 GOL C2126 559 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 49.01 14.50 52.53 46.99 14.61 52.78 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 41.59 7.83 54.15 41.16 9.87 53.87 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 42.22 14.55 52.50 43.91 14.87 53.60 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU E 100 GLU^? 7.50 CH1 MLY E 92 516 HIS B 99 HIS^? 8.19 O2 GOL C2126 559 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 49.01 14.50 52.53 46.99 14.61 52.78 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 41.59 7.83 54.15 41.16 9.87 53.87 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 42.22 14.55 52.50 43.91 14.87 53.60 10.43 63.28 -44.90 9.66 63.00 -42.97 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 4 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 80 GLU^? 4.05 CH2 MLY A 92 A 47 ASP E 42 ASP^? 3.02 NZ MLY E 104 A 161 TYR E 66 TYR^? -3.37 C3 PEG E4126s coo 37.12 18.35 73.76 37.09 16.69 72.44 13.22 55.53 -66.00 11.94 55.88 -64.34 coo 29.81 8.06 73.13 30.21 10.11 72.95 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 37.29 15.56 67.90 37.37 13.79 70.08 20.78 52.34 -65.13 20.44 50.34 -67.07 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU B 13 GLU^? 4.19 CD MLY B 38 A 47 ASP B 42 ASP^? 3.93 N MLY B 56 A 161 TYR B 37 TYR^? 5.81 N MLY B 38 coo 37.12 18.35 73.76 37.09 16.69 72.44 23.91 48.46 -16.95 22.31 49.84 -16.69 coo 29.81 8.06 73.13 30.21 10.11 72.95 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 37.29 15.56 67.90 37.37 13.79 70.08 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU B 80 GLU^? 3.91 CD MLY C 63 A 47 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 161 TYR C 66 TYR^? 7.67 C MLY C 63 coo 37.12 18.35 73.76 37.09 16.69 72.44 14.10 69.89 -23.30 12.25 70.25 -24.24 coo 29.81 8.06 73.13 30.21 10.11 72.95 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 37.29 15.56 67.90 37.37 13.79 70.08 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU D 22 GLU^? 2.79 NZ MLY D 56 A 47 ASP C 86 ASP^? 3.69 CB MLY D 63 A 161 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 37.12 18.35 73.76 37.09 16.69 72.44 26.53 100.29 -40.96 24.92 100.36 -42.34 coo 29.81 8.06 73.13 30.21 10.11 72.95 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 37.29 15.56 67.90 37.37 13.79 70.08 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU D 22 GLU^? 2.79 NZ MLY D 56 A 47 ASP D 42 ASP^? 3.03 NZ MLY D 104 A 161 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 37.12 18.35 73.76 37.09 16.69 72.44 26.53 100.29 -40.96 24.92 100.36 -42.34 coo 29.81 8.06 73.13 30.21 10.11 72.95 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 37.29 15.56 67.90 37.37 13.79 70.08 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 A 36 GLU D 80 GLU^? 4.08 CH1 MLY D 92 A 47 ASP A 42 ASP^? 3.07 NZ MLY A 104 A 161 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 37.12 18.35 73.76 37.09 16.69 72.44 15.29 82.50 -64.93 13.31 81.80 -64.63 coo 29.81 8.06 73.13 30.21 10.11 72.95 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 37.29 15.56 67.90 37.37 13.79 70.08 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 A 36 GLU E 80 GLU^? 3.80 CD MLY B 63 A 47 ASP B 42 ASP^? 3.93 N MLY B 56 A 161 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 37.12 18.35 73.76 37.09 16.69 72.44 12.20 46.96 -37.99 10.63 48.40 -38.11 coo 29.81 8.06 73.13 30.21 10.11 72.95 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 37.29 15.56 67.90 37.37 13.79 70.08 19.82 45.97 -35.59 19.43 43.56 -34.25 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 7 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 80 GLU^? 4.05 CH2 MLY A 92 B 47 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 161 TYR E 66 TYR^? -3.37 C3 PEG E4126s coo 53.87 35.49 53.22 55.44 35.72 54.61 13.22 55.53 -66.00 11.94 55.88 -64.34 coo 63.47 43.65 53.95 61.45 43.07 54.06 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 56.38 35.81 59.19 58.25 35.77 57.10 20.78 52.34 -65.13 20.44 50.34 -67.07 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU B 13 GLU^? 4.19 CD MLY B 38 B 47 ASP B 42 ASP^? 3.93 N MLY B 56 B 161 TYR B 37 TYR^? 5.81 N MLY B 38 coo 53.87 35.49 53.22 55.44 35.72 54.61 23.91 48.46 -16.95 22.31 49.84 -16.69 coo 63.47 43.65 53.95 61.45 43.07 54.06 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 56.38 35.81 59.19 58.25 35.77 57.10 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU B 80 GLU^? 3.91 CD MLY C 63 B 47 ASP C 42 ASP^? 3.04 NZ MLY C 104 B 161 TYR C 66 TYR^? 7.67 C MLY C 63 coo 53.87 35.49 53.22 55.44 35.72 54.61 14.10 69.89 -23.30 12.25 70.25 -24.24 coo 63.47 43.65 53.95 61.45 43.07 54.06 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 56.38 35.81 59.19 58.25 35.77 57.10 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU D 22 GLU^? 2.79 NZ MLY D 56 B 47 ASP C 86 ASP^? 3.69 CB MLY D 63 B 161 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 53.87 35.49 53.22 55.44 35.72 54.61 26.53 100.29 -40.96 24.92 100.36 -42.34 coo 63.47 43.65 53.95 61.45 43.07 54.06 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 56.38 35.81 59.19 58.25 35.77 57.10 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU D 22 GLU^? 2.79 NZ MLY D 56 B 47 ASP D 42 ASP^? 3.03 NZ MLY D 104 B 161 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 53.87 35.49 53.22 55.44 35.72 54.61 26.53 100.29 -40.96 24.92 100.36 -42.34 coo 63.47 43.65 53.95 61.45 43.07 54.06 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 56.38 35.81 59.19 58.25 35.77 57.10 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 B 36 GLU D 80 GLU^? 4.08 CH1 MLY D 92 B 47 ASP A 42 ASP^? 3.07 NZ MLY A 104 B 161 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 53.87 35.49 53.22 55.44 35.72 54.61 15.29 82.50 -64.93 13.31 81.80 -64.63 coo 63.47 43.65 53.95 61.45 43.07 54.06 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 56.38 35.81 59.19 58.25 35.77 57.10 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 B 36 GLU E 80 GLU^? 3.80 CD MLY B 63 B 47 ASP B 42 ASP^? 3.93 N MLY B 56 B 161 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 53.87 35.49 53.22 55.44 35.72 54.61 12.20 46.96 -37.99 10.63 48.40 -38.11 coo 63.47 43.65 53.95 61.45 43.07 54.06 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 56.38 35.81 59.19 58.25 35.77 57.10 19.82 45.97 -35.59 19.43 43.56 -34.25 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 7 hits 1geq_c03 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP A 42 ASP^? 3.07 NZ MLY A 104 41 HIS A 67 HIS^? 6.87 CH2 MLY A 104 224 GLN A 57 GLN^? 5.22 O MLY A 56 coo -3.80 50.71 49.48 -5.59 51.85 49.27 18.51 71.25 -71.50 16.64 71.28 -70.53 coo -6.45 47.32 41.99 -8.32 46.87 42.83 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -12.35 49.13 49.89 -13.38 48.89 48.03 13.11 78.06 -68.28 13.58 77.51 -66.25 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 1 hits 1gim_c00 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 34 GLN^? 5.94 N MLY A 49 A 296 GLU A 31 GLU.? 4.36 CB MLY A 49 A 383 TYR A 71 TYR^? 4.26 O MLY A 49 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 36.66 71.75 -68.75 37.27 70.94 -66.90 coo 40.93 4.45 2.36 38.91 3.75 2.26 34.46 78.41 -64.99 32.63 79.05 -64.17 coo 30.54 7.22 6.23 31.38 5.79 3.97 30.64 69.73 -60.98 30.99 70.47 -63.67 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN B 34 GLN^? 6.20 N MLY B 49 A 296 GLU B 31 GLU^? 4.39 CB MLY B 49 A 383 TYR B 71 TYR^? 3.83 C MLY B 49 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 35.01 51.68 -29.94 36.18 53.25 -30.71 coo 40.93 4.45 2.36 38.91 3.75 2.26 32.53 49.41 -36.99 30.60 49.55 -37.82 coo 30.54 7.22 6.23 31.38 5.79 3.97 30.33 58.66 -35.11 30.25 56.72 -33.11 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN C 34 GLN^? 5.86 N MLY C 49 A 296 GLU C 31 GLU^? 4.33 CB MLY C 49 A 383 TYR C 71 TYR^? 4.47 O MLY C 49 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 37.62 79.04 -26.19 38.04 78.38 -28.16 coo 40.93 4.45 2.36 38.91 3.75 2.26 34.85 71.37 -25.71 32.93 70.57 -26.04 coo 30.54 7.22 6.23 31.38 5.79 3.97 31.85 76.68 -34.13 32.03 77.49 -31.46 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 4 3 # 4 A 271 GLN D 34 GLN^? 6.03 N MLY D 49 A 296 GLU D 31 GLU^? 4.34 CB MLY D 49 A 383 TYR D 71 TYR^? 4.33 C MLY D 49 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 37.38 92.19 -50.67 38.01 90.19 -50.80 coo 40.93 4.45 2.36 38.91 3.75 2.26 35.32 90.11 -43.10 33.53 89.40 -42.25 coo 30.54 7.22 6.23 31.38 5.79 3.97 31.72 83.62 -50.20 31.88 86.39 -50.26 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 5 3 # 5 A 271 GLN E 34 GLN^? 6.12 N MLY E 49 A 296 GLU E 31 GLU^? 4.40 CB MLY E 49 A 383 TYR E 71 TYR^? 4.22 C MLY E 49 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 34.73 47.56 -56.16 35.60 48.88 -54.79 coo 40.93 4.45 2.36 38.91 3.75 2.26 33.05 53.64 -60.92 31.27 54.73 -61.16 coo 30.54 7.22 6.23 31.38 5.79 3.97 29.43 54.82 -51.42 29.48 52.53 -53.00 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 5 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 88 ASP^? 3.30 CG MLY A 107 A 327 GLU D 31 GLU^? 4.34 CB MLY D 49 A 339 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 85.81 57.99 116.01 86.03 55.86 115.89 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 35.32 90.11 -43.10 33.53 89.40 -42.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP B 55 ASP^? 2.74 NZ MLY B 104 A 327 GLU D 105 GLU^? 3.44 CH1 MLY D 107 A 339 ARG D 41 ARG^? 6.40 CH1 MLY D 104 coo 85.81 57.99 116.01 86.03 55.86 115.89 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 75.11 41.01 160.30 76.65 40.06 161.41 13.06 92.19 -59.56 11.66 93.71 -59.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 13.18 94.01 -50.58 11.63 94.04 -47.91 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP D 86 ASP^? 8.22 CH1 MLY A 63 A 327 GLU E 31 GLU^? 4.40 CB MLY E 49 A 339 ARG E 50 ARG^? 6.44 CA MLY A 117 coo 85.81 57.99 116.01 86.03 55.86 115.89 6.01 94.81 -68.58 5.43 92.90 -69.25 coo 75.11 41.01 160.30 76.65 40.06 161.41 33.05 53.64 -60.92 31.27 54.73 -61.16 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.70 55.94 -59.52 28.04 56.21 -62.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP E 42 ASP^? 3.02 NZ MLY E 104 A 327 GLU C 105 GLU^? 4.13 CH1 MLY C 107 A 339 ARG C 41 ARG^? 4.97 CH1 MLY C 104 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 75.11 41.01 160.30 76.65 40.06 161.41 13.07 87.54 -28.77 11.38 88.10 -27.56 coo 82.23 40.35 159.87 85.09 40.67 161.01 13.30 82.18 -23.38 11.50 79.88 -24.41 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP E 42 ASP^? 3.02 NZ MLY E 104 A 327 GLU D 31 GLU^? 4.34 CB MLY D 49 A 339 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 75.11 41.01 160.30 76.65 40.06 161.41 35.32 90.11 -43.10 33.53 89.40 -42.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP E 55 ASP^? 3.37 N MLY E 56 A 327 GLU C 105 GLU^? 4.13 CH1 MLY C 107 A 339 ARG C 41 ARG^? 4.97 CH1 MLY C 104 coo 85.81 57.99 116.01 86.03 55.86 115.89 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 75.11 41.01 160.30 76.65 40.06 161.41 13.07 87.54 -28.77 11.38 88.10 -27.56 coo 82.23 40.35 159.87 85.09 40.67 161.01 13.30 82.18 -23.38 11.50 79.88 -24.41 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP E 86 ASP^? 8.77 C MLY E 107 A 327 GLU C 31 GLU^? 4.33 CB MLY C 49 A 339 ARG C 50 ARG^? 6.37 CA MLY B 117 coo 85.81 57.99 116.01 86.03 55.86 115.89 9.40 32.25 -40.91 9.16 32.31 -43.02 coo 75.11 41.01 160.30 76.65 40.06 161.41 34.85 71.37 -25.71 32.93 70.57 -26.04 coo 82.23 40.35 159.87 85.09 40.67 161.01 29.38 71.17 -28.15 29.46 68.99 -25.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP E 88 ASP^? 7.64 NZ MLY E 107 A 327 GLU C 105 GLU^? 4.13 CH1 MLY C 107 A 339 ARG C 41 ARG^? 4.97 CH1 MLY C 104 coo 85.81 57.99 116.01 86.03 55.86 115.89 9.12 40.44 -42.05 7.36 39.34 -42.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 13.07 87.54 -28.77 11.38 88.10 -27.56 coo 82.23 40.35 159.87 85.09 40.67 161.01 13.30 82.18 -23.38 11.50 79.88 -24.41 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 8 hits 1hto_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 88 ASP^? 3.30 CG MLY A 107 158 THR A 110 THR^? 3.07 O MLY A 107 317 ASP A 42 ASP^? 3.07 NZ MLY A 104 coo -2.63 8.40 35.07 -3.66 9.81 36.17 14.06 59.10 -75.34 13.56 59.34 -77.37 coo -5.30 12.75 41.86 -4.34 13.05 39.99 22.59 62.21 -79.15 21.09 63.58 -78.35 coo -12.63 17.64 33.66 -10.65 17.90 34.40 18.51 71.25 -71.50 16.64 71.28 -70.53 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP B 88 ASP^? 3.13 NZ MLY B 107 158 THR B 81 THR^? 6.25 CB MLY C 63 317 ASP B 111 ASP^? 8.02 CB MLY B 117 coo -2.63 8.40 35.07 -3.66 9.81 36.17 11.27 60.93 -19.56 10.57 59.24 -18.48 coo -5.30 12.75 41.86 -4.34 13.05 39.99 15.94 67.40 -19.49 17.89 67.02 -18.58 coo -12.63 17.64 33.66 -10.65 17.90 34.40 24.09 56.67 -18.17 25.86 57.71 -17.69 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP B 88 ASP^? 3.13 NZ MLY B 107 158 THR B 84 THR^? -10.76 O MLY B 107s 317 ASP B 111 ASP^? 8.02 CB MLY B 117 coo -2.63 8.40 35.07 -3.66 9.81 36.17 11.27 60.93 -19.56 10.57 59.24 -18.48 coo -5.30 12.75 41.86 -4.34 13.05 39.99 16.08 64.61 -11.36 17.85 64.34 -10.13 coo -12.63 17.64 33.66 -10.65 17.90 34.40 24.09 56.67 -18.17 25.86 57.71 -17.69 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP B 88 ASP^? 3.13 NZ MLY B 107 158 THR B 110 THR^? 3.52 O MLY B 107 317 ASP B 42 ASP^? 3.93 N MLY B 56 coo -2.63 8.40 35.07 -3.66 9.81 36.17 11.27 60.93 -19.56 10.57 59.24 -18.48 coo -5.30 12.75 41.86 -4.34 13.05 39.99 19.20 56.29 -18.11 18.49 56.38 -20.17 coo -12.63 17.64 33.66 -10.65 17.90 34.40 16.33 50.59 -26.42 14.26 50.43 -26.72 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP C 86 ASP^? 3.69 CB MLY D 63 158 THR D 60 THR^? 3.64 CD MLY D 62 317 ASP D 55 ASP^? 3.95 N MLY D 56 coo -2.63 8.40 35.07 -3.66 9.81 36.17 13.78 99.19 -34.67 12.49 98.36 -36.08 coo -5.30 12.75 41.86 -4.34 13.05 39.99 12.97 106.24 -41.34 11.58 106.06 -39.68 coo -12.63 17.64 33.66 -10.65 17.90 34.40 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP C 88 ASP^? 3.98 CA MLY C 107 158 THR C 110 THR^? 3.53 O MLY C 107 317 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo -2.63 8.40 35.07 -3.66 9.81 36.17 14.72 94.17 -28.91 13.94 94.86 -27.07 coo -5.30 12.75 41.86 -4.34 13.05 39.99 22.16 92.02 -24.46 21.13 90.28 -25.31 coo -12.63 17.64 33.66 -10.65 17.90 34.40 19.26 82.21 -24.59 17.46 81.65 -25.59 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 6 hits 1inp_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 15 ASP~? -3.42 O1 GOL A 128s A 204 GLU A 13 GLU.? 5.36 C1 GOL A 127s A 279 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 5.85 5.60 30.32 5.00 7.49 29.88 31.25 75.86 -81.75 33.13 76.66 -82.26 coo 7.79 1.83 27.81 9.08 3.25 26.92 30.21 69.38 -81.53 31.47 68.83 -83.15 coo 8.22 7.77 18.64 7.58 8.47 21.28 26.61 66.73 -73.48 28.75 65.06 -72.74 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 1 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU C 100 GLU^? -7.78 O1 GOL C2126s A 61 GLU B 100 GLU^? -7.17 O2 GOL B1126s A 162 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 11.61 77.43 -41.88 9.59 77.35 -41.33 coo -4.89 20.85 5.22 -3.95 21.69 6.91 10.96 66.18 -39.67 10.01 67.63 -38.45 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU D 100 GLU^? 8.65 CH2 MLY D 92 A 61 GLU A 100 GLU^? 8.29 NZ MLY A 92 A 162 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 11.08 79.64 -49.38 10.05 78.59 -50.94 coo -4.89 20.85 5.22 -3.95 21.69 6.91 9.74 67.82 -56.04 9.26 65.81 -55.60 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 12.99 72.79 -44.62 12.72 70.82 -45.29 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU D 100 GLU^? 8.65 CH2 MLY D 92 A 61 GLU A 100 GLU^? 8.29 NZ MLY A 92 A 162 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 11.08 79.64 -49.38 10.05 78.59 -50.94 coo -4.89 20.85 5.22 -3.95 21.69 6.91 9.74 67.82 -56.04 9.26 65.81 -55.60 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU E 100 GLU^? 7.50 CH1 MLY E 92 A 61 GLU A 100 GLU^? 8.29 NZ MLY A 92 A 162 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 8.93 59.60 -48.26 8.00 59.34 -46.39 coo -4.89 20.85 5.22 -3.95 21.69 6.91 9.74 67.82 -56.04 9.26 65.81 -55.60 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 10.43 63.28 -44.90 9.66 63.00 -42.97 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 5 3 # 5 A 14 GLU E 100 GLU^? 7.50 CH1 MLY E 92 A 61 GLU B 100 GLU^? -7.17 O2 GOL B1126s A 162 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 8.93 59.60 -48.26 8.00 59.34 -46.39 coo -4.89 20.85 5.22 -3.95 21.69 6.91 10.96 66.18 -39.67 10.01 67.63 -38.45 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 11.74 66.03 -51.26 10.97 64.13 -50.86 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 5 hits 1j53_c00 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 34 GLN^? 5.94 N MLY A 49 A 79 PHE A 46 PHE^? 7.94 C MLY A 117 A 80 THR A 47 THR^? 4.03 N MLY A 49 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 36.66 71.75 -68.75 37.27 70.94 -66.90 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 29.34 69.15 -68.08 27.07 67.52 -67.70 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 32.85 73.96 -66.87 31.89 75.74 -65.94 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN B 34 GLN^? 6.20 N MLY B 49 A 79 PHE B 46 PHE^? 7.55 C MLY B 117 A 80 THR B 47 THR^? 4.12 N MLY B 49 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 35.01 51.68 -29.94 36.18 53.25 -30.71 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 28.29 55.43 -28.83 26.34 57.33 -28.10 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 31.27 51.81 -32.66 30.11 51.14 -34.38 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 3 3 # 3 A 78 GLN C 34 GLN^? 5.86 N MLY C 49 A 79 PHE C 46 PHE^? 7.87 C MLY C 117 A 80 THR C 47 THR^? 4.11 N MLY C 49 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 37.62 79.04 -26.19 38.04 78.38 -28.16 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 30.55 81.03 -28.50 28.46 82.32 -29.83 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 33.65 76.18 -26.71 32.58 74.28 -26.42 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 4 3 # 4 A 78 GLN D 34 GLN^? 6.03 N MLY D 49 A 79 PHE D 46 PHE^? 7.98 C MLY D 117 A 80 THR D 47 THR^? 4.10 N MLY D 49 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 37.38 92.19 -50.67 38.01 90.19 -50.80 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 30.22 90.03 -52.89 28.06 88.97 -54.31 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 33.65 90.58 -47.93 32.78 90.34 -45.97 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 5 3 # 5 A 78 GLN E 34 GLN^? 6.12 N MLY E 49 A 79 PHE E 46 PHE^? 7.91 C MLY E 117 A 80 THR E 47 THR^? 4.13 N MLY E 49 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 34.73 47.56 -56.16 35.60 48.88 -54.79 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 27.56 48.03 -53.18 25.40 48.10 -51.41 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 31.16 50.49 -57.38 30.28 51.97 -58.73 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 5 hits 1j7g_c00 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 86 ASP^? 4.13 CB MLY E 62 A 58 ASP A 88 ASP^? 3.30 CG MLY A 107 A 424 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 58.42 47.76 20.67 58.01 49.10 19.12 10.80 52.06 -74.41 9.44 51.94 -72.75 coo 58.59 41.80 18.81 58.94 43.89 18.94 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 52.85 46.34 13.34 54.09 44.97 14.42 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 88 ASP^? 3.30 CG MLY A 107 A 58 ASP A 86 ASP^? 4.13 CB MLY E 62 A 424 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 58.42 47.76 20.67 58.01 49.10 19.12 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 58.59 41.80 18.81 58.94 43.89 18.94 10.80 52.06 -74.41 9.44 51.94 -72.75 coo 52.85 46.34 13.34 54.09 44.97 14.42 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP C 86 ASP^? 3.69 CB MLY D 63 A 58 ASP C 88 ASP^? 3.98 CA MLY C 107 A 424 GLU C 80 GLU^? 4.30 CE MLY D 63 coo 58.42 47.76 20.67 58.01 49.10 19.12 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 58.59 41.80 18.81 58.94 43.89 18.94 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 52.85 46.34 13.34 54.09 44.97 14.42 15.56 92.60 -38.66 14.20 91.79 -40.09 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP C 88 ASP^? 3.98 CA MLY C 107 A 58 ASP C 86 ASP^? 3.69 CB MLY D 63 A 424 GLU C 80 GLU^? 4.30 CE MLY D 63 coo 58.42 47.76 20.67 58.01 49.10 19.12 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 58.59 41.80 18.81 58.94 43.89 18.94 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 52.85 46.34 13.34 54.09 44.97 14.42 15.56 92.60 -38.66 14.20 91.79 -40.09 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 4 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 86 ASP^? 4.13 CB MLY E 62 B 58 ASP A 88 ASP^? 3.30 CG MLY A 107 B 424 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 112.10 61.46 19.99 111.82 60.65 18.07 10.80 52.06 -74.41 9.44 51.94 -72.75 coo 117.85 63.62 21.08 115.96 63.25 20.18 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 118.47 57.23 15.57 119.32 58.77 16.73 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 88 ASP^? 3.30 CG MLY A 107 B 58 ASP A 86 ASP^? 4.13 CB MLY E 62 B 424 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 112.10 61.46 19.99 111.82 60.65 18.07 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 117.85 63.62 21.08 115.96 63.25 20.18 10.80 52.06 -74.41 9.44 51.94 -72.75 coo 118.47 57.23 15.57 119.32 58.77 16.73 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP C 86 ASP^? 3.69 CB MLY D 63 B 58 ASP C 88 ASP^? 3.98 CA MLY C 107 B 424 GLU C 80 GLU^? 4.30 CE MLY D 63 coo 112.10 61.46 19.99 111.82 60.65 18.07 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 117.85 63.62 21.08 115.96 63.25 20.18 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 118.47 57.23 15.57 119.32 58.77 16.73 15.56 92.60 -38.66 14.20 91.79 -40.09 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP C 88 ASP^? 3.98 CA MLY C 107 B 58 ASP C 86 ASP^? 3.69 CB MLY D 63 B 424 GLU C 80 GLU^? 4.30 CE MLY D 63 coo 112.10 61.46 19.99 111.82 60.65 18.07 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 117.85 63.62 21.08 115.96 63.25 20.18 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 118.47 57.23 15.57 119.32 58.77 16.73 15.56 92.60 -38.66 14.20 91.79 -40.09 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 4 hits 1js4_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 11 ALA~? 5.95 CH1 MLY A 38 A 317 GLY A 9 GLY~? -3.63 O2 GOL A 126s A 318 ASP A 111 ASP^? -3.93 O2 GOL A 126s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 24.44 65.30 -82.79 23.53 64.04 -82.67 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 28.89 62.90 -80.66 28.35 62.99 -81.30 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 26.79 62.16 -76.74 28.45 60.97 -76.09 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 82 ALA^? 6.93 O MLY A 104 A 317 GLY A 83 GLY^? 7.64 CG MLY A 107 A 318 ASP A 86 ASP^? 4.13 CB MLY E 62 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 10.80 52.06 -74.41 9.44 51.94 -72.75 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA A 82 ALA^? 6.93 O MLY A 104 A 317 GLY A 83 GLY^? 7.64 CG MLY A 107 A 318 ASP A 88 ASP^? 3.30 CG MLY A 107 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 14.06 59.10 -75.34 13.56 59.34 -77.37 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA C 82 ALA^? 5.29 NZ MLY D 63 A 317 GLY C 83 GLY^? 6.95 NZ MLY D 63 A 318 ASP C 86 ASP^? 3.69 CB MLY D 63 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 13.78 99.19 -34.67 12.49 98.36 -36.08 ULMN 3 1lij_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA C 82 ALA^? 5.29 NZ MLY D 63 A 317 GLY C 83 GLY^? 6.95 NZ MLY D 63 A 318 ASP C 88 ASP^? 3.98 CA MLY C 107 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 14.72 94.17 -28.91 13.94 94.86 -27.07 1lij_c01 source 1lij ADENOSINE KINASE : 5 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 11 ALA~? 5.95 CH1 MLY A 38 A 317 GLY A 9 GLY~? -3.63 O2 GOL A 126s A 318 ASP A 111 ASP^? -3.93 O2 GOL A 126s coo 27.04 23.54 41.85 25.72 24.19 42.18 24.44 65.30 -82.79 23.53 64.04 -82.67 coo 27.87 23.16 38.17 28.43 22.97 38.87 28.89 62.90 -80.66 28.35 62.99 -81.30 coo 32.11 22.71 40.58 33.42 24.22 39.78 26.79 62.16 -76.74 28.45 60.97 -76.09 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 82 ALA^? 6.93 O MLY A 104 A 317 GLY A 83 GLY^? 7.64 CG MLY A 107 A 318 ASP A 86 ASP^? 4.13 CB MLY E 62 coo 27.04 23.54 41.85 25.72 24.19 42.18 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 27.87 23.16 38.17 28.43 22.97 38.87 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 32.11 22.71 40.58 33.42 24.22 39.78 10.80 52.06 -74.41 9.44 51.94 -72.75 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA A 82 ALA^? 6.93 O MLY A 104 A 317 GLY A 83 GLY^? 7.64 CG MLY A 107 A 318 ASP A 88 ASP^? 3.30 CG MLY A 107 coo 27.04 23.54 41.85 25.72 24.19 42.18 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 27.87 23.16 38.17 28.43 22.97 38.87 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 32.11 22.71 40.58 33.42 24.22 39.78 14.06 59.10 -75.34 13.56 59.34 -77.37 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA C 82 ALA^? 5.29 NZ MLY D 63 A 317 GLY C 83 GLY^? 6.95 NZ MLY D 63 A 318 ASP C 86 ASP^? 3.69 CB MLY D 63 coo 27.04 23.54 41.85 25.72 24.19 42.18 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 27.87 23.16 38.17 28.43 22.97 38.87 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 32.11 22.71 40.58 33.42 24.22 39.78 13.78 99.19 -34.67 12.49 98.36 -36.08 ULMN 3 1lio_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA C 82 ALA^? 5.29 NZ MLY D 63 A 317 GLY C 83 GLY^? 6.95 NZ MLY D 63 A 318 ASP C 88 ASP^? 3.98 CA MLY C 107 coo 27.04 23.54 41.85 25.72 24.19 42.18 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 27.87 23.16 38.17 28.43 22.97 38.87 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 32.11 22.71 40.58 33.42 24.22 39.78 14.72 94.17 -28.91 13.94 94.86 -27.07 1lio_c01 source 1lio ADENOSINE KINASE : 5 hits 1lio_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 76 HIS^? 7.10 O MLY A 92 A 45 HIS E 67 HIS^? 7.33 CH2 MLY E 104 A 261 PHE E 44 PHE^? 4.99 CG MLY E 104 coo 49.89 1.93 30.83 50.54 1.43 32.81 20.27 61.30 -55.15 18.31 61.65 -54.51 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 21.13 47.25 -53.69 19.15 48.66 -52.33 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 45 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 261 PHE C 44 PHE^? 5.33 CG MLY C 104 coo 49.89 1.93 30.83 50.54 1.43 32.81 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 20.47 72.89 -29.97 19.97 72.66 -31.99 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 24.06 82.47 -27.06 21.61 83.19 -28.27 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 45 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 261 PHE C 46 PHE^? 7.87 C MLY C 117 coo 49.89 1.93 30.83 50.54 1.43 32.81 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 20.47 72.89 -29.97 19.97 72.66 -31.99 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 30.55 81.03 -28.50 28.46 82.32 -29.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS C 76 HIS^? 7.27 O MLY C 92 A 45 HIS D 67 HIS^? 7.34 O MLY C 92 A 261 PHE D 46 PHE^? 7.98 C MLY D 117 coo 49.89 1.93 30.83 50.54 1.43 32.81 22.40 81.23 -44.05 20.46 80.64 -44.59 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 30.22 90.03 -52.89 28.06 88.97 -54.31 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS D 76 HIS^? 7.07 O MLY D 92 A 45 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 261 PHE A 44 PHE^? 5.16 CG MLY A 104 coo 49.89 1.93 30.83 50.54 1.43 32.81 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 23.11 69.14 -69.99 20.74 67.92 -69.33 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS E 76 HIS^? -4.59 O1 GOL B1126s A 45 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 261 PHE B 44 PHE^? 5.16 CG MLY B 104 coo 49.89 1.93 30.83 50.54 1.43 32.81 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 21.55 55.13 -26.95 19.27 56.76 -26.83 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 6 hits 1luc_c00 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 15 ASP^? 3.54 CB MLY B 18 A 279 GLU B 31 GLU^? 4.39 CB MLY B 49 A 369 ASP B 5 ASP^? 11.56 CH1 MLY B 38 coo 11.74 38.14 80.19 10.63 36.40 80.65 27.82 41.92 -21.37 29.40 40.51 -21.49 coo 16.54 46.37 63.94 14.77 45.79 62.95 32.53 49.41 -36.99 30.60 49.55 -37.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 29.67 45.39 -10.95 29.64 43.82 -9.50 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 88 ASP^? 3.13 NZ MLY B 107 A 279 GLU B 100 GLU^? -7.17 O2 GOL B1126s A 369 ASP B 86 ASP^? 8.21 CH2 MLY B 107 coo 11.74 38.14 80.19 10.63 36.40 80.65 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 16.54 46.37 63.94 14.77 45.79 62.95 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.64 63.45 -11.70 8.10 61.49 -11.14 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP E 88 ASP^? 7.64 NZ MLY E 107 A 279 GLU E 100 GLU^? 7.50 CH1 MLY E 92 A 369 ASP E 86 ASP^? 8.77 C MLY E 107 coo 11.74 38.14 80.19 10.63 36.40 80.65 9.12 40.44 -42.05 7.36 39.34 -42.35 coo 16.54 46.37 63.94 14.77 45.79 62.95 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 9.40 32.25 -40.91 9.16 32.31 -43.02 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 3 hits 1m53_c06 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 50 ARG^? 6.59 CA MLY D 117 229 SER A 48 SER^? 3.36 N MLY A 49 325 GLU A 31 GLU.? 4.36 CB MLY A 49 coo 2.54 15.84 18.57 3.24 17.85 16.30 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 10.17 13.48 15.92 9.61 15.76 15.27 35.82 73.21 -64.61 36.98 75.34 -64.56 coo 5.42 13.04 19.75 5.74 13.81 17.79 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 50 ARG^? 6.45 CA MLY E 117 229 SER B 48 SER^? 3.58 N MLY B 49 325 GLU B 31 GLU^? 4.39 CB MLY B 49 coo 2.54 15.84 18.57 3.24 17.85 16.30 27.11 51.81 -37.88 27.02 48.95 -39.10 coo 10.17 13.48 15.92 9.61 15.76 15.27 34.44 53.39 -34.08 35.35 51.53 -35.36 coo 5.42 13.04 19.75 5.74 13.81 17.79 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG C 50 ARG^? 6.37 CA MLY B 117 229 SER C 48 SER^? 3.29 N MLY C 49 325 GLU C 31 GLU^? 4.33 CB MLY C 49 coo 2.54 15.84 18.57 3.24 17.85 16.30 29.38 71.17 -28.15 29.46 68.99 -25.90 coo 10.17 13.48 15.92 9.61 15.76 15.27 36.60 75.26 -28.91 37.65 73.40 -27.84 coo 5.42 13.04 19.75 5.74 13.81 17.79 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 4 3 # 4 159 ARG D 50 ARG^? 6.49 CA MLY C 117 229 SER D 48 SER^? 3.48 N MLY D 49 325 GLU D 31 GLU^? 4.34 CB MLY D 49 coo 2.54 15.84 18.57 3.24 17.85 16.30 29.95 87.67 -43.01 30.32 89.04 -40.28 coo 10.17 13.48 15.92 9.61 15.76 15.27 36.73 88.33 -47.99 37.96 89.07 -46.06 coo 5.42 13.04 19.75 5.74 13.81 17.79 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 5 3 # 5 159 ARG E 50 ARG^? 6.44 CA MLY A 117 229 SER E 48 SER^? 3.44 N MLY E 49 325 GLU E 31 GLU^? 4.40 CB MLY E 49 coo 2.54 15.84 18.57 3.24 17.85 16.30 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 10.17 13.48 15.92 9.61 15.76 15.27 34.26 52.12 -55.96 35.52 52.85 -57.90 coo 5.42 13.04 19.75 5.74 13.81 17.79 33.05 53.64 -60.92 31.27 54.73 -61.16 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 5 hits 1mbb_c00 naa= 3 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 1 3 # 1 92 SER A 65 SER^? 6.25 CH2 MLY A 104 201 HIS A 67 HIS^? 6.87 CH2 MLY A 104 250 GLN D 78 GLN^? 3.52 CH1 MLY D 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 17.55 80.47 -67.90 17.09 78.92 -66.03 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 18.03 79.88 -62.79 16.06 79.00 -62.61 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 2 3 # 2 92 SER A 68 SER^? 8.30 O MLY D 92 201 HIS A 67 HIS^? 6.87 CH2 MLY A 104 250 GLN D 78 GLN^? 3.52 CH1 MLY D 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 24.61 77.27 -62.31 25.74 79.33 -62.97 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 18.03 79.88 -62.79 16.06 79.00 -62.61 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 3 3 # 3 92 SER A 96 SER^? 5.92 O MLY A 72 201 HIS D 76 HIS^? 7.07 O MLY D 92 250 GLN A 98 GLN^? 8.94 CH2 MLY D 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 21.16 70.03 -52.65 22.56 70.77 -50.83 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 16.33 72.22 -55.12 14.93 73.71 -54.65 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 4 3 # 4 92 SER B 65 SER^? 5.68 N MLY B 56 201 HIS B 67 HIS^? -4.73 O3 GOL B1126s 250 GLN E 78 GLN^? 4.64 CD MLY E 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 15.33 47.83 -35.47 14.54 49.92 -34.62 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 16.39 50.68 -39.20 14.58 51.66 -38.76 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 5 3 # 5 92 SER B 68 SER^? 8.39 O MLY E 92 201 HIS B 67 HIS^? -4.73 O3 GOL B1126s 250 GLN E 78 GLN^? 4.64 CD MLY E 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 22.79 53.21 -37.95 23.70 50.99 -38.49 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 16.39 50.68 -39.20 14.58 51.66 -38.76 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 6 3 # 6 92 SER B 96 SER^? 5.90 O MLY B 72 201 HIS E 76 HIS^? -4.59 O1 GOL B1126s 250 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 38.34 0.72 11.82 37.33 1.15 14.05 22.87 65.56 -42.63 24.42 65.74 -44.43 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 18.15 63.11 -42.95 16.88 62.03 -44.28 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 7 3 # 7 92 SER C 65 SER^? 5.92 CH2 MLY C 104 201 HIS C 67 HIS^? -4.41 O3 GOL C2126s 250 GLN B 78 GLN^? 4.59 CD MLY B 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 17.46 72.45 -23.42 17.18 72.60 -25.76 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 20.47 72.89 -29.97 19.97 72.66 -31.99 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 18.44 69.85 -27.48 16.82 70.99 -28.18 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 8 3 # 8 92 SER C 96 SER^? 5.54 O MLY C 72 201 HIS B 76 HIS^? -4.78 C3 GOL C2126s 250 GLN C 98 GLN^? -3.27 O2 GOL C2126s coo 38.34 0.72 11.82 37.33 1.15 14.05 22.75 72.50 -41.71 24.26 71.19 -43.03 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 17.44 72.80 -39.41 16.11 71.18 -39.17 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 9 3 # 9 92 SER D 65 SER^? 5.84 N MLY D 56 201 HIS D 67 HIS^? 7.34 O MLY C 92 250 GLN C 78 GLN^? 4.49 CD MLY C 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 18.90 93.40 -41.01 17.66 92.55 -42.90 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 19.22 88.39 -40.34 17.47 88.29 -41.46 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 10 3 # 10 92 SER D 96 SER^? 5.96 O MLY D 72 201 HIS C 76 HIS^? 7.27 O MLY C 92 250 GLN D 98 GLN^? 7.57 CH2 MLY D 104 coo 38.34 0.72 11.82 37.33 1.15 14.05 22.18 75.94 -47.53 23.49 74.14 -46.77 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 22.40 81.23 -44.05 20.46 80.64 -44.59 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 16.59 80.12 -46.90 17.21 82.12 -47.27 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 11 3 # 11 92 SER E 65 SER^? 4.83 N MLY E 56 201 HIS E 67 HIS^? 7.33 CH2 MLY E 104 250 GLN A 78 GLN^? 4.04 CH2 MLY A 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 16.26 52.91 -64.19 14.97 52.38 -62.27 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 17.04 57.32 -61.85 15.23 57.01 -60.79 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 12 3 # 12 92 SER E 68 SER^? 8.34 C MLY E 49 201 HIS E 67 HIS^? 7.33 CH2 MLY E 104 250 GLN A 78 GLN^? 4.04 CH2 MLY A 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 23.32 56.54 -58.94 24.53 56.34 -61.01 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 17.04 57.32 -61.85 15.23 57.01 -60.79 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 13 3 # 13 92 SER E 96 SER^? 5.86 O MLY E 72 201 HIS A 76 HIS^? 7.10 O MLY A 92 250 GLN E 98 GLN^? 9.14 CD MLY A 92 coo 38.34 0.72 11.82 37.33 1.15 14.05 20.41 63.14 -48.27 21.90 65.05 -48.29 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 20.27 61.30 -55.15 18.31 61.65 -54.51 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 15.60 61.89 -51.50 14.20 63.00 -52.67 1mla_c00 source 1mla MALONYL-COENZYME A ACYL CARRIER PROTEIN TRANSA: 13 hits 1mla_c00 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 28 GLY.? 4.82 CH1 MLY D 117 A 501 ASP A 42 ASP^? 3.07 NZ MLY A 104 B 367 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 35.13 83.16 -63.26 35.19 83.02 -64.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 28 GLY.? 4.82 CH1 MLY D 117 A 501 ASP A 55 ASP^? 3.55 CH2 MLY A 104 B 367 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 35.13 83.16 -63.26 35.19 83.02 -64.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 83 GLY^? 7.64 CG MLY A 107 A 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 367 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 97 GLY^? 10.02 O MLY A 72 A 501 ASP E 55 ASP^? 3.37 N MLY E 56 B 367 TYR B 122 TYR^? 6.49 N MLY B 49 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 18.19 71.63 -50.83 18.06 71.10 -51.41 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 32.21 58.64 -31.04 33.28 56.43 -29.79 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 58 GLY^? 5.49 CB MLY B 63 A 501 ASP B 111 ASP^? 8.02 CB MLY B 117 B 367 TYR E 37 TYR^? 5.92 N MLY E 38 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 5.68 46.13 -30.22 6.16 46.29 -29.57 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 24.09 56.67 -18.17 25.86 57.71 -17.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 24.28 42.38 -52.54 26.48 42.21 -50.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY B 61 GLY^? 2.45 N MLY B 62 A 501 ASP B 111 ASP^? 8.02 CB MLY B 117 B 367 TYR E 37 TYR^? 5.92 N MLY E 38 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 9.36 43.37 -28.22 9.03 42.74 -28.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 24.09 56.67 -18.17 25.86 57.71 -17.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 24.28 42.38 -52.54 26.48 42.21 -50.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY B 83 GLY^? 7.45 O MLY C 62 A 501 ASP B 55 ASP^? 2.74 NZ MLY B 104 B 367 TYR C 122 TYR^? 7.12 N MLY C 49 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 17.29 66.64 -14.32 16.50 66.35 -14.43 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 33.60 80.42 -32.80 34.88 80.54 -30.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 97 GLY^? 8.30 O MLY E 72 A 501 ASP B 55 ASP^? 2.74 NZ MLY B 104 B 367 TYR C 37 TYR^? 5.94 N MLY C 38 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 20.42 66.45 -45.35 20.23 66.16 -44.64 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 97 GLY^? 8.30 O MLY E 72 A 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 367 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 20.42 66.45 -45.35 20.23 66.16 -44.64 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY B 97 GLY^? 8.30 O MLY E 72 A 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 367 TYR B 37 TYR^? 5.81 N MLY B 38 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 20.42 66.45 -45.35 20.23 66.16 -44.64 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY C 28 GLY^? 4.67 CE MLY B 117 A 501 ASP C 42 ASP^? 3.04 NZ MLY C 104 B 367 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 35.09 66.57 -24.01 35.09 67.19 -23.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 19.82 45.97 -35.59 19.43 43.56 -34.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY C 83 GLY^? 6.95 NZ MLY D 63 A 501 ASP D 42 ASP^? 3.03 NZ MLY D 104 B 367 TYR C 66 TYR^? 7.67 C MLY C 63 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY C 97 GLY^? 7.40 O2 GOL C2126 A 501 ASP C 42 ASP^? 3.04 NZ MLY C 104 B 367 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 19.85 70.30 -42.97 19.72 71.05 -42.79 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 19.82 45.97 -35.59 19.43 43.56 -34.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY C 97 GLY^? 7.40 O2 GOL C2126 A 501 ASP C 42 ASP^? 3.04 NZ MLY C 104 B 367 TYR D 37 TYR^? 5.94 N MLY D 38 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 19.85 70.30 -42.97 19.72 71.05 -42.79 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 27.03 94.32 -56.77 29.28 93.30 -58.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY D 28 GLY^? 4.52 NZ MLY C 117 A 501 ASP D 42 ASP^? 3.03 NZ MLY D 104 B 367 TYR C 66 TYR^? 7.67 C MLY C 63 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 35.81 89.39 -38.07 35.92 90.19 -38.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY D 61 GLY^? 2.45 N MLY D 62 A 501 ASP D 111 ASP^? 7.67 CB MLY D 117 B 367 TYR C 37 TYR^? 5.94 N MLY C 38 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 15.30 103.31 -42.19 14.96 103.47 -41.46 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 27.01 96.00 -62.25 28.81 95.13 -62.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY D 83 GLY^? -3.44 O MLY A 62s A 501 ASP D 42 ASP^? 3.03 NZ MLY D 104 B 367 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 11.73 87.92 -71.70 11.80 88.76 -71.59 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY D 114 GLY^? 4.53 N MLY D 117 A 501 ASP D 86 ASP^? 8.22 CH1 MLY A 63 B 367 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 29.18 91.87 -63.07 28.51 91.45 -62.96 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 6.01 94.81 -68.58 5.43 92.90 -69.25 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY E 28 GLY^? 4.62 CE MLY A 117 A 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 367 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 33.91 56.81 -64.88 33.92 55.95 -65.02 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY E 83 GLY^? 4.16 O MLY B 62 A 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 367 TYR B 37 TYR^? 5.81 N MLY B 38 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 9.06 38.01 -35.45 9.80 38.36 -35.35 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY E 97 GLY^? 9.86 O MLY E 72 A 501 ASP B 55 ASP^? 2.74 NZ MLY B 104 B 367 TYR C 122 TYR^? 7.12 N MLY C 49 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 17.65 65.64 -49.15 17.45 64.90 -48.93 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 33.60 80.42 -32.80 34.88 80.54 -30.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY E 97 GLY^? 9.86 O MLY E 72 A 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 367 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 17.65 65.64 -49.15 17.45 64.90 -48.93 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 22.17 81.84 -68.52 22.05 83.01 -71.05 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 22 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 28 GLY.? 4.82 CH1 MLY D 117 D 501 ASP A 42 ASP^? 3.07 NZ MLY A 104 E 367 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 35.13 83.16 -63.26 35.19 83.02 -64.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 28 GLY.? 4.82 CH1 MLY D 117 D 501 ASP A 55 ASP^? 3.55 CH2 MLY A 104 E 367 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 35.13 83.16 -63.26 35.19 83.02 -64.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 23.81 93.85 -40.58 24.25 96.59 -40.12 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 83 GLY^? 7.64 CG MLY A 107 D 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 E 367 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 97 GLY^? 10.02 O MLY A 72 D 501 ASP E 55 ASP^? 3.37 N MLY E 56 E 367 TYR B 122 TYR^? 6.49 N MLY B 49 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 18.19 71.63 -50.83 18.06 71.10 -51.41 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 32.21 58.64 -31.04 33.28 56.43 -29.79 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 28 GLY^? 4.51 CE MLY E 117 D 501 ASP B 55 ASP^? 2.74 NZ MLY B 104 E 367 TYR E 66 TYR^? -3.37 C3 PEG E4126s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.60 46.29 -40.92 32.70 45.96 -40.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.78 52.34 -65.13 20.44 50.34 -67.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 61 GLY^? 2.45 N MLY B 62 D 501 ASP B 111 ASP^? 8.02 CB MLY B 117 E 367 TYR E 37 TYR^? 5.92 N MLY E 38 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 9.36 43.37 -28.22 9.03 42.74 -28.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 24.09 56.67 -18.17 25.86 57.71 -17.69 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 24.28 42.38 -52.54 26.48 42.21 -50.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 83 GLY^? 7.45 O MLY C 62 D 501 ASP B 55 ASP^? 2.74 NZ MLY B 104 E 367 TYR C 122 TYR^? 7.12 N MLY C 49 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 17.29 66.64 -14.32 16.50 66.35 -14.43 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 33.60 80.42 -32.80 34.88 80.54 -30.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY B 97 GLY^? 8.30 O MLY E 72 D 501 ASP B 55 ASP^? 2.74 NZ MLY B 104 E 367 TYR C 37 TYR^? 5.94 N MLY C 38 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 20.42 66.45 -45.35 20.23 66.16 -44.64 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY B 97 GLY^? 8.30 O MLY E 72 D 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 E 367 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 20.42 66.45 -45.35 20.23 66.16 -44.64 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 97 GLY^? 8.30 O MLY E 72 D 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 E 367 TYR B 37 TYR^? 5.81 N MLY B 38 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 20.42 66.45 -45.35 20.23 66.16 -44.64 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY C 28 GLY^? 4.67 CE MLY B 117 D 501 ASP C 42 ASP^? 3.04 NZ MLY C 104 E 367 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 35.09 66.57 -24.01 35.09 67.19 -23.42 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 19.82 45.97 -35.59 19.43 43.56 -34.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY C 83 GLY^? 6.95 NZ MLY D 63 D 501 ASP D 42 ASP^? 3.03 NZ MLY D 104 E 367 TYR C 66 TYR^? 7.67 C MLY C 63 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY C 97 GLY^? 7.40 O2 GOL C2126 D 501 ASP B 55 ASP^? 2.74 NZ MLY B 104 E 367 TYR E 66 TYR^? -3.37 C3 PEG E4126s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 19.85 70.30 -42.97 19.72 71.05 -42.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.78 52.34 -65.13 20.44 50.34 -67.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY C 97 GLY^? 7.40 O2 GOL C2126 D 501 ASP C 42 ASP^? 3.04 NZ MLY C 104 E 367 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 19.85 70.30 -42.97 19.72 71.05 -42.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 19.82 45.97 -35.59 19.43 43.56 -34.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY C 97 GLY^? 7.40 O2 GOL C2126 D 501 ASP C 42 ASP^? 3.04 NZ MLY C 104 E 367 TYR D 37 TYR^? 5.94 N MLY D 38 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 19.85 70.30 -42.97 19.72 71.05 -42.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 27.03 94.32 -56.77 29.28 93.30 -58.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY D 28 GLY^? 4.52 NZ MLY C 117 D 501 ASP D 42 ASP^? 3.03 NZ MLY D 104 E 367 TYR C 66 TYR^? 7.67 C MLY C 63 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 35.81 89.39 -38.07 35.92 90.19 -38.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.79 71.25 -21.62 21.33 71.81 -18.88 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY D 61 GLY^? 2.45 N MLY D 62 D 501 ASP D 111 ASP^? 7.67 CB MLY D 117 E 367 TYR C 37 TYR^? 5.94 N MLY C 38 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 15.30 103.31 -42.19 14.96 103.47 -41.46 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 27.01 96.00 -62.25 28.81 95.13 -62.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY D 83 GLY^? -3.44 O MLY A 62s D 501 ASP D 42 ASP^? 3.03 NZ MLY D 104 E 367 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 11.73 87.92 -71.70 11.80 88.76 -71.59 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY D 114 GLY^? 4.53 N MLY D 117 D 501 ASP D 86 ASP^? 8.22 CH1 MLY A 63 E 367 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 29.18 91.87 -63.07 28.51 91.45 -62.96 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 6.01 94.81 -68.58 5.43 92.90 -69.25 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY E 28 GLY^? 4.62 CE MLY A 117 D 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 E 367 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 33.91 56.81 -64.88 33.92 55.95 -65.02 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY E 83 GLY^? 4.16 O MLY B 62 D 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 E 367 TYR B 37 TYR^? 5.81 N MLY B 38 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 9.06 38.01 -35.45 9.80 38.36 -35.35 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY E 97 GLY^? 9.86 O MLY E 72 D 501 ASP B 55 ASP^? 2.74 NZ MLY B 104 E 367 TYR C 122 TYR^? 7.12 N MLY C 49 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 17.65 65.64 -49.15 17.45 64.90 -48.93 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 33.60 80.42 -32.80 34.88 80.54 -30.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY E 97 GLY^? 9.86 O MLY E 72 D 501 ASP E 42 ASP^? 3.02 NZ MLY E 104 E 367 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 17.65 65.64 -49.15 17.45 64.90 -48.93 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 22.17 81.84 -68.52 22.05 83.01 -71.05 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 23 hits 1mro_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 197 ASP B 55 ASP^? 2.74 NZ MLY B 104 A 223 ALA E 89 ALA^? 6.15 N MLY E 107 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 18.03 54.22 -37.13 17.47 55.93 -38.18 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 14.45 50.68 -30.88 15.66 52.47 -30.45 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 13.32 41.94 -42.69 14.68 41.23 -42.73 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 197 ASP C 55 ASP^? 3.93 N MLY C 56 A 223 ALA B 89 ALA^? 5.31 CH1 MLY C 63 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 16.82 77.26 -24.21 14.93 78.15 -24.18 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 14.54 63.64 -20.90 16.02 63.63 -20.57 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS D 67 HIS^? 7.34 O MLY C 92 A 197 ASP D 55 ASP^? 3.95 N MLY D 56 A 223 ALA C 89 ALA^? 6.02 N MLY C 107 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 17.41 92.58 -31.86 18.92 92.61 -31.93 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS D 67 HIS^? 7.34 O MLY C 92 A 197 ASP D 55 ASP^? 3.95 N MLY D 56 A 223 ALA D 36 ALA^? 5.90 N MLY D 38 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 29.13 96.10 -52.90 29.07 97.20 -51.85 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS E 67 HIS^? 7.33 CH2 MLY E 104 A 197 ASP E 55 ASP^? 3.37 N MLY E 56 A 223 ALA A 89 ALA^? 4.05 O1 PEG E4126 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 14.69 49.71 -60.49 12.90 49.11 -59.47 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 16.00 58.61 -71.58 17.49 58.35 -71.38 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 5 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS B 67 HIS^? -4.73 O3 GOL B1126s B 197 ASP B 55 ASP^? 2.74 NZ MLY B 104 B 223 ALA E 89 ALA^? 6.15 N MLY E 107 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 18.03 54.22 -37.13 17.47 55.93 -38.18 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 14.45 50.68 -30.88 15.66 52.47 -30.45 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 13.32 41.94 -42.69 14.68 41.23 -42.73 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS C 67 HIS^? -4.41 O3 GOL C2126s B 197 ASP C 55 ASP^? 3.93 N MLY C 56 B 223 ALA B 89 ALA^? 5.31 CH1 MLY C 63 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 16.82 77.26 -24.21 14.93 78.15 -24.18 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 14.54 63.64 -20.90 16.02 63.63 -20.57 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS D 67 HIS^? 7.34 O MLY C 92 B 197 ASP D 55 ASP^? 3.95 N MLY D 56 B 223 ALA C 89 ALA^? 6.02 N MLY C 107 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 17.41 92.58 -31.86 18.92 92.61 -31.93 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS D 67 HIS^? 7.34 O MLY C 92 B 197 ASP D 55 ASP^? 3.95 N MLY D 56 B 223 ALA D 36 ALA^? 5.90 N MLY D 38 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 29.13 96.10 -52.90 29.07 97.20 -51.85 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS E 67 HIS^? 7.33 CH2 MLY E 104 B 197 ASP E 55 ASP^? 3.37 N MLY E 56 B 223 ALA A 89 ALA^? 4.05 O1 PEG E4126 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 14.69 49.71 -60.49 12.90 49.11 -59.47 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 16.00 58.61 -71.58 17.49 58.35 -71.38 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 5 hits 1n2t_c03 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 90 GLU^? 4.57 CE MLY A 92 B 128 HIS A 76 HIS^? 7.10 O MLY A 92 C 263 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 6.12 5.94 82.00 7.16 6.32 83.81 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 12.51 16.35 80.99 13.16 14.90 82.37 20.27 61.30 -55.15 18.31 61.65 -54.51 coo 11.58 14.94 93.26 12.25 14.03 91.50 11.74 66.03 -51.26 10.97 64.13 -50.86 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 90 GLU^? 4.57 CE MLY A 92 B 128 HIS E 67 HIS^? 7.33 CH2 MLY E 104 C 263 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 6.12 5.94 82.00 7.16 6.32 83.81 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 12.51 16.35 80.99 13.16 14.90 82.37 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 11.58 14.94 93.26 12.25 14.03 91.50 11.74 66.03 -51.26 10.97 64.13 -50.86 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU A 100 GLU^? 8.29 NZ MLY A 92 B 128 HIS A 76 HIS^? 7.10 O MLY A 92 C 263 HIS D 76 HIS^? 7.07 O MLY D 92 coo 6.12 5.94 82.00 7.16 6.32 83.81 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 12.51 16.35 80.99 13.16 14.90 82.37 20.27 61.30 -55.15 18.31 61.65 -54.51 coo 11.58 14.94 93.26 12.25 14.03 91.50 21.19 75.42 -56.78 19.17 75.05 -56.40 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU A 100 GLU^? 8.29 NZ MLY A 92 B 128 HIS D 99 HIS^? 11.73 CH2 MLY D 92 C 263 HIS D 76 HIS^? 7.07 O MLY D 92 coo 6.12 5.94 82.00 7.16 6.32 83.81 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 12.51 16.35 80.99 13.16 14.90 82.37 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 11.58 14.94 93.26 12.25 14.03 91.50 21.19 75.42 -56.78 19.17 75.05 -56.40 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU B 90 GLU^? 4.73 CE MLY B 92 B 128 HIS B 76 HIS^? -4.78 C3 GOL C2126s C 263 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 6.12 5.94 82.00 7.16 6.32 83.81 13.18 64.24 -26.74 11.27 65.00 -27.34 coo 12.51 16.35 80.99 13.16 14.90 82.37 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 11.58 14.94 93.26 12.25 14.03 91.50 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 B 59 GLU B 90 GLU^? 4.73 CE MLY B 92 B 128 HIS B 76 HIS^? -4.78 C3 GOL C2126s C 263 HIS E 76 HIS^? -4.59 O1 GOL B1126s coo 6.12 5.94 82.00 7.16 6.32 83.81 13.18 64.24 -26.74 11.27 65.00 -27.34 coo 12.51 16.35 80.99 13.16 14.90 82.37 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 11.58 14.94 93.26 12.25 14.03 91.50 19.53 58.10 -41.26 17.57 58.86 -41.26 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 B 59 GLU C 100 GLU^? -7.78 O1 GOL C2126s B 128 HIS C 76 HIS^? 7.27 O MLY C 92 C 263 HIS B 76 HIS^? -4.78 C3 GOL C2126s coo 6.12 5.94 82.00 7.16 6.32 83.81 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 12.51 16.35 80.99 13.16 14.90 82.37 22.40 81.23 -44.05 20.46 80.64 -44.59 coo 11.58 14.94 93.26 12.25 14.03 91.50 22.13 70.54 -35.03 20.24 71.08 -35.76 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 B 59 GLU D 90 GLU^? 4.45 CE MLY D 92 B 128 HIS D 76 HIS^? 7.07 O MLY D 92 C 263 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 6.12 5.94 82.00 7.16 6.32 83.81 14.28 86.95 -60.58 12.27 86.36 -60.48 coo 12.51 16.35 80.99 13.16 14.90 82.37 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 11.58 14.94 93.26 12.25 14.03 91.50 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 B 59 GLU E 90 GLU^? 4.38 CE MLY E 92 B 128 HIS B 67 HIS^? -4.73 O3 GOL B1126s C 263 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 6.12 5.94 82.00 7.16 6.32 83.81 11.64 47.22 -44.78 9.75 48.01 -44.25 coo 12.51 16.35 80.99 13.16 14.90 82.37 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 11.58 14.94 93.26 12.25 14.03 91.50 10.43 63.28 -44.90 9.66 63.00 -42.97 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 10 3 # 10 B 59 GLU E 90 GLU^? 4.38 CE MLY E 92 B 128 HIS E 76 HIS^? -4.59 O1 GOL B1126s C 263 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 6.12 5.94 82.00 7.16 6.32 83.81 11.64 47.22 -44.78 9.75 48.01 -44.25 coo 12.51 16.35 80.99 13.16 14.90 82.37 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 11.58 14.94 93.26 12.25 14.03 91.50 10.43 63.28 -44.90 9.66 63.00 -42.97 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 10 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 99 HIS^? 11.42 NZ MLY A 92 D 59 GLU A 90 GLU^? 4.57 CE MLY A 92 D 128 HIS A 76 HIS^? 7.10 O MLY A 92 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 20.27 61.30 -55.15 18.31 61.65 -54.51 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 99 HIS^? 11.42 NZ MLY A 92 D 59 GLU A 90 GLU^? 4.57 CE MLY A 92 D 128 HIS E 67 HIS^? 7.33 CH2 MLY E 104 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 13.22 61.52 -67.04 11.19 61.45 -66.51 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 18.54 56.25 -57.78 18.20 57.67 -56.27 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS B 76 HIS^? -4.78 C3 GOL C2126s D 59 GLU C 100 GLU^? -7.78 O1 GOL C2126s D 128 HIS C 76 HIS^? 7.27 O MLY C 92 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS B 99 HIS^? 8.19 O2 GOL C2126 D 59 GLU B 90 GLU^? 4.73 CE MLY B 92 D 128 HIS B 76 HIS^? -4.78 C3 GOL C2126s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 13.18 64.24 -26.74 11.27 65.00 -27.34 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 22.13 70.54 -35.03 20.24 71.08 -35.76 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 A 263 HIS D 76 HIS^? 7.07 O MLY D 92 D 59 GLU A 100 GLU^? 8.29 NZ MLY A 92 D 128 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 A 263 HIS D 76 HIS^? 7.07 O MLY D 92 D 59 GLU D 100 GLU^? 8.65 CH2 MLY D 92 D 128 HIS C 76 HIS^? 7.27 O MLY C 92 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 11.08 79.64 -49.38 10.05 78.59 -50.94 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 A 263 HIS D 99 HIS^? 11.73 CH2 MLY D 92 D 59 GLU D 90 GLU^? 4.45 CE MLY D 92 D 128 HIS D 76 HIS^? 7.07 O MLY D 92 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 14.28 86.95 -60.58 12.27 86.36 -60.48 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 21.19 75.42 -56.78 19.17 75.05 -56.40 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 A 263 HIS E 76 HIS^? -4.59 O1 GOL B1126s D 59 GLU B 90 GLU^? 4.73 CE MLY B 92 D 128 HIS B 76 HIS^? -4.78 C3 GOL C2126s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 13.18 64.24 -26.74 11.27 65.00 -27.34 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 22.13 70.54 -35.03 20.24 71.08 -35.76 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 A 263 HIS E 99 HIS^? 5.87 C1 GOL B1126 D 59 GLU E 90 GLU^? 4.38 CE MLY E 92 D 128 HIS B 67 HIS^? -4.73 O3 GOL B1126s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 11.64 47.22 -44.78 9.75 48.01 -44.25 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 18.03 54.22 -37.13 17.47 55.93 -38.18 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 10 3 # 10 A 263 HIS E 99 HIS^? 5.87 C1 GOL B1126 D 59 GLU E 90 GLU^? 4.38 CE MLY E 92 D 128 HIS E 76 HIS^? -4.59 O1 GOL B1126s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 11.64 47.22 -44.78 9.75 48.01 -44.25 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 19.53 58.10 -41.26 17.57 58.86 -41.26 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 10 hits 1ni4_c01 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 108 ARG^? 7.18 O1 PEG E4126 A 101 ASP A 88 ASP^? 3.30 CG MLY A 107 A 132 ASP A 86 ASP^? 4.13 CB MLY E 62 coo 11.61 22.83 17.30 14.06 21.71 15.78 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 11.37 24.94 11.48 12.48 24.45 13.28 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 16.14 18.17 13.37 15.92 19.81 14.71 10.80 52.06 -74.41 9.44 51.94 -72.75 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 108 ARG^? 7.66 C MLY B 107s A 101 ASP B 86 ASP^? 8.21 CH2 MLY B 107 A 132 ASP B 88 ASP^? 3.13 NZ MLY B 107 coo 11.61 22.83 17.30 14.06 21.71 15.78 14.28 61.53 -14.52 14.41 61.31 -11.40 coo 11.37 24.94 11.48 12.48 24.45 13.28 8.64 63.45 -11.70 8.10 61.49 -11.14 coo 16.14 18.17 13.37 15.92 19.81 14.71 11.27 60.93 -19.56 10.57 59.24 -18.48 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 108 ARG^? 7.66 C MLY B 107s A 101 ASP B 88 ASP^? 3.13 NZ MLY B 107 A 132 ASP B 86 ASP^? 8.21 CH2 MLY B 107 coo 11.61 22.83 17.30 14.06 21.71 15.78 14.28 61.53 -14.52 14.41 61.31 -11.40 coo 11.37 24.94 11.48 12.48 24.45 13.28 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 16.14 18.17 13.37 15.92 19.81 14.71 8.64 63.45 -11.70 8.10 61.49 -11.14 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG D 108 ARG^? -4.43 O2 GOL D3126s A 101 ASP D 88 ASP^? 3.08 NZ MLY D 107 A 132 ASP D 86 ASP^? 8.22 CH1 MLY A 63 coo 11.61 22.83 17.30 14.06 21.71 15.78 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 11.37 24.94 11.48 12.48 24.45 13.28 13.64 92.96 -63.76 13.01 94.95 -63.51 coo 16.14 18.17 13.37 15.92 19.81 14.71 6.01 94.81 -68.58 5.43 92.90 -69.25 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG E 108 ARG^? 5.63 NZ MLY E 107 A 101 ASP E 86 ASP^? 8.77 C MLY E 107 A 132 ASP E 88 ASP^? 7.64 NZ MLY E 107 coo 11.61 22.83 17.30 14.06 21.71 15.78 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 11.37 24.94 11.48 12.48 24.45 13.28 9.40 32.25 -40.91 9.16 32.31 -43.02 coo 16.14 18.17 13.37 15.92 19.81 14.71 9.12 40.44 -42.05 7.36 39.34 -42.35 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG E 108 ARG^? 5.63 NZ MLY E 107 A 101 ASP E 88 ASP^? 7.64 NZ MLY E 107 A 132 ASP E 86 ASP^? 8.77 C MLY E 107 coo 11.61 22.83 17.30 14.06 21.71 15.78 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 11.37 24.94 11.48 12.48 24.45 13.28 9.12 40.44 -42.05 7.36 39.34 -42.35 coo 16.14 18.17 13.37 15.92 19.81 14.71 9.40 32.25 -40.91 9.16 32.31 -43.02 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 6 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 108 ARG^? 7.18 O1 PEG E4126 B 101 ASP A 88 ASP^? 3.30 CG MLY A 107 B 132 ASP A 86 ASP^? 4.13 CB MLY E 62 coo 11.61 3.43 18.38 9.11 4.29 16.86 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 11.74 0.51 12.98 10.75 1.32 14.67 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 6.93 7.52 14.08 7.18 6.08 15.65 10.80 52.06 -74.41 9.44 51.94 -72.75 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 108 ARG^? 7.66 C MLY B 107s B 101 ASP B 86 ASP^? 8.21 CH2 MLY B 107 B 132 ASP B 88 ASP^? 3.13 NZ MLY B 107 coo 11.61 3.43 18.38 9.11 4.29 16.86 14.28 61.53 -14.52 14.41 61.31 -11.40 coo 11.74 0.51 12.98 10.75 1.32 14.67 8.64 63.45 -11.70 8.10 61.49 -11.14 coo 6.93 7.52 14.08 7.18 6.08 15.65 11.27 60.93 -19.56 10.57 59.24 -18.48 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 108 ARG^? 7.66 C MLY B 107s B 101 ASP B 88 ASP^? 3.13 NZ MLY B 107 B 132 ASP B 86 ASP^? 8.21 CH2 MLY B 107 coo 11.61 3.43 18.38 9.11 4.29 16.86 14.28 61.53 -14.52 14.41 61.31 -11.40 coo 11.74 0.51 12.98 10.75 1.32 14.67 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 6.93 7.52 14.08 7.18 6.08 15.65 8.64 63.45 -11.70 8.10 61.49 -11.14 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG D 108 ARG^? -4.43 O2 GOL D3126s B 101 ASP D 88 ASP^? 3.08 NZ MLY D 107 B 132 ASP D 86 ASP^? 8.22 CH1 MLY A 63 coo 11.61 3.43 18.38 9.11 4.29 16.86 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 11.74 0.51 12.98 10.75 1.32 14.67 13.64 92.96 -63.76 13.01 94.95 -63.51 coo 6.93 7.52 14.08 7.18 6.08 15.65 6.01 94.81 -68.58 5.43 92.90 -69.25 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG E 108 ARG^? 5.63 NZ MLY E 107 B 101 ASP E 86 ASP^? 8.77 C MLY E 107 B 132 ASP E 88 ASP^? 7.64 NZ MLY E 107 coo 11.61 3.43 18.38 9.11 4.29 16.86 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 11.74 0.51 12.98 10.75 1.32 14.67 9.40 32.25 -40.91 9.16 32.31 -43.02 coo 6.93 7.52 14.08 7.18 6.08 15.65 9.12 40.44 -42.05 7.36 39.34 -42.35 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG E 108 ARG^? 5.63 NZ MLY E 107 B 101 ASP E 88 ASP^? 7.64 NZ MLY E 107 B 132 ASP E 86 ASP^? 8.77 C MLY E 107 coo 11.61 3.43 18.38 9.11 4.29 16.86 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 11.74 0.51 12.98 10.75 1.32 14.67 9.12 40.44 -42.05 7.36 39.34 -42.35 coo 6.93 7.52 14.08 7.18 6.08 15.65 9.40 32.25 -40.91 9.16 32.31 -43.02 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 6 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 108 ARG^? 7.18 O1 PEG E4126 A 101 ASP A 88 ASP^? 3.30 CG MLY A 107 A 132 ASP A 86 ASP^? 4.13 CB MLY E 62 coo 11.50 22.77 17.24 14.00 21.62 15.86 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 11.19 25.00 11.76 12.16 24.45 13.59 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 16.04 18.11 13.43 15.88 19.70 14.83 10.80 52.06 -74.41 9.44 51.94 -72.75 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 108 ARG^? 7.66 C MLY B 107s A 101 ASP B 86 ASP^? 8.21 CH2 MLY B 107 A 132 ASP B 88 ASP^? 3.13 NZ MLY B 107 coo 11.50 22.77 17.24 14.00 21.62 15.86 14.28 61.53 -14.52 14.41 61.31 -11.40 coo 11.19 25.00 11.76 12.16 24.45 13.59 8.64 63.45 -11.70 8.10 61.49 -11.14 coo 16.04 18.11 13.43 15.88 19.70 14.83 11.27 60.93 -19.56 10.57 59.24 -18.48 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 108 ARG^? 7.66 C MLY B 107s A 101 ASP B 88 ASP^? 3.13 NZ MLY B 107 A 132 ASP B 86 ASP^? 8.21 CH2 MLY B 107 coo 11.50 22.77 17.24 14.00 21.62 15.86 14.28 61.53 -14.52 14.41 61.31 -11.40 coo 11.19 25.00 11.76 12.16 24.45 13.59 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 16.04 18.11 13.43 15.88 19.70 14.83 8.64 63.45 -11.70 8.10 61.49 -11.14 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG E 108 ARG^? 5.63 NZ MLY E 107 A 101 ASP E 86 ASP^? 8.77 C MLY E 107 A 132 ASP E 88 ASP^? 7.64 NZ MLY E 107 coo 11.50 22.77 17.24 14.00 21.62 15.86 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 11.19 25.00 11.76 12.16 24.45 13.59 9.40 32.25 -40.91 9.16 32.31 -43.02 coo 16.04 18.11 13.43 15.88 19.70 14.83 9.12 40.44 -42.05 7.36 39.34 -42.35 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG E 108 ARG^? 5.63 NZ MLY E 107 A 101 ASP E 88 ASP^? 7.64 NZ MLY E 107 A 132 ASP E 86 ASP^? 8.77 C MLY E 107 coo 11.50 22.77 17.24 14.00 21.62 15.86 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 11.19 25.00 11.76 12.16 24.45 13.59 9.12 40.44 -42.05 7.36 39.34 -42.35 coo 16.04 18.11 13.43 15.88 19.70 14.83 9.40 32.25 -40.91 9.16 32.31 -43.02 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 5 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 108 ARG^? 7.18 O1 PEG E4126 B 101 ASP A 88 ASP^? 3.30 CG MLY A 107 B 132 ASP A 86 ASP^? 4.13 CB MLY E 62 coo 11.48 3.09 18.25 9.01 4.07 16.77 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 11.83 0.33 13.01 10.88 1.04 14.81 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 6.85 7.33 14.07 7.10 5.88 15.60 10.80 52.06 -74.41 9.44 51.94 -72.75 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 108 ARG^? 7.66 C MLY B 107s B 101 ASP B 86 ASP^? 8.21 CH2 MLY B 107 B 132 ASP B 88 ASP^? 3.13 NZ MLY B 107 coo 11.48 3.09 18.25 9.01 4.07 16.77 14.28 61.53 -14.52 14.41 61.31 -11.40 coo 11.83 0.33 13.01 10.88 1.04 14.81 8.64 63.45 -11.70 8.10 61.49 -11.14 coo 6.85 7.33 14.07 7.10 5.88 15.60 11.27 60.93 -19.56 10.57 59.24 -18.48 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 108 ARG^? 7.66 C MLY B 107s B 101 ASP B 88 ASP^? 3.13 NZ MLY B 107 B 132 ASP B 86 ASP^? 8.21 CH2 MLY B 107 coo 11.48 3.09 18.25 9.01 4.07 16.77 14.28 61.53 -14.52 14.41 61.31 -11.40 coo 11.83 0.33 13.01 10.88 1.04 14.81 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 6.85 7.33 14.07 7.10 5.88 15.60 8.64 63.45 -11.70 8.10 61.49 -11.14 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG D 108 ARG^? -4.43 O2 GOL D3126s B 101 ASP D 88 ASP^? 3.08 NZ MLY D 107 B 132 ASP D 86 ASP^? 8.22 CH1 MLY A 63 coo 11.48 3.09 18.25 9.01 4.07 16.77 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 11.83 0.33 13.01 10.88 1.04 14.81 13.64 92.96 -63.76 13.01 94.95 -63.51 coo 6.85 7.33 14.07 7.10 5.88 15.60 6.01 94.81 -68.58 5.43 92.90 -69.25 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG E 108 ARG^? 5.63 NZ MLY E 107 B 101 ASP E 86 ASP^? 8.77 C MLY E 107 B 132 ASP E 88 ASP^? 7.64 NZ MLY E 107 coo 11.48 3.09 18.25 9.01 4.07 16.77 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 11.83 0.33 13.01 10.88 1.04 14.81 9.40 32.25 -40.91 9.16 32.31 -43.02 coo 6.85 7.33 14.07 7.10 5.88 15.60 9.12 40.44 -42.05 7.36 39.34 -42.35 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG E 108 ARG^? 5.63 NZ MLY E 107 B 101 ASP E 88 ASP^? 7.64 NZ MLY E 107 B 132 ASP E 86 ASP^? 8.77 C MLY E 107 coo 11.48 3.09 18.25 9.01 4.07 16.77 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 11.83 0.33 13.01 10.88 1.04 14.81 9.12 40.44 -42.05 7.36 39.34 -42.35 coo 6.85 7.33 14.07 7.10 5.88 15.60 9.40 32.25 -40.91 9.16 32.31 -43.02 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 6 hits 1nww_c03 naa= 3 ULMN 3 1opm_c00 1.14.17.0003 user 1 3 # 1 A 108 HIS A 99 HIS^? 11.42 NZ MLY A 92 A 170 GLN E 98 GLN^? 9.14 CD MLY A 92 A 242 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 36.16 34.36 39.40 38.12 34.09 40.00 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 40.85 35.41 43.73 41.85 33.73 42.88 15.60 61.89 -51.50 14.20 63.00 -52.67 coo 40.72 26.15 37.61 42.10 27.69 37.19 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 1opm_c00 1.14.17.0003 user 2 3 # 2 A 108 HIS B 99 HIS^? 8.19 O2 GOL C2126 A 170 GLN B 98 GLN^? -4.27 O1 GOL B1126s A 242 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 36.16 34.36 39.40 38.12 34.09 40.00 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 40.85 35.41 43.73 41.85 33.73 42.88 18.15 63.11 -42.95 16.88 62.03 -44.28 coo 40.72 26.15 37.61 42.10 27.69 37.19 11.74 66.03 -51.26 10.97 64.13 -50.86 ULMN 3 1opm_c00 1.14.17.0003 user 3 3 # 3 A 108 HIS B 99 HIS^? 8.19 O2 GOL C2126 A 170 GLN C 98 GLN^? -3.27 O2 GOL C2126s A 242 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 36.16 34.36 39.40 38.12 34.09 40.00 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 40.85 35.41 43.73 41.85 33.73 42.88 17.44 72.80 -39.41 16.11 71.18 -39.17 coo 40.72 26.15 37.61 42.10 27.69 37.19 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 1opm_c00 1.14.17.0003 user 4 3 # 4 A 108 HIS C 99 HIS^? 9.14 O1 GOL C2126 A 170 GLN C 98 GLN^? -3.27 O2 GOL C2126s A 242 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 36.16 34.36 39.40 38.12 34.09 40.00 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 40.85 35.41 43.73 41.85 33.73 42.88 17.44 72.80 -39.41 16.11 71.18 -39.17 coo 40.72 26.15 37.61 42.10 27.69 37.19 10.43 63.28 -44.90 9.66 63.00 -42.97 ULMN 3 1opm_c00 1.14.17.0003 user 5 3 # 5 A 108 HIS D 99 HIS^? 11.73 CH2 MLY D 92 A 170 GLN D 98 GLN^? 7.57 CH2 MLY D 104 A 242 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 36.16 34.36 39.40 38.12 34.09 40.00 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 40.85 35.41 43.73 41.85 33.73 42.88 16.59 80.12 -46.90 17.21 82.12 -47.27 coo 40.72 26.15 37.61 42.10 27.69 37.19 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 1opm_c00 1.14.17.0003 user 6 3 # 6 A 108 HIS E 99 HIS^? 5.87 C1 GOL B1126 A 170 GLN B 98 GLN^? -4.27 O1 GOL B1126s A 242 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 36.16 34.36 39.40 38.12 34.09 40.00 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 40.85 35.41 43.73 41.85 33.73 42.88 18.15 63.11 -42.95 16.88 62.03 -44.28 coo 40.72 26.15 37.61 42.10 27.69 37.19 12.99 72.79 -44.62 12.72 70.82 -45.29 ULMN 3 1opm_c00 1.14.17.0003 user 7 3 # 7 A 108 HIS E 99 HIS^? 5.87 C1 GOL B1126 A 170 GLN E 98 GLN^? 9.14 CD MLY A 92 A 242 HIS E 76 HIS^? -4.59 O1 GOL B1126s coo 36.16 34.36 39.40 38.12 34.09 40.00 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 40.85 35.41 43.73 41.85 33.73 42.88 15.60 61.89 -51.50 14.20 63.00 -52.67 coo 40.72 26.15 37.61 42.10 27.69 37.19 19.53 58.10 -41.26 17.57 58.86 -41.26 1opm_c00 source 1opm 1.14.17.0003 : 7 hits 1opm_c00 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP C 86 ASP^? 3.69 CB MLY D 63 A 247 ASP C 88 ASP^? 3.98 CA MLY C 107 A 342 GLU C 90 GLU^? 4.76 CH2 MLY C 92 coo 44.36 35.68 9.71 43.29 36.20 11.51 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 41.40 28.81 12.91 40.82 30.90 12.97 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 40.37 33.11 18.06 39.99 34.93 17.06 14.69 87.71 -34.04 12.64 87.68 -34.52 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP C 88 ASP^? 3.98 CA MLY C 107 A 247 ASP C 86 ASP^? 3.69 CB MLY D 63 A 342 GLU C 80 GLU^? 4.30 CE MLY D 63 coo 44.36 35.68 9.71 43.29 36.20 11.51 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 41.40 28.81 12.91 40.82 30.90 12.97 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 40.37 33.11 18.06 39.99 34.93 17.06 15.56 92.60 -38.66 14.20 91.79 -40.09 1oyg_c00 source 1oyg LEVANSUCRASE : 2 hits 1oyg_c00 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 68 SER^? 8.30 O MLY D 92 A 709 ASP A 55 ASP^? 3.55 CH2 MLY A 104 A 740 HIS A 67 HIS^? 6.87 CH2 MLY A 104 coo -7.09 7.44 6.22 -7.53 5.14 5.59 24.61 77.27 -62.31 25.74 79.33 -62.97 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 16.41 75.18 -70.84 15.40 75.53 -68.95 coo -8.70 2.86 9.96 -8.03 3.92 8.29 19.88 76.04 -62.54 19.35 75.17 -60.71 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER D 68 SER^? 8.33 C MLY D 49 A 709 ASP D 42 ASP^? 3.03 NZ MLY D 104 A 740 HIS D 67 HIS^? 7.34 O MLY C 92 coo -7.09 7.44 6.22 -7.53 5.14 5.59 25.58 86.91 -43.38 26.68 88.19 -41.66 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 18.87 94.10 -49.63 18.55 92.53 -51.05 coo -8.70 2.86 9.96 -8.03 3.92 8.29 20.80 86.81 -44.45 20.29 84.80 -44.77 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER D 68 SER^? 8.33 C MLY D 49 A 709 ASP D 55 ASP^? 3.95 N MLY D 56 A 740 HIS D 67 HIS^? 7.34 O MLY C 92 coo -7.09 7.44 6.22 -7.53 5.14 5.59 25.58 86.91 -43.38 26.68 88.19 -41.66 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -8.70 2.86 9.96 -8.03 3.92 8.29 20.80 86.81 -44.45 20.29 84.80 -44.77 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 3 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 68 SER^? 8.30 O MLY D 92 B 709 ASP A 55 ASP^? 3.55 CH2 MLY A 104 B 740 HIS A 67 HIS^? 6.87 CH2 MLY A 104 coo 4.44 13.29 37.64 6.01 11.66 38.49 24.61 77.27 -62.31 25.74 79.33 -62.97 coo 10.26 2.81 31.69 11.64 4.30 32.43 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 8.57 10.09 34.47 7.10 10.73 35.82 19.88 76.04 -62.54 19.35 75.17 -60.71 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER D 68 SER^? 8.33 C MLY D 49 B 709 ASP D 42 ASP^? 3.03 NZ MLY D 104 B 740 HIS D 67 HIS^? 7.34 O MLY C 92 coo 4.44 13.29 37.64 6.01 11.66 38.49 25.58 86.91 -43.38 26.68 88.19 -41.66 coo 10.26 2.81 31.69 11.64 4.30 32.43 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 8.57 10.09 34.47 7.10 10.73 35.82 20.80 86.81 -44.45 20.29 84.80 -44.77 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER D 68 SER^? 8.33 C MLY D 49 B 709 ASP D 55 ASP^? 3.95 N MLY D 56 B 740 HIS D 67 HIS^? 7.34 O MLY C 92 coo 4.44 13.29 37.64 6.01 11.66 38.49 25.58 86.91 -43.38 26.68 88.19 -41.66 coo 10.26 2.81 31.69 11.64 4.30 32.43 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 8.57 10.09 34.47 7.10 10.73 35.82 20.80 86.81 -44.45 20.29 84.80 -44.77 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 3 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 259 TYR A 66 TYR^? -4.01 O2 PEG D3127s A 552 ASP C 88 ASP^? 3.98 CA MLY C 107 coo 11.34 95.90 25.54 12.13 96.42 23.67 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 14.91 97.39 18.63 13.39 95.60 20.20 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 46.37 82.54 38.83 45.97 84.66 38.77 14.72 94.17 -28.91 13.94 94.86 -27.07 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 259 TYR B 66 TYR^? 7.57 CH2 MLY B 56 A 552 ASP A 86 ASP^? 4.13 CB MLY E 62 coo 11.34 95.90 25.54 12.13 96.42 23.67 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 14.91 97.39 18.63 13.39 95.60 20.20 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 46.37 82.54 38.83 45.97 84.66 38.77 10.80 52.06 -74.41 9.44 51.94 -72.75 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 2 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 20 ALA~? 5.28 C MLY A 18 A 126 LEU A 27 LEU~? 5.81 CH1 MLY D 117 A 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.08 80.55 -74.34 34.47 79.99 -74.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 33.10 82.19 -67.15 32.12 80.67 -68.35 coo -0.83 29.57 149.77 -0.39 31.47 148.95 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 20 ALA~? 5.28 C MLY A 18 A 126 LEU A 33 LEU^? 7.95 C MLY A 18 A 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.08 80.55 -74.34 34.47 79.99 -74.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 33.69 75.91 -71.76 32.12 77.42 -71.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 20 ALA~? 5.28 C MLY A 18 A 126 LEU A 33 LEU^? 7.95 C MLY A 18 A 158 GLU A 32 GLU.? 8.63 N MLY A 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.08 80.55 -74.34 34.47 79.99 -74.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 33.69 75.91 -71.76 32.12 77.42 -71.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 38.81 75.22 -68.09 40.53 74.26 -68.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 120 ALA^? 3.56 O MLY A 117 A 126 LEU A 124 LEU^? 4.05 CB MLY E 49 A 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 29.58 60.59 -63.04 29.64 59.10 -63.58 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.68 60.19 -58.60 29.86 59.04 -58.80 coo -0.83 29.57 149.77 -0.39 31.47 148.95 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 123 ALA^? 6.48 CH1 MLY E 72 A 126 LEU A 124 LEU^? 4.05 CB MLY E 49 A 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 29.84 64.54 -59.46 28.37 64.12 -59.72 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.68 60.19 -58.60 29.86 59.04 -58.80 coo -0.83 29.57 149.77 -0.39 31.47 148.95 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 20 ALA^? 5.21 C MLY B 18 A 126 LEU B 27 LEU^? 6.96 CH1 MLY E 117 A 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.49 42.57 -29.95 31.97 42.76 -29.59 coo -4.62 32.83 147.14 -5.50 32.85 149.12 30.61 45.15 -37.03 29.85 45.97 -35.10 coo -0.83 29.57 149.77 -0.39 31.47 148.95 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 20 ALA^? 5.21 C MLY B 18 A 126 LEU B 33 LEU^? 7.56 C MLY B 18 A 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.49 42.57 -29.95 31.97 42.76 -29.59 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.67 46.94 -30.35 29.95 46.77 -29.09 coo -0.83 29.57 149.77 -0.39 31.47 148.95 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 20 ALA^? 5.21 C MLY B 18 A 126 LEU B 33 LEU^? 7.56 C MLY B 18 A 158 GLU B 32 GLU^? 10.10 CG MLY B 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.49 42.57 -29.95 31.97 42.76 -29.59 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.67 46.94 -30.35 29.95 46.77 -29.09 coo -0.83 29.57 149.77 -0.39 31.47 148.95 37.56 47.47 -33.54 37.52 45.31 -33.22 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 120 ALA^? 3.52 O MLY B 117 A 126 LEU B 124 LEU^? 4.14 CB MLY C 49 A 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.33 64.86 -28.19 30.42 65.65 -26.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 32.93 67.52 -31.41 31.29 68.54 -30.46 coo -0.83 29.57 149.77 -0.39 31.47 148.95 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 123 ALA^? 6.77 N MLY B 72 A 126 LEU B 124 LEU^? 4.14 CB MLY C 49 A 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.48 63.94 -33.33 28.98 64.11 -33.02 coo -4.62 32.83 147.14 -5.50 32.85 149.12 32.93 67.52 -31.41 31.29 68.54 -30.46 coo -0.83 29.57 149.77 -0.39 31.47 148.95 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA C 20 ALA^? 5.18 C MLY C 18 A 126 LEU C 27 LEU^? 7.14 NZ MLY B 117 A 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.43 75.29 -17.34 34.87 75.67 -17.62 coo -4.62 32.83 147.14 -5.50 32.85 149.12 32.97 69.63 -21.68 32.40 71.70 -21.70 coo -0.83 29.57 149.77 -0.39 31.47 148.95 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA C 20 ALA^? 5.18 C MLY C 18 A 126 LEU C 33 LEU^? 7.55 C MLY C 18 A 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.43 75.29 -17.34 34.87 75.67 -17.62 coo -4.62 32.83 147.14 -5.50 32.85 149.12 34.37 76.77 -21.54 32.81 78.00 -20.81 coo -0.83 29.57 149.77 -0.39 31.47 148.95 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA C 20 ALA^? 5.18 C MLY C 18 A 126 LEU C 33 LEU^? 7.55 C MLY C 18 A 158 GLU C 32 GLU^? 8.94 N MLY C 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.43 75.29 -17.34 34.87 75.67 -17.62 coo -4.62 32.83 147.14 -5.50 32.85 149.12 34.37 76.77 -21.54 32.81 78.00 -20.81 coo -0.83 29.57 149.77 -0.39 31.47 148.95 39.53 76.40 -23.53 41.02 77.67 -24.52 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA C 120 ALA^? 3.44 O MLY C 117 A 126 LEU C 124 LEU^? 4.10 CB MLY D 49 A 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 31.59 85.56 -37.27 31.77 87.04 -37.58 coo -4.62 32.83 147.14 -5.50 32.85 149.12 33.54 83.48 -41.21 31.81 84.76 -41.61 coo -0.83 29.57 149.77 -0.39 31.47 148.95 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 A 70 ALA C 123 ALA^? 4.61 CH1 MLY D 72 A 126 LEU C 124 LEU^? 4.10 CB MLY D 49 A 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 31.48 80.31 -38.28 30.00 80.71 -38.14 coo -4.62 32.83 147.14 -5.50 32.85 149.12 33.54 83.48 -41.21 31.81 84.76 -41.61 coo -0.83 29.57 149.77 -0.39 31.47 148.95 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 A 70 ALA D 20 ALA^? 5.21 C MLY D 18 A 126 LEU D 27 LEU^? 6.28 CH1 MLY C 117 A 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.26 99.65 -43.41 34.75 99.88 -43.89 coo -4.62 32.83 147.14 -5.50 32.85 149.12 34.07 93.11 -39.75 33.39 93.79 -41.71 coo -0.83 29.57 149.77 -0.39 31.47 148.95 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 A 70 ALA D 20 ALA^? 5.21 C MLY D 18 A 126 LEU D 33 LEU^? 7.57 C MLY D 18 A 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.26 99.65 -43.41 34.75 99.88 -43.89 coo -4.62 32.83 147.14 -5.50 32.85 149.12 34.29 95.91 -47.31 33.10 96.30 -45.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 A 70 ALA D 20 ALA^? 5.21 C MLY D 18 A 126 LEU D 33 LEU^? 7.57 C MLY D 18 A 158 GLU D 32 GLU^? 9.20 N MLY D 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.26 99.65 -43.41 34.75 99.88 -43.89 coo -4.62 32.83 147.14 -5.50 32.85 149.12 34.29 95.91 -47.31 33.10 96.30 -45.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 40.33 93.18 -45.60 42.01 93.18 -46.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 A 70 ALA D 120 ALA^? 3.60 O MLY D 117 A 126 LEU D 124 LEU^? 3.92 CB MLY A 49 A 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.86 82.78 -59.49 30.93 82.70 -61.04 coo -4.62 32.83 147.14 -5.50 32.85 149.12 32.93 78.59 -58.39 31.05 78.22 -59.42 coo -0.83 29.57 149.77 -0.39 31.47 148.95 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 A 70 ALA D 123 ALA^? 4.74 CH2 MLY A 72 A 126 LEU D 124 LEU^? 3.92 CB MLY A 49 A 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 31.15 80.74 -54.59 29.74 80.76 -55.11 coo -4.62 32.83 147.14 -5.50 32.85 149.12 32.93 78.59 -58.39 31.05 78.22 -59.42 coo -0.83 29.57 149.77 -0.39 31.47 148.95 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 A 70 ALA E 20 ALA^? 5.54 C MLY E 18 A 126 LEU E 27 LEU^? 6.44 CH2 MLY A 117 A 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.89 45.45 -65.97 32.28 45.00 -65.60 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.73 52.98 -65.25 30.70 51.36 -64.16 coo -0.83 29.57 149.77 -0.39 31.47 148.95 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 A 70 ALA E 20 ALA^? 5.54 C MLY E 18 A 126 LEU E 33 LEU^? 8.04 C MLY E 18 A 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.89 45.45 -65.97 32.28 45.00 -65.60 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.80 46.49 -61.07 30.30 47.30 -62.44 coo -0.83 29.57 149.77 -0.39 31.47 148.95 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 A 70 ALA E 20 ALA^? 5.54 C MLY E 18 A 126 LEU E 33 LEU^? 8.04 C MLY E 18 A 158 GLU E 32 GLU^? 9.00 N MLY E 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.89 45.45 -65.97 32.28 45.00 -65.60 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.80 46.49 -61.07 30.30 47.30 -62.44 coo -0.83 29.57 149.77 -0.39 31.47 148.95 36.93 48.99 -59.01 38.56 47.63 -58.62 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 A 70 ALA E 120 ALA^? 3.53 O MLY E 117 A 126 LEU E 124 LEU^? 3.79 CB MLY B 49 A 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.22 49.84 -43.66 28.35 48.84 -42.48 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.07 53.61 -41.98 29.33 53.08 -40.79 coo -0.83 29.57 149.77 -0.39 31.47 148.95 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 A 70 ALA E 123 ALA^? 5.61 CH1 MLY B 72 A 126 LEU E 124 LEU^? 3.79 CB MLY B 49 A 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.74 54.46 -46.12 27.30 54.15 -45.63 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.07 53.61 -41.98 29.33 53.08 -40.79 coo -0.83 29.57 149.77 -0.39 31.47 148.95 32.53 49.41 -36.99 30.60 49.55 -37.82 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 25 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 20 ALA~? 5.28 C MLY A 18 B 126 LEU A 27 LEU~? 5.81 CH1 MLY D 117 B 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.08 80.55 -74.34 34.47 79.99 -74.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 33.10 82.19 -67.15 32.12 80.67 -68.35 coo -33.03 9.93 151.71 -34.98 9.38 151.11 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 20 ALA~? 5.28 C MLY A 18 B 126 LEU A 33 LEU^? 7.95 C MLY A 18 B 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.08 80.55 -74.34 34.47 79.99 -74.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 33.69 75.91 -71.76 32.12 77.42 -71.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 20 ALA~? 5.28 C MLY A 18 B 126 LEU A 33 LEU^? 7.95 C MLY A 18 B 158 GLU A 32 GLU.? 8.63 N MLY A 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.08 80.55 -74.34 34.47 79.99 -74.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 33.69 75.91 -71.76 32.12 77.42 -71.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 38.81 75.22 -68.09 40.53 74.26 -68.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 120 ALA^? 3.56 O MLY A 117 B 126 LEU A 124 LEU^? 4.05 CB MLY E 49 B 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 29.58 60.59 -63.04 29.64 59.10 -63.58 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.68 60.19 -58.60 29.86 59.04 -58.80 coo -33.03 9.93 151.71 -34.98 9.38 151.11 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 123 ALA^? 6.48 CH1 MLY E 72 B 126 LEU A 124 LEU^? 4.05 CB MLY E 49 B 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 29.84 64.54 -59.46 28.37 64.12 -59.72 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.68 60.19 -58.60 29.86 59.04 -58.80 coo -33.03 9.93 151.71 -34.98 9.38 151.11 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA B 20 ALA^? 5.21 C MLY B 18 B 126 LEU B 27 LEU^? 6.96 CH1 MLY E 117 B 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.49 42.57 -29.95 31.97 42.76 -29.59 coo -34.22 5.06 149.25 -33.65 4.24 151.15 30.61 45.15 -37.03 29.85 45.97 -35.10 coo -33.03 9.93 151.71 -34.98 9.38 151.11 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA B 20 ALA^? 5.21 C MLY B 18 B 126 LEU B 33 LEU^? 7.56 C MLY B 18 B 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.49 42.57 -29.95 31.97 42.76 -29.59 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.67 46.94 -30.35 29.95 46.77 -29.09 coo -33.03 9.93 151.71 -34.98 9.38 151.11 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 20 ALA^? 5.21 C MLY B 18 B 126 LEU B 33 LEU^? 7.56 C MLY B 18 B 158 GLU B 32 GLU^? 10.10 CG MLY B 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.49 42.57 -29.95 31.97 42.76 -29.59 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.67 46.94 -30.35 29.95 46.77 -29.09 coo -33.03 9.93 151.71 -34.98 9.38 151.11 37.56 47.47 -33.54 37.52 45.31 -33.22 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 120 ALA^? 3.52 O MLY B 117 B 126 LEU B 124 LEU^? 4.14 CB MLY C 49 B 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.33 64.86 -28.19 30.42 65.65 -26.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 32.93 67.52 -31.41 31.29 68.54 -30.46 coo -33.03 9.93 151.71 -34.98 9.38 151.11 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 123 ALA^? 6.77 N MLY B 72 B 126 LEU B 124 LEU^? 4.14 CB MLY C 49 B 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.48 63.94 -33.33 28.98 64.11 -33.02 coo -34.22 5.06 149.25 -33.65 4.24 151.15 32.93 67.52 -31.41 31.29 68.54 -30.46 coo -33.03 9.93 151.71 -34.98 9.38 151.11 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA C 20 ALA^? 5.18 C MLY C 18 B 126 LEU C 27 LEU^? 7.14 NZ MLY B 117 B 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.43 75.29 -17.34 34.87 75.67 -17.62 coo -34.22 5.06 149.25 -33.65 4.24 151.15 32.97 69.63 -21.68 32.40 71.70 -21.70 coo -33.03 9.93 151.71 -34.98 9.38 151.11 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA C 20 ALA^? 5.18 C MLY C 18 B 126 LEU C 33 LEU^? 7.55 C MLY C 18 B 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.43 75.29 -17.34 34.87 75.67 -17.62 coo -34.22 5.06 149.25 -33.65 4.24 151.15 34.37 76.77 -21.54 32.81 78.00 -20.81 coo -33.03 9.93 151.71 -34.98 9.38 151.11 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA C 20 ALA^? 5.18 C MLY C 18 B 126 LEU C 33 LEU^? 7.55 C MLY C 18 B 158 GLU C 32 GLU^? 8.94 N MLY C 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.43 75.29 -17.34 34.87 75.67 -17.62 coo -34.22 5.06 149.25 -33.65 4.24 151.15 34.37 76.77 -21.54 32.81 78.00 -20.81 coo -33.03 9.93 151.71 -34.98 9.38 151.11 39.53 76.40 -23.53 41.02 77.67 -24.52 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA C 120 ALA^? 3.44 O MLY C 117 B 126 LEU C 124 LEU^? 4.10 CB MLY D 49 B 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 31.59 85.56 -37.27 31.77 87.04 -37.58 coo -34.22 5.06 149.25 -33.65 4.24 151.15 33.54 83.48 -41.21 31.81 84.76 -41.61 coo -33.03 9.93 151.71 -34.98 9.38 151.11 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 B 70 ALA C 123 ALA^? 4.61 CH1 MLY D 72 B 126 LEU C 124 LEU^? 4.10 CB MLY D 49 B 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 31.48 80.31 -38.28 30.00 80.71 -38.14 coo -34.22 5.06 149.25 -33.65 4.24 151.15 33.54 83.48 -41.21 31.81 84.76 -41.61 coo -33.03 9.93 151.71 -34.98 9.38 151.11 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 B 70 ALA D 20 ALA^? 5.21 C MLY D 18 B 126 LEU D 27 LEU^? 6.28 CH1 MLY C 117 B 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.26 99.65 -43.41 34.75 99.88 -43.89 coo -34.22 5.06 149.25 -33.65 4.24 151.15 34.07 93.11 -39.75 33.39 93.79 -41.71 coo -33.03 9.93 151.71 -34.98 9.38 151.11 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 B 70 ALA D 20 ALA^? 5.21 C MLY D 18 B 126 LEU D 33 LEU^? 7.57 C MLY D 18 B 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.26 99.65 -43.41 34.75 99.88 -43.89 coo -34.22 5.06 149.25 -33.65 4.24 151.15 34.29 95.91 -47.31 33.10 96.30 -45.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 B 70 ALA D 20 ALA^? 5.21 C MLY D 18 B 126 LEU D 33 LEU^? 7.57 C MLY D 18 B 158 GLU D 32 GLU^? 9.20 N MLY D 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.26 99.65 -43.41 34.75 99.88 -43.89 coo -34.22 5.06 149.25 -33.65 4.24 151.15 34.29 95.91 -47.31 33.10 96.30 -45.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 40.33 93.18 -45.60 42.01 93.18 -46.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 B 70 ALA D 120 ALA^? 3.60 O MLY D 117 B 126 LEU D 124 LEU^? 3.92 CB MLY A 49 B 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.86 82.78 -59.49 30.93 82.70 -61.04 coo -34.22 5.06 149.25 -33.65 4.24 151.15 32.93 78.59 -58.39 31.05 78.22 -59.42 coo -33.03 9.93 151.71 -34.98 9.38 151.11 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 B 70 ALA D 123 ALA^? 4.74 CH2 MLY A 72 B 126 LEU D 124 LEU^? 3.92 CB MLY A 49 B 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 31.15 80.74 -54.59 29.74 80.76 -55.11 coo -34.22 5.06 149.25 -33.65 4.24 151.15 32.93 78.59 -58.39 31.05 78.22 -59.42 coo -33.03 9.93 151.71 -34.98 9.38 151.11 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 B 70 ALA E 20 ALA^? 5.54 C MLY E 18 B 126 LEU E 27 LEU^? 6.44 CH2 MLY A 117 B 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.89 45.45 -65.97 32.28 45.00 -65.60 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.73 52.98 -65.25 30.70 51.36 -64.16 coo -33.03 9.93 151.71 -34.98 9.38 151.11 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 B 70 ALA E 20 ALA^? 5.54 C MLY E 18 B 126 LEU E 33 LEU^? 8.04 C MLY E 18 B 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.89 45.45 -65.97 32.28 45.00 -65.60 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.80 46.49 -61.07 30.30 47.30 -62.44 coo -33.03 9.93 151.71 -34.98 9.38 151.11 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 B 70 ALA E 20 ALA^? 5.54 C MLY E 18 B 126 LEU E 33 LEU^? 8.04 C MLY E 18 B 158 GLU E 32 GLU^? 9.00 N MLY E 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.89 45.45 -65.97 32.28 45.00 -65.60 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.80 46.49 -61.07 30.30 47.30 -62.44 coo -33.03 9.93 151.71 -34.98 9.38 151.11 36.93 48.99 -59.01 38.56 47.63 -58.62 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 B 70 ALA E 120 ALA^? 3.53 O MLY E 117 B 126 LEU E 124 LEU^? 3.79 CB MLY B 49 B 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.22 49.84 -43.66 28.35 48.84 -42.48 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.07 53.61 -41.98 29.33 53.08 -40.79 coo -33.03 9.93 151.71 -34.98 9.38 151.11 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 B 70 ALA E 123 ALA^? 5.61 CH1 MLY B 72 B 126 LEU E 124 LEU^? 3.79 CB MLY B 49 B 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.74 54.46 -46.12 27.30 54.15 -45.63 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.07 53.61 -41.98 29.33 53.08 -40.79 coo -33.03 9.93 151.71 -34.98 9.38 151.11 32.53 49.41 -36.99 30.60 49.55 -37.82 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 25 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 20 ALA~? 5.28 C MLY A 18 C 126 LEU A 27 LEU~? 5.81 CH1 MLY D 117 C 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.08 80.55 -74.34 34.47 79.99 -74.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 33.10 82.19 -67.15 32.12 80.67 -68.35 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 20 ALA~? 5.28 C MLY A 18 C 126 LEU A 33 LEU^? 7.95 C MLY A 18 C 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.08 80.55 -74.34 34.47 79.99 -74.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 33.69 75.91 -71.76 32.12 77.42 -71.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 20 ALA~? 5.28 C MLY A 18 C 126 LEU A 33 LEU^? 7.95 C MLY A 18 C 158 GLU A 32 GLU.? 8.63 N MLY A 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.08 80.55 -74.34 34.47 79.99 -74.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 33.69 75.91 -71.76 32.12 77.42 -71.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 38.81 75.22 -68.09 40.53 74.26 -68.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 120 ALA^? 3.56 O MLY A 117 C 126 LEU A 124 LEU^? 4.05 CB MLY E 49 C 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 29.58 60.59 -63.04 29.64 59.10 -63.58 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.68 60.19 -58.60 29.86 59.04 -58.80 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 123 ALA^? 6.48 CH1 MLY E 72 C 126 LEU A 124 LEU^? 4.05 CB MLY E 49 C 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 29.84 64.54 -59.46 28.37 64.12 -59.72 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.68 60.19 -58.60 29.86 59.04 -58.80 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 20 ALA^? 5.21 C MLY B 18 C 126 LEU B 27 LEU^? 6.96 CH1 MLY E 117 C 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.49 42.57 -29.95 31.97 42.76 -29.59 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 30.61 45.15 -37.03 29.85 45.97 -35.10 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 20 ALA^? 5.21 C MLY B 18 C 126 LEU B 33 LEU^? 7.56 C MLY B 18 C 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.49 42.57 -29.95 31.97 42.76 -29.59 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.67 46.94 -30.35 29.95 46.77 -29.09 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 20 ALA^? 5.21 C MLY B 18 C 126 LEU B 33 LEU^? 7.56 C MLY B 18 C 158 GLU B 32 GLU^? 10.10 CG MLY B 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.49 42.57 -29.95 31.97 42.76 -29.59 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.67 46.94 -30.35 29.95 46.77 -29.09 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 37.56 47.47 -33.54 37.52 45.31 -33.22 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 120 ALA^? 3.52 O MLY B 117 C 126 LEU B 124 LEU^? 4.14 CB MLY C 49 C 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.33 64.86 -28.19 30.42 65.65 -26.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 32.93 67.52 -31.41 31.29 68.54 -30.46 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA B 123 ALA^? 6.77 N MLY B 72 C 126 LEU B 124 LEU^? 4.14 CB MLY C 49 C 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.48 63.94 -33.33 28.98 64.11 -33.02 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 32.93 67.52 -31.41 31.29 68.54 -30.46 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA C 20 ALA^? 5.18 C MLY C 18 C 126 LEU C 27 LEU^? 7.14 NZ MLY B 117 C 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.43 75.29 -17.34 34.87 75.67 -17.62 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 32.97 69.63 -21.68 32.40 71.70 -21.70 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA C 20 ALA^? 5.18 C MLY C 18 C 126 LEU C 33 LEU^? 7.55 C MLY C 18 C 158 GLU C 31 GLU^? 4.33 CB MLY C 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.43 75.29 -17.34 34.87 75.67 -17.62 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 34.37 76.77 -21.54 32.81 78.00 -20.81 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 34.85 71.37 -25.71 32.93 70.57 -26.04 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA C 20 ALA^? 5.18 C MLY C 18 C 126 LEU C 33 LEU^? 7.55 C MLY C 18 C 158 GLU C 32 GLU^? 8.94 N MLY C 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.43 75.29 -17.34 34.87 75.67 -17.62 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 34.37 76.77 -21.54 32.81 78.00 -20.81 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 39.53 76.40 -23.53 41.02 77.67 -24.52 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 C 70 ALA C 120 ALA^? 3.44 O MLY C 117 C 126 LEU C 124 LEU^? 4.10 CB MLY D 49 C 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 31.59 85.56 -37.27 31.77 87.04 -37.58 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 33.54 83.48 -41.21 31.81 84.76 -41.61 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 C 70 ALA C 123 ALA^? 4.61 CH1 MLY D 72 C 126 LEU C 124 LEU^? 4.10 CB MLY D 49 C 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 31.48 80.31 -38.28 30.00 80.71 -38.14 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 33.54 83.48 -41.21 31.81 84.76 -41.61 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 C 70 ALA D 20 ALA^? 5.21 C MLY D 18 C 126 LEU D 27 LEU^? 6.28 CH1 MLY C 117 C 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.26 99.65 -43.41 34.75 99.88 -43.89 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 34.07 93.11 -39.75 33.39 93.79 -41.71 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 C 70 ALA D 20 ALA^? 5.21 C MLY D 18 C 126 LEU D 33 LEU^? 7.57 C MLY D 18 C 158 GLU D 31 GLU^? 4.34 CB MLY D 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.26 99.65 -43.41 34.75 99.88 -43.89 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 34.29 95.91 -47.31 33.10 96.30 -45.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 C 70 ALA D 20 ALA^? 5.21 C MLY D 18 C 126 LEU D 33 LEU^? 7.57 C MLY D 18 C 158 GLU D 32 GLU^? 9.20 N MLY D 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.26 99.65 -43.41 34.75 99.88 -43.89 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 34.29 95.91 -47.31 33.10 96.30 -45.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 40.33 93.18 -45.60 42.01 93.18 -46.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 C 70 ALA D 120 ALA^? 3.60 O MLY D 117 C 126 LEU D 124 LEU^? 3.92 CB MLY A 49 C 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.86 82.78 -59.49 30.93 82.70 -61.04 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 32.93 78.59 -58.39 31.05 78.22 -59.42 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 C 70 ALA D 123 ALA^? 4.74 CH2 MLY A 72 C 126 LEU D 124 LEU^? 3.92 CB MLY A 49 C 158 GLU A 31 GLU.? 4.36 CB MLY A 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 31.15 80.74 -54.59 29.74 80.76 -55.11 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 32.93 78.59 -58.39 31.05 78.22 -59.42 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 34.46 78.41 -64.99 32.63 79.05 -64.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 C 70 ALA E 20 ALA^? 5.54 C MLY E 18 C 126 LEU E 27 LEU^? 6.44 CH2 MLY A 117 C 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.89 45.45 -65.97 32.28 45.00 -65.60 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.73 52.98 -65.25 30.70 51.36 -64.16 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 C 70 ALA E 20 ALA^? 5.54 C MLY E 18 C 126 LEU E 33 LEU^? 8.04 C MLY E 18 C 158 GLU E 31 GLU^? 4.40 CB MLY E 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.89 45.45 -65.97 32.28 45.00 -65.60 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.80 46.49 -61.07 30.30 47.30 -62.44 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 33.05 53.64 -60.92 31.27 54.73 -61.16 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 C 70 ALA E 20 ALA^? 5.54 C MLY E 18 C 126 LEU E 33 LEU^? 8.04 C MLY E 18 C 158 GLU E 32 GLU^? 9.00 N MLY E 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.89 45.45 -65.97 32.28 45.00 -65.60 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.80 46.49 -61.07 30.30 47.30 -62.44 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 36.93 48.99 -59.01 38.56 47.63 -58.62 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 C 70 ALA E 120 ALA^? 3.53 O MLY E 117 C 126 LEU E 124 LEU^? 3.79 CB MLY B 49 C 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.22 49.84 -43.66 28.35 48.84 -42.48 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.07 53.61 -41.98 29.33 53.08 -40.79 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 32.53 49.41 -36.99 30.60 49.55 -37.82 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 C 70 ALA E 123 ALA^? 5.61 CH1 MLY B 72 C 126 LEU E 124 LEU^? 3.79 CB MLY B 49 C 158 GLU B 31 GLU^? 4.39 CB MLY B 49 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.74 54.46 -46.12 27.30 54.15 -45.63 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.07 53.61 -41.98 29.33 53.08 -40.79 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 32.53 49.41 -36.99 30.60 49.55 -37.82 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 25 hits 1pjh_c02 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 5 ASP~? 10.39 CH1 MLY A 117 A 68 ALA A 6 ALA~? 9.62 O2 GOL A 126 A 72 LEU A 7 LEU~? 10.09 O1 GOL A 126 coo 46.76 7.59 18.65 45.27 6.01 18.52 30.98 56.12 -81.35 30.72 54.26 -80.37 coo 48.88 4.35 16.59 48.73 5.09 15.20 30.87 59.45 -84.22 31.57 59.23 -85.57 coo 53.89 6.25 15.09 52.88 7.92 14.14 26.35 59.82 -86.09 24.47 60.64 -86.81 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 88 ASP^? 3.30 CG MLY A 107 A 68 ALA A 89 ALA^? 4.05 O1 PEG E4126 A 72 LEU A 106 LEU^? 4.49 N MLY A 107 coo 46.76 7.59 18.65 45.27 6.01 18.52 14.06 59.10 -75.34 13.56 59.34 -77.37 coo 48.88 4.35 16.59 48.73 5.09 15.20 16.00 58.61 -71.58 17.49 58.35 -71.38 coo 53.89 6.25 15.09 52.88 7.92 14.14 18.84 62.27 -72.65 19.88 62.92 -70.88 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP B 5 ASP^? 11.56 CH1 MLY B 38 A 68 ALA B 6 ALA^? 8.19 CH2 MLY B 38 A 72 LEU B 7 LEU^? 11.75 CH2 MLY B 38 coo 46.76 7.59 18.65 45.27 6.01 18.52 29.67 45.39 -10.95 29.64 43.82 -9.50 coo 48.88 4.35 16.59 48.73 5.09 15.20 28.77 49.31 -13.16 27.47 49.42 -13.96 coo 53.89 6.25 15.09 52.88 7.92 14.14 27.46 52.42 -9.67 25.67 53.53 -10.20 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP B 88 ASP^? 3.13 NZ MLY B 107 A 68 ALA B 89 ALA^? 5.31 CH1 MLY C 63 A 72 LEU B 106 LEU^? 4.45 O MLY B 104 coo 46.76 7.59 18.65 45.27 6.01 18.52 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 48.88 4.35 16.59 48.73 5.09 15.20 14.54 63.64 -20.90 16.02 63.63 -20.57 coo 53.89 6.25 15.09 52.88 7.92 14.14 16.83 60.07 -22.23 18.38 60.26 -23.76 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP C 88 ASP^? 3.98 CA MLY C 107 A 68 ALA C 89 ALA^? 6.02 N MLY C 107 A 72 LEU C 106 LEU^? 4.70 N MLY C 107 coo 46.76 7.59 18.65 45.27 6.01 18.52 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 48.88 4.35 16.59 48.73 5.09 15.20 17.41 92.58 -31.86 18.92 92.61 -31.93 coo 53.89 6.25 15.09 52.88 7.92 14.14 19.70 89.87 -28.90 20.88 88.27 -29.84 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP E 88 ASP^? 7.64 NZ MLY E 107 A 68 ALA E 89 ALA^? 6.15 N MLY E 107 A 72 LEU E 106 LEU^? 4.61 O MLY E 104 coo 46.76 7.59 18.65 45.27 6.01 18.52 9.12 40.44 -42.05 7.36 39.34 -42.35 coo 48.88 4.35 16.59 48.73 5.09 15.20 13.32 41.94 -42.69 14.68 41.23 -42.73 coo 53.89 6.25 15.09 52.88 7.92 14.14 16.10 41.71 -46.26 17.55 43.36 -46.16 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 6 hits 1q6l_c05 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 50 ARG^? 6.59 CA MLY D 117 C 163 TYR A 66 TYR^? -4.01 O2 PEG D3127s C 236 ASP A 55 ASP^? 3.55 CH2 MLY A 104 coo 39.01 29.77 22.02 37.48 31.30 19.84 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 39.51 34.34 13.63 37.63 32.61 14.79 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 45.78 31.11 9.51 44.25 30.06 10.53 16.41 75.18 -70.84 15.40 75.53 -68.95 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 50 ARG^? 6.45 CA MLY E 117 C 163 TYR B 66 TYR^? 7.57 CH2 MLY B 56 C 236 ASP B 55 ASP^? 2.74 NZ MLY B 104 coo 39.01 29.77 22.02 37.48 31.30 19.84 27.11 51.81 -37.88 27.02 48.95 -39.10 coo 39.51 34.34 13.63 37.63 32.61 14.79 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 45.78 31.11 9.51 44.25 30.06 10.53 14.45 50.68 -30.88 15.66 52.47 -30.45 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG C 50 ARG^? 6.37 CA MLY B 117 C 163 TYR C 66 TYR^? 7.67 C MLY C 63 C 236 ASP C 55 ASP^? 3.93 N MLY C 56 coo 39.01 29.77 22.02 37.48 31.30 19.84 29.38 71.17 -28.15 29.46 68.99 -25.90 coo 39.51 34.34 13.63 37.63 32.61 14.79 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 45.78 31.11 9.51 44.25 30.06 10.53 16.82 77.26 -24.21 14.93 78.15 -24.18 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG D 50 ARG^? 6.49 CA MLY C 117 C 163 TYR D 66 TYR^? 6.79 CE MLY D 56 C 236 ASP D 55 ASP^? 3.95 N MLY D 56 coo 39.01 29.77 22.02 37.48 31.30 19.84 29.95 87.67 -43.01 30.32 89.04 -40.28 coo 39.51 34.34 13.63 37.63 32.61 14.79 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG E 50 ARG^? 6.44 CA MLY A 117 C 163 TYR E 66 TYR^? -3.37 C3 PEG E4126s C 236 ASP E 55 ASP^? 3.37 N MLY E 56 coo 39.01 29.77 22.02 37.48 31.30 19.84 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 39.51 34.34 13.63 37.63 32.61 14.79 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 45.78 31.11 9.51 44.25 30.06 10.53 14.69 49.71 -60.49 12.90 49.11 -59.47 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 50 ARG^? 6.59 CA MLY D 117 D 163 TYR A 66 TYR^? -4.01 O2 PEG D3127s D 236 ASP A 55 ASP^? 3.55 CH2 MLY A 104 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 16.41 75.18 -70.84 15.40 75.53 -68.95 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 50 ARG^? 6.45 CA MLY E 117 D 163 TYR B 66 TYR^? 7.57 CH2 MLY B 56 D 236 ASP B 55 ASP^? 2.74 NZ MLY B 104 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 27.11 51.81 -37.88 27.02 48.95 -39.10 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 14.45 50.68 -30.88 15.66 52.47 -30.45 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG C 50 ARG^? 6.37 CA MLY B 117 D 163 TYR C 66 TYR^? 7.67 C MLY C 63 D 236 ASP C 55 ASP^? 3.93 N MLY C 56 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 29.38 71.17 -28.15 29.46 68.99 -25.90 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 16.82 77.26 -24.21 14.93 78.15 -24.18 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG D 50 ARG^? 6.49 CA MLY C 117 D 163 TYR D 66 TYR^? 6.79 CE MLY D 56 D 236 ASP D 55 ASP^? 3.95 N MLY D 56 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 29.95 87.67 -43.01 30.32 89.04 -40.28 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG E 50 ARG^? 6.44 CA MLY A 117 D 163 TYR E 66 TYR^? -3.37 C3 PEG E4126s D 236 ASP E 55 ASP^? 3.37 N MLY E 56 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 14.69 49.71 -60.49 12.90 49.11 -59.47 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 66 TYR^? -4.01 O2 PEG D3127s A 236 ASP A 55 ASP^? 3.55 CH2 MLY A 104 C 110 ARG A 50 ARG^? 6.59 CA MLY D 117 coo 55.48 26.51 40.65 55.39 23.99 39.43 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 48.87 29.19 44.63 49.10 27.34 43.63 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 52.39 23.42 32.10 54.51 23.27 34.29 28.95 77.70 -62.89 29.34 80.69 -63.51 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 66 TYR^? 7.57 CH2 MLY B 56 A 236 ASP B 55 ASP^? 2.74 NZ MLY B 104 C 110 ARG B 50 ARG^? 6.45 CA MLY E 117 coo 55.48 26.51 40.65 55.39 23.99 39.43 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 48.87 29.19 44.63 49.10 27.34 43.63 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 52.39 23.42 32.10 54.51 23.27 34.29 27.11 51.81 -37.88 27.02 48.95 -39.10 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR C 66 TYR^? 7.67 C MLY C 63 A 236 ASP C 55 ASP^? 3.93 N MLY C 56 C 110 ARG C 50 ARG^? 6.37 CA MLY B 117 coo 55.48 26.51 40.65 55.39 23.99 39.43 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 48.87 29.19 44.63 49.10 27.34 43.63 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 52.39 23.42 32.10 54.51 23.27 34.29 29.38 71.17 -28.15 29.46 68.99 -25.90 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR D 66 TYR^? 6.79 CE MLY D 56 A 236 ASP D 55 ASP^? 3.95 N MLY D 56 C 110 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 55.48 26.51 40.65 55.39 23.99 39.43 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 52.39 23.42 32.10 54.51 23.27 34.29 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR E 66 TYR^? -3.37 C3 PEG E4126s A 236 ASP E 55 ASP^? 3.37 N MLY E 56 C 110 ARG E 50 ARG^? 6.44 CA MLY A 117 coo 55.48 26.51 40.65 55.39 23.99 39.43 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 48.87 29.19 44.63 49.10 27.34 43.63 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 52.39 23.42 32.10 54.51 23.27 34.29 27.70 55.94 -59.52 28.04 56.21 -62.59 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 66 TYR^? -4.01 O2 PEG D3127s B 236 ASP A 55 ASP^? 3.55 CH2 MLY A 104 D 110 ARG A 50 ARG^? 6.59 CA MLY D 117 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 28.95 77.70 -62.89 29.34 80.69 -63.51 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 66 TYR^? 7.57 CH2 MLY B 56 B 236 ASP B 55 ASP^? 2.74 NZ MLY B 104 D 110 ARG B 50 ARG^? 6.45 CA MLY E 117 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 27.11 51.81 -37.88 27.02 48.95 -39.10 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR C 66 TYR^? 7.67 C MLY C 63 B 236 ASP C 55 ASP^? 3.93 N MLY C 56 D 110 ARG C 50 ARG^? 6.37 CA MLY B 117 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 29.38 71.17 -28.15 29.46 68.99 -25.90 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR D 66 TYR^? 6.79 CE MLY D 56 B 236 ASP D 55 ASP^? 3.95 N MLY D 56 D 110 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR E 66 TYR^? -3.37 C3 PEG E4126s B 236 ASP E 55 ASP^? 3.37 N MLY E 56 D 110 ARG E 50 ARG^? 6.44 CA MLY A 117 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 27.70 55.94 -59.52 28.04 56.21 -62.59 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 50 ARG^? 6.59 CA MLY D 117 G 163 TYR A 66 TYR^? -4.01 O2 PEG D3127s G 236 ASP A 55 ASP^? 3.55 CH2 MLY A 104 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 16.41 75.18 -70.84 15.40 75.53 -68.95 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 50 ARG^? 6.45 CA MLY E 117 G 163 TYR B 66 TYR^? 7.57 CH2 MLY B 56 G 236 ASP B 55 ASP^? 2.74 NZ MLY B 104 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 27.11 51.81 -37.88 27.02 48.95 -39.10 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 14.45 50.68 -30.88 15.66 52.47 -30.45 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG C 50 ARG^? 6.37 CA MLY B 117 G 163 TYR C 66 TYR^? 7.67 C MLY C 63 G 236 ASP C 55 ASP^? 3.93 N MLY C 56 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 29.38 71.17 -28.15 29.46 68.99 -25.90 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 16.82 77.26 -24.21 14.93 78.15 -24.18 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG D 50 ARG^? 6.49 CA MLY C 117 G 163 TYR D 66 TYR^? 6.79 CE MLY D 56 G 236 ASP D 55 ASP^? 3.95 N MLY D 56 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 29.95 87.67 -43.01 30.32 89.04 -40.28 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG E 50 ARG^? 6.44 CA MLY A 117 G 163 TYR E 66 TYR^? -3.37 C3 PEG E4126s G 236 ASP E 55 ASP^? 3.37 N MLY E 56 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 14.69 49.71 -60.49 12.90 49.11 -59.47 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 50 ARG^? 6.59 CA MLY D 117 H 163 TYR A 66 TYR^? -4.01 O2 PEG D3127s H 236 ASP A 55 ASP^? 3.55 CH2 MLY A 104 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 16.41 75.18 -70.84 15.40 75.53 -68.95 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 50 ARG^? 6.45 CA MLY E 117 H 163 TYR B 66 TYR^? 7.57 CH2 MLY B 56 H 236 ASP B 55 ASP^? 2.74 NZ MLY B 104 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 27.11 51.81 -37.88 27.02 48.95 -39.10 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 14.45 50.68 -30.88 15.66 52.47 -30.45 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG C 50 ARG^? 6.37 CA MLY B 117 H 163 TYR C 66 TYR^? 7.67 C MLY C 63 H 236 ASP C 55 ASP^? 3.93 N MLY C 56 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 29.38 71.17 -28.15 29.46 68.99 -25.90 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 16.82 77.26 -24.21 14.93 78.15 -24.18 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG D 50 ARG^? 6.49 CA MLY C 117 H 163 TYR D 66 TYR^? 6.79 CE MLY D 56 H 236 ASP D 55 ASP^? 3.95 N MLY D 56 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 29.95 87.67 -43.01 30.32 89.04 -40.28 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG E 50 ARG^? 6.44 CA MLY A 117 H 163 TYR E 66 TYR^? -3.37 C3 PEG E4126s H 236 ASP E 55 ASP^? 3.37 N MLY E 56 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 14.69 49.71 -60.49 12.90 49.11 -59.47 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 66 TYR^? -4.01 O2 PEG D3127s E 236 ASP A 55 ASP^? 3.55 CH2 MLY A 104 G 110 ARG A 50 ARG^? 6.59 CA MLY D 117 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 28.95 77.70 -62.89 29.34 80.69 -63.51 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 66 TYR^? 7.57 CH2 MLY B 56 E 236 ASP B 55 ASP^? 2.74 NZ MLY B 104 G 110 ARG B 50 ARG^? 6.45 CA MLY E 117 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 27.11 51.81 -37.88 27.02 48.95 -39.10 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR C 66 TYR^? 7.67 C MLY C 63 E 236 ASP C 55 ASP^? 3.93 N MLY C 56 G 110 ARG C 50 ARG^? 6.37 CA MLY B 117 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 29.38 71.17 -28.15 29.46 68.99 -25.90 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR D 66 TYR^? 6.79 CE MLY D 56 E 236 ASP D 55 ASP^? 3.95 N MLY D 56 G 110 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR E 66 TYR^? -3.37 C3 PEG E4126s E 236 ASP E 55 ASP^? 3.37 N MLY E 56 G 110 ARG E 50 ARG^? 6.44 CA MLY A 117 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 27.70 55.94 -59.52 28.04 56.21 -62.59 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 66 TYR^? -4.01 O2 PEG D3127s F 236 ASP A 55 ASP^? 3.55 CH2 MLY A 104 H 110 ARG A 50 ARG^? 6.59 CA MLY D 117 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 28.95 77.70 -62.89 29.34 80.69 -63.51 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 66 TYR^? 7.57 CH2 MLY B 56 F 236 ASP B 55 ASP^? 2.74 NZ MLY B 104 H 110 ARG B 50 ARG^? 6.45 CA MLY E 117 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 27.11 51.81 -37.88 27.02 48.95 -39.10 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR C 66 TYR^? 7.67 C MLY C 63 F 236 ASP C 55 ASP^? 3.93 N MLY C 56 H 110 ARG C 50 ARG^? 6.37 CA MLY B 117 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 29.38 71.17 -28.15 29.46 68.99 -25.90 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR D 66 TYR^? 6.79 CE MLY D 56 F 236 ASP D 55 ASP^? 3.95 N MLY D 56 H 110 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR E 66 TYR^? -3.37 C3 PEG E4126s F 236 ASP E 55 ASP^? 3.37 N MLY E 56 H 110 ARG E 50 ARG^? 6.44 CA MLY A 117 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 27.70 55.94 -59.52 28.04 56.21 -62.59 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 86 ASP^? 4.13 CB MLY E 62 A 147 THR A 81 THR^? 4.00 CA MLY E 63 A 294 ASP E 55 ASP^? 3.37 N MLY E 56 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 10.80 52.06 -74.41 9.44 51.94 -72.75 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 14.15 54.67 -70.12 13.73 52.73 -70.95 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 14.69 49.71 -60.49 12.90 49.11 -59.47 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP C 88 ASP^? 3.98 CA MLY C 107 A 147 THR C 110 THR^? 3.53 O MLY C 107 A 294 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 14.72 94.17 -28.91 13.94 94.86 -27.07 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 22.16 92.02 -24.46 21.13 90.28 -25.31 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 19.26 82.21 -24.59 17.46 81.65 -25.59 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 2 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP C 86 ASP^? 3.69 CB MLY D 63 A 256 GLU C 80 GLU^? 4.30 CE MLY D 63 A 329 ASP D 55 ASP^? 3.95 N MLY D 56 coo 28.46 69.88 26.74 30.40 70.70 26.53 13.78 99.19 -34.67 12.49 98.36 -36.08 coo 30.54 71.65 32.58 31.73 72.26 30.92 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 17.25 94.50 -45.91 15.33 95.13 -46.57 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP D 55 ASP^? 3.95 N MLY D 56 A 256 GLU C 80 GLU^? 4.30 CE MLY D 63 A 329 ASP C 86 ASP^? 3.69 CB MLY D 63 coo 28.46 69.88 26.74 30.40 70.70 26.53 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 30.54 71.65 32.58 31.73 72.26 30.92 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 13.78 99.19 -34.67 12.49 98.36 -36.08 1qho_c04 source 1qho ALPHA-AMYLASE : 2 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 5 ASP^? 11.56 CH1 MLY B 38 A 261 ASP B 42 ASP^? 3.93 N MLY B 56 A 329 ASP B 15 ASP^? 3.54 CB MLY B 18 coo 28.46 69.88 26.74 30.40 70.70 26.53 29.67 45.39 -10.95 29.64 43.82 -9.50 coo 34.02 79.89 42.60 34.73 78.01 41.86 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 27.82 41.92 -21.37 29.40 40.51 -21.49 1qho_c05 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 5 ASP^? 11.56 CH1 MLY B 38 A 260 ASP B 111 ASP^? 8.02 CB MLY B 117 A 329 ASP B 15 ASP^? 3.54 CB MLY B 18 coo 28.46 69.88 26.74 30.40 70.70 26.53 29.67 45.39 -10.95 29.64 43.82 -9.50 coo 30.73 81.29 37.61 31.23 82.07 35.69 24.09 56.67 -18.17 25.86 57.71 -17.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 27.82 41.92 -21.37 29.40 40.51 -21.49 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 15 ASP^? 3.54 CB MLY B 18 A 260 ASP B 111 ASP^? 8.02 CB MLY B 117 A 329 ASP B 5 ASP^? 11.56 CH1 MLY B 38 coo 28.46 69.88 26.74 30.40 70.70 26.53 27.82 41.92 -21.37 29.40 40.51 -21.49 coo 30.73 81.29 37.61 31.23 82.07 35.69 24.09 56.67 -18.17 25.86 57.71 -17.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 29.67 45.39 -10.95 29.64 43.82 -9.50 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 260 ASP C 15 ASP^? 3.79 N MLY C 18 A 329 ASP C 111 ASP^? 8.04 N MLY C 117 coo 28.46 69.88 26.74 30.40 70.70 26.53 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 30.73 81.29 37.61 31.23 82.07 35.69 32.23 83.07 -12.97 34.08 82.39 -12.17 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.96 91.49 -25.34 28.70 92.35 -26.18 1qho_c07 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c07 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 A 741 SER A 65 SER^? 6.25 CH2 MLY A 104 coo -20.72 2.99 34.37 -21.94 1.82 35.61 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 18.51 71.25 -71.50 16.64 71.28 -70.53 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 17.55 80.47 -67.90 17.09 78.92 -66.03 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 A 741 SER A 68 SER^? 8.30 O MLY D 92 coo -20.72 2.99 34.37 -21.94 1.82 35.61 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 18.51 71.25 -71.50 16.64 71.28 -70.53 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 24.61 77.27 -62.31 25.74 79.33 -62.97 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 646 ASP A 55 ASP^? 3.55 CH2 MLY A 104 A 741 SER A 68 SER^? 8.30 O MLY D 92 coo -20.72 2.99 34.37 -21.94 1.82 35.61 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 16.41 75.18 -70.84 15.40 75.53 -68.95 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 24.61 77.27 -62.31 25.74 79.33 -62.97 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 646 ASP B 55 ASP^? 2.74 NZ MLY B 104 A 741 SER B 68 SER^? 8.39 O MLY E 92 coo -20.72 2.99 34.37 -21.94 1.82 35.61 18.03 54.22 -37.13 17.47 55.93 -38.18 coo -18.83 7.68 26.86 -20.89 7.78 26.56 14.45 50.68 -30.88 15.66 52.47 -30.45 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 22.79 53.21 -37.95 23.70 50.99 -38.49 ULMN 3 1qrz_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 646 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 741 SER C 65 SER^? 5.92 CH2 MLY C 104 coo -20.72 2.99 34.37 -21.94 1.82 35.61 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 19.26 82.21 -24.59 17.46 81.65 -25.59 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 17.46 72.45 -23.42 17.18 72.60 -25.76 ULMN 3 1qrz_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 646 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 741 SER C 68 SER^? 8.27 C MLY C 49 coo -20.72 2.99 34.37 -21.94 1.82 35.61 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 19.26 82.21 -24.59 17.46 81.65 -25.59 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 25.14 71.48 -29.19 26.05 70.14 -27.42 ULMN 3 1qrz_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 646 ASP C 55 ASP^? 3.93 N MLY C 56 A 741 SER C 68 SER^? 8.27 C MLY C 49 coo -20.72 2.99 34.37 -21.94 1.82 35.61 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 16.82 77.26 -24.21 14.93 78.15 -24.18 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 25.14 71.48 -29.19 26.05 70.14 -27.42 ULMN 3 1qrz_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS D 67 HIS^? 7.34 O MLY C 92 A 646 ASP D 42 ASP^? 3.03 NZ MLY D 104 A 741 SER D 68 SER^? 8.33 C MLY D 49 coo -20.72 2.99 34.37 -21.94 1.82 35.61 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 18.87 94.10 -49.63 18.55 92.53 -51.05 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 25.58 86.91 -43.38 26.68 88.19 -41.66 ULMN 3 1qrz_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS D 67 HIS^? 7.34 O MLY C 92 A 646 ASP D 55 ASP^? 3.95 N MLY D 56 A 741 SER D 68 SER^? 8.33 C MLY D 49 coo -20.72 2.99 34.37 -21.94 1.82 35.61 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 25.58 86.91 -43.38 26.68 88.19 -41.66 ULMN 3 1qrz_c12 PLASMINOGEN user 10 3 # 10 A 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 A 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 A 741 SER E 65 SER^? 4.83 N MLY E 56 coo -20.72 2.99 34.37 -21.94 1.82 35.61 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -18.83 7.68 26.86 -20.89 7.78 26.56 16.27 46.44 -56.46 15.46 48.32 -56.74 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 16.26 52.91 -64.19 14.97 52.38 -62.27 ULMN 3 1qrz_c12 PLASMINOGEN user 11 3 # 11 A 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 A 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 A 741 SER E 68 SER^? 8.34 C MLY E 49 coo -20.72 2.99 34.37 -21.94 1.82 35.61 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -18.83 7.68 26.86 -20.89 7.78 26.56 16.27 46.44 -56.46 15.46 48.32 -56.74 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 23.32 56.54 -58.94 24.53 56.34 -61.01 ULMN 3 1qrz_c12 PLASMINOGEN user 12 3 # 12 A 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 A 646 ASP E 55 ASP^? 3.37 N MLY E 56 A 741 SER E 68 SER^? 8.34 C MLY E 49 coo -20.72 2.99 34.37 -21.94 1.82 35.61 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -18.83 7.68 26.86 -20.89 7.78 26.56 14.69 49.71 -60.49 12.90 49.11 -59.47 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 23.32 56.54 -58.94 24.53 56.34 -61.01 1qrz_c12 source 1qrz PLASMINOGEN : 12 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 B 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 B 741 SER A 65 SER^? 6.25 CH2 MLY A 104 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 18.51 71.25 -71.50 16.64 71.28 -70.53 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 17.55 80.47 -67.90 17.09 78.92 -66.03 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 B 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 741 SER E 65 SER^? 4.83 N MLY E 56 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 16.27 46.44 -56.46 15.46 48.32 -56.74 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 16.26 52.91 -64.19 14.97 52.38 -62.27 1qrz_c13 source 1qrz PLASMINOGEN : 2 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 C 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 C 741 SER A 65 SER^? 6.25 CH2 MLY A 104 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 17.55 80.47 -67.90 17.09 78.92 -66.03 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 C 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 C 741 SER A 68 SER^? 8.30 O MLY D 92 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 24.61 77.27 -62.31 25.74 79.33 -62.97 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 C 646 ASP A 55 ASP^? 3.55 CH2 MLY A 104 C 741 SER A 68 SER^? 8.30 O MLY D 92 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 24.61 77.27 -62.31 25.74 79.33 -62.97 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 67 HIS^? -4.73 O3 GOL B1126s C 646 ASP B 55 ASP^? 2.74 NZ MLY B 104 C 741 SER B 68 SER^? 8.39 O MLY E 92 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 18.03 54.22 -37.13 17.47 55.93 -38.18 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 14.45 50.68 -30.88 15.66 52.47 -30.45 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 22.79 53.21 -37.95 23.70 50.99 -38.49 ULMN 3 1qrz_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS C 67 HIS^? -4.41 O3 GOL C2126s C 646 ASP C 55 ASP^? 3.93 N MLY C 56 C 741 SER C 68 SER^? 8.27 C MLY C 49 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 20.47 72.89 -29.97 19.97 72.66 -31.99 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 25.14 71.48 -29.19 26.05 70.14 -27.42 ULMN 3 1qrz_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS D 67 HIS^? 7.34 O MLY C 92 C 646 ASP D 42 ASP^? 3.03 NZ MLY D 104 C 741 SER D 68 SER^? 8.33 C MLY D 49 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 25.58 86.91 -43.38 26.68 88.19 -41.66 ULMN 3 1qrz_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS D 67 HIS^? 7.34 O MLY C 92 C 646 ASP D 55 ASP^? 3.95 N MLY D 56 C 741 SER D 68 SER^? 8.33 C MLY D 49 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 17.25 94.50 -45.91 15.33 95.13 -46.57 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 25.58 86.91 -43.38 26.68 88.19 -41.66 ULMN 3 1qrz_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 C 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 C 741 SER E 65 SER^? 4.83 N MLY E 56 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 16.26 52.91 -64.19 14.97 52.38 -62.27 ULMN 3 1qrz_c14 PLASMINOGEN user 9 3 # 9 C 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 C 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 C 741 SER E 68 SER^? 8.34 C MLY E 49 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 23.32 56.54 -58.94 24.53 56.34 -61.01 ULMN 3 1qrz_c14 PLASMINOGEN user 10 3 # 10 C 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 C 646 ASP E 55 ASP^? 3.37 N MLY E 56 C 741 SER E 68 SER^? 8.34 C MLY E 49 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 23.32 56.54 -58.94 24.53 56.34 -61.01 1qrz_c14 source 1qrz PLASMINOGEN : 10 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 D 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 D 741 SER A 65 SER^? 6.25 CH2 MLY A 104 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 18.51 71.25 -71.50 16.64 71.28 -70.53 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 17.55 80.47 -67.90 17.09 78.92 -66.03 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 D 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 D 741 SER A 68 SER^? 8.30 O MLY D 92 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 18.51 71.25 -71.50 16.64 71.28 -70.53 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 24.61 77.27 -62.31 25.74 79.33 -62.97 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 D 646 ASP A 55 ASP^? 3.55 CH2 MLY A 104 D 741 SER A 68 SER^? 8.30 O MLY D 92 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 16.41 75.18 -70.84 15.40 75.53 -68.95 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 24.61 77.27 -62.31 25.74 79.33 -62.97 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 67 HIS^? -4.73 O3 GOL B1126s D 646 ASP B 55 ASP^? 2.74 NZ MLY B 104 D 741 SER B 68 SER^? 8.39 O MLY E 92 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 18.03 54.22 -37.13 17.47 55.93 -38.18 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 14.45 50.68 -30.88 15.66 52.47 -30.45 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 22.79 53.21 -37.95 23.70 50.99 -38.49 ULMN 3 1qrz_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS C 67 HIS^? -4.41 O3 GOL C2126s D 646 ASP C 42 ASP^? 3.04 NZ MLY C 104 D 741 SER C 65 SER^? 5.92 CH2 MLY C 104 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 19.26 82.21 -24.59 17.46 81.65 -25.59 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 17.46 72.45 -23.42 17.18 72.60 -25.76 ULMN 3 1qrz_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS C 67 HIS^? -4.41 O3 GOL C2126s D 646 ASP C 55 ASP^? 3.93 N MLY C 56 D 741 SER C 68 SER^? 8.27 C MLY C 49 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 16.82 77.26 -24.21 14.93 78.15 -24.18 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 25.14 71.48 -29.19 26.05 70.14 -27.42 ULMN 3 1qrz_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS D 67 HIS^? 7.34 O MLY C 92 D 646 ASP D 42 ASP^? 3.03 NZ MLY D 104 D 741 SER D 68 SER^? 8.33 C MLY D 49 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 18.87 94.10 -49.63 18.55 92.53 -51.05 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 25.58 86.91 -43.38 26.68 88.19 -41.66 ULMN 3 1qrz_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS D 67 HIS^? 7.34 O MLY C 92 D 646 ASP D 55 ASP^? 3.95 N MLY D 56 D 741 SER D 68 SER^? 8.33 C MLY D 49 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 25.58 86.91 -43.38 26.68 88.19 -41.66 ULMN 3 1qrz_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 D 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 D 741 SER E 65 SER^? 4.83 N MLY E 56 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 16.27 46.44 -56.46 15.46 48.32 -56.74 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 16.26 52.91 -64.19 14.97 52.38 -62.27 ULMN 3 1qrz_c15 PLASMINOGEN user 10 3 # 10 D 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 D 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 D 741 SER E 68 SER^? 8.34 C MLY E 49 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 16.27 46.44 -56.46 15.46 48.32 -56.74 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 23.32 56.54 -58.94 24.53 56.34 -61.01 ULMN 3 1qrz_c15 PLASMINOGEN user 11 3 # 11 D 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 D 646 ASP E 55 ASP^? 3.37 N MLY E 56 D 741 SER E 68 SER^? 8.34 C MLY E 49 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 14.69 49.71 -60.49 12.90 49.11 -59.47 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 23.32 56.54 -58.94 24.53 56.34 -61.01 1qrz_c15 source 1qrz PLASMINOGEN : 11 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 A 739 GLY A 58 GLY^? 4.23 CG MLY A 63 coo -20.72 2.99 34.37 -21.94 1.82 35.61 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 18.51 71.25 -71.50 16.64 71.28 -70.53 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 8.59 81.71 -69.27 8.46 80.93 -69.54 1qrz_c20 source 1qrz PLASMINOGEN : 1 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 B 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 B 739 GLY A 58 GLY^? 4.23 CG MLY A 63 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 18.51 71.25 -71.50 16.64 71.28 -70.53 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 8.59 81.71 -69.27 8.46 80.93 -69.54 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 B 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 B 739 GLY E 58 GLY^? 4.59 CB MLY E 63 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 16.27 46.44 -56.46 15.46 48.32 -56.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 6.58 51.10 -65.74 6.52 50.77 -64.99 1qrz_c21 source 1qrz PLASMINOGEN : 2 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 C 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 C 739 GLY A 58 GLY^? 4.23 CG MLY A 63 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 19.88 76.04 -62.54 19.35 75.17 -60.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 18.51 71.25 -71.50 16.64 71.28 -70.53 coo 7.82 1.25 3.03 7.30 1.31 3.65 8.59 81.71 -69.27 8.46 80.93 -69.54 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 C 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 C 739 GLY E 58 GLY^? 4.59 CB MLY E 63 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 16.27 46.44 -56.46 15.46 48.32 -56.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 6.58 51.10 -65.74 6.52 50.77 -64.99 1qrz_c22 source 1qrz PLASMINOGEN : 2 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 67 HIS^? 6.87 CH2 MLY A 104 D 646 ASP A 42 ASP^? 3.07 NZ MLY A 104 D 739 GLY A 58 GLY^? 4.23 CG MLY A 63 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 18.51 71.25 -71.50 16.64 71.28 -70.53 coo -45.82 1.31 41.67 -46.38 1.39 42.31 8.59 81.71 -69.27 8.46 80.93 -69.54 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS E 67 HIS^? 7.33 CH2 MLY E 104 D 646 ASP E 42 ASP^? 3.02 NZ MLY E 104 D 739 GLY E 58 GLY^? 4.59 CB MLY E 63 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 16.27 46.44 -56.46 15.46 48.32 -56.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 6.58 51.10 -65.74 6.52 50.77 -64.99 1qrz_c23 source 1qrz PLASMINOGEN : 2 hits 1qrz_c23 naa= 3 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 1 3 # 1 A 39 HIS A 99 HIS^? 11.42 NZ MLY A 92 A 43 TRP A 94 TRP^? 5.02 CB MLY A 92 A 108 GLU A 100 GLU^? 8.29 NZ MLY A 92 coo 33.67 25.97 25.39 31.70 26.60 25.75 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 29.43 26.12 28.46 27.08 29.25 29.01 16.06 64.44 -55.83 16.24 61.26 -58.13 coo 29.13 31.14 24.26 29.28 29.08 24.66 9.74 67.82 -56.04 9.26 65.81 -55.60 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 2 3 # 2 A 39 HIS D 99 HIS^? 11.73 CH2 MLY D 92 A 43 TRP D 94 TRP^? 4.97 CB MLY D 92 A 108 GLU D 100 GLU^? 8.65 CH2 MLY D 92 coo 33.67 25.97 25.39 31.70 26.60 25.75 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 29.43 26.12 28.46 27.08 29.25 29.01 16.97 77.28 -53.85 17.05 78.22 -57.65 coo 29.13 31.14 24.26 29.28 29.08 24.66 11.08 79.64 -49.38 10.05 78.59 -50.94 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 3 3 # 3 A 39 HIS E 99 HIS^? 5.87 C1 GOL B1126 A 43 TRP E 94 TRP^? 4.89 O3 GOL B1126 A 108 GLU E 100 GLU^? 7.50 CH1 MLY E 92 coo 33.67 25.97 25.39 31.70 26.60 25.75 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 29.43 26.12 28.46 27.08 29.25 29.01 15.33 58.47 -44.21 15.55 55.34 -41.88 coo 29.13 31.14 24.26 29.28 29.08 24.66 8.93 59.60 -48.26 8.00 59.34 -46.39 1rhc_c00 source 1rhc F420-DEPENDENT ALCOHOL DEHYDROGENASE : 3 hits 1rhc_c00 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP C 55 ASP^? 3.93 N MLY C 56 35 SER C 65 SER^? 5.92 CH2 MLY C 104 215 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo 11.85 17.24 72.81 11.09 15.37 72.36 16.82 77.26 -24.21 14.93 78.15 -24.18 coo 12.20 12.71 75.45 13.69 13.84 74.03 17.46 72.45 -23.42 17.18 72.60 -25.76 coo 5.22 15.03 71.43 7.19 14.88 70.83 19.26 82.21 -24.59 17.46 81.65 -25.59 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP E 55 ASP^? 3.37 N MLY E 56 35 SER E 65 SER^? 4.83 N MLY E 56 215 ASP E 42 ASP^? 3.02 NZ MLY E 104 coo 11.85 17.24 72.81 11.09 15.37 72.36 14.69 49.71 -60.49 12.90 49.11 -59.47 coo 12.20 12.71 75.45 13.69 13.84 74.03 16.26 52.91 -64.19 14.97 52.38 -62.27 coo 5.22 15.03 71.43 7.19 14.88 70.83 16.27 46.44 -56.46 15.46 48.32 -56.74 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 2 hits 1rne_c04 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS B 99 HIS^? 8.19 O2 GOL C2126 62 GLU B 100 GLU^? -7.17 O2 GOL B1126s 101 HIS E 76 HIS^? -4.59 O1 GOL B1126s coo 13.91 26.31 13.70 14.98 27.08 12.06 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 9.15 26.32 13.85 8.75 28.20 13.02 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 7.90 34.31 7.89 9.24 33.73 9.42 19.53 58.10 -41.26 17.57 58.86 -41.26 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 2 3 # 2 41 HIS C 99 HIS^? 9.14 O1 GOL C2126 62 GLU C 100 GLU^? -7.78 O1 GOL C2126s 101 HIS C 76 HIS^? 7.27 O MLY C 92 coo 13.91 26.31 13.70 14.98 27.08 12.06 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 9.15 26.32 13.85 8.75 28.20 13.02 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 7.90 34.31 7.89 9.24 33.73 9.42 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 3 3 # 3 41 HIS E 99 HIS^? 5.87 C1 GOL B1126 62 GLU B 100 GLU^? -7.17 O2 GOL B1126s 101 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 13.91 26.31 13.70 14.98 27.08 12.06 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 9.15 26.32 13.85 8.75 28.20 13.02 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 7.90 34.31 7.89 9.24 33.73 9.42 12.99 72.79 -44.62 12.72 70.82 -45.29 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 4 3 # 4 41 HIS E 99 HIS^? 5.87 C1 GOL B1126 62 GLU B 100 GLU^? -7.17 O2 GOL B1126s 101 HIS E 76 HIS^? -4.59 O1 GOL B1126s coo 13.91 26.31 13.70 14.98 27.08 12.06 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 9.15 26.32 13.85 8.75 28.20 13.02 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 7.90 34.31 7.89 9.24 33.73 9.42 19.53 58.10 -41.26 17.57 58.86 -41.26 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 4 hits 1rtu_c00 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 55 ASP^? 3.55 CH2 MLY A 104 595 GLU D 80 GLU^? 4.08 CH1 MLY D 92 713 TYR A 66 TYR^? -4.01 O2 PEG D3127s coo 5.64 2.82 38.49 4.59 4.19 37.25 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 4.35 13.73 37.63 3.39 12.18 36.55 15.29 82.50 -64.93 13.31 81.80 -64.63 coo 3.76 10.25 31.38 3.16 9.87 34.10 22.17 81.84 -68.52 22.05 83.01 -71.05 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP B 42 ASP^? 3.93 N MLY B 56 595 GLU B 13 GLU^? 4.19 CD MLY B 38 713 TYR B 37 TYR^? 5.81 N MLY B 38 coo 5.64 2.82 38.49 4.59 4.19 37.25 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 4.35 13.73 37.63 3.39 12.18 36.55 23.91 48.46 -16.95 22.31 49.84 -16.69 coo 3.76 10.25 31.38 3.16 9.87 34.10 25.34 54.50 -22.67 27.69 55.92 -22.25 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP B 42 ASP^? 3.93 N MLY B 56 595 GLU E 80 GLU^? 3.80 CD MLY B 63 713 TYR B 66 TYR^? 7.57 CH2 MLY B 56 coo 5.64 2.82 38.49 4.59 4.19 37.25 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 4.35 13.73 37.63 3.39 12.18 36.55 12.20 46.96 -37.99 10.63 48.40 -38.11 coo 3.76 10.25 31.38 3.16 9.87 34.10 19.82 45.97 -35.59 19.43 43.56 -34.25 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP D 42 ASP^? 3.03 NZ MLY D 104 595 GLU C 80 GLU^? 4.30 CE MLY D 63 713 TYR D 66 TYR^? 6.79 CE MLY D 56 coo 5.64 2.82 38.49 4.59 4.19 37.25 18.87 94.10 -49.63 18.55 92.53 -51.05 coo 4.35 13.73 37.63 3.39 12.18 36.55 15.56 92.60 -38.66 14.20 91.79 -40.09 coo 3.76 10.25 31.38 3.16 9.87 34.10 23.81 93.85 -40.58 24.25 96.59 -40.12 1sll_c00 source 1sll SIALIDASE L : 4 hits 1sll_c00 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 99 HIS^? 11.42 NZ MLY A 92 B 80 GLU A 100 GLU^? 8.29 NZ MLY A 92 B 223 ARG D 121 ARG^? 4.29 CG MLY D 117 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 11.74 66.03 -51.26 10.97 64.13 -50.86 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 9.74 67.82 -56.04 9.26 65.81 -55.60 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 36.09 87.23 -59.47 34.81 89.98 -60.22 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS B 99 HIS^? 8.19 O2 GOL C2126 B 80 GLU B 100 GLU^? -7.17 O2 GOL B1126s B 223 ARG A 41 ARG^? 6.93 CH1 MLY A 107 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 12.56 69.06 -42.37 11.08 70.30 -41.55 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 10.96 66.18 -39.67 10.01 67.63 -38.45 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 12.57 70.18 -72.86 9.93 70.06 -74.53 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 99 HIS^? 8.19 O2 GOL C2126 B 80 GLU B 100 GLU^? -7.17 O2 GOL B1126s B 223 ARG C 121 ARG^? 5.28 O MLY C 117 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 12.56 69.06 -42.37 11.08 70.30 -41.55 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 10.96 66.18 -39.67 10.01 67.63 -38.45 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 35.65 87.14 -33.14 35.84 86.33 -30.16 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 99 HIS^? 8.19 O2 GOL C2126 B 80 GLU B 100 GLU^? -7.17 O2 GOL B1126s B 223 ARG E 121 ARG^? 4.47 O MLY E 117 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 12.56 69.06 -42.37 11.08 70.30 -41.55 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 10.96 66.18 -39.67 10.01 67.63 -38.45 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 33.54 46.74 -47.77 31.94 44.02 -47.62 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS C 99 HIS^? 9.14 O1 GOL C2126 B 80 GLU C 100 GLU^? -7.78 O1 GOL C2126s B 223 ARG B 108 ARG^? 7.66 C MLY B 107s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 12.99 72.79 -44.62 12.72 70.82 -45.29 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 11.61 77.43 -41.88 9.59 77.35 -41.33 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 14.28 61.53 -14.52 14.41 61.31 -11.40 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS C 99 HIS^? 9.14 O1 GOL C2126 B 80 GLU C 100 GLU^? -7.78 O1 GOL C2126s B 223 ARG B 121 ARG^? 4.18 CG MLY B 117 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 12.99 72.79 -44.62 12.72 70.82 -45.29 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 11.61 77.43 -41.88 9.59 77.35 -41.33 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 35.03 59.35 -26.67 34.56 60.48 -23.81 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 7 3 # 7 B 8 HIS C 99 HIS^? 9.14 O1 GOL C2126 B 80 GLU C 100 GLU^? -7.78 O1 GOL C2126s B 223 ARG D 121 ARG^? 4.29 CG MLY D 117 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 12.99 72.79 -44.62 12.72 70.82 -45.29 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 11.61 77.43 -41.88 9.59 77.35 -41.33 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 36.09 87.23 -59.47 34.81 89.98 -60.22 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 8 3 # 8 B 8 HIS D 99 HIS^? 11.73 CH2 MLY D 92 B 80 GLU D 100 GLU^? 8.65 CH2 MLY D 92 B 223 ARG A 121 ARG^? 4.33 CG MLY A 117 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 12.57 74.67 -48.82 11.85 73.34 -50.27 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 11.08 79.64 -49.38 10.05 78.59 -50.94 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 35.71 63.07 -66.37 34.42 61.95 -68.98 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 9 3 # 9 B 8 HIS E 99 HIS^? 5.87 C1 GOL B1126 B 80 GLU E 100 GLU^? 7.50 CH1 MLY E 92 B 223 ARG A 121 ARG^? 4.33 CG MLY A 117 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 10.43 63.28 -44.90 9.66 63.00 -42.97 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 8.93 59.60 -48.26 8.00 59.34 -46.39 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 35.71 63.07 -66.37 34.42 61.95 -68.98 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 10 3 # 10 B 8 HIS E 99 HIS^? 5.87 C1 GOL B1126 B 80 GLU E 100 GLU^? 7.50 CH1 MLY E 92 B 223 ARG B 108 ARG^? 7.66 C MLY B 107s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 10.43 63.28 -44.90 9.66 63.00 -42.97 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 8.93 59.60 -48.26 8.00 59.34 -46.39 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 14.28 61.53 -14.52 14.41 61.31 -11.40 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 11 3 # 11 B 8 HIS E 99 HIS^? 5.87 C1 GOL B1126 B 80 GLU E 100 GLU^? 7.50 CH1 MLY E 92 B 223 ARG B 121 ARG^? 4.18 CG MLY B 117 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 10.43 63.28 -44.90 9.66 63.00 -42.97 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 8.93 59.60 -48.26 8.00 59.34 -46.39 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 35.03 59.35 -26.67 34.56 60.48 -23.81 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 11 hits 1t0u_c01 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 11 ALA~? 5.95 CH1 MLY A 38 A 251 GLY A 9 GLY~? -3.63 O2 GOL A 126s A 252 ASP A 111 ASP^? -3.93 O2 GOL A 126s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 24.44 65.30 -82.79 23.53 64.04 -82.67 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 28.89 62.90 -80.66 28.35 62.99 -81.30 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 26.79 62.16 -76.74 28.45 60.97 -76.09 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA A 82 ALA^? 6.93 O MLY A 104 A 251 GLY A 83 GLY^? 7.64 CG MLY A 107 A 252 ASP A 86 ASP^? 4.13 CB MLY E 62 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 10.80 52.06 -74.41 9.44 51.94 -72.75 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA A 82 ALA^? 6.93 O MLY A 104 A 251 GLY A 83 GLY^? 7.64 CG MLY A 107 A 252 ASP A 88 ASP^? 3.30 CG MLY A 107 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 14.06 59.10 -75.34 13.56 59.34 -77.37 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA C 82 ALA^? 5.29 NZ MLY D 63 A 251 GLY C 83 GLY^? 6.95 NZ MLY D 63 A 252 ASP C 86 ASP^? 3.69 CB MLY D 63 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 13.78 99.19 -34.67 12.49 98.36 -36.08 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 5 3 # 5 A 250 ALA C 82 ALA^? 5.29 NZ MLY D 63 A 251 GLY C 83 GLY^? 6.95 NZ MLY D 63 A 252 ASP C 88 ASP^? 3.98 CA MLY C 107 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 14.72 94.17 -28.91 13.94 94.86 -27.07 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 5 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 11 ALA~? 5.95 CH1 MLY A 38 B 251 GLY A 9 GLY~? -3.63 O2 GOL A 126s B 252 ASP A 111 ASP^? -3.93 O2 GOL A 126s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 24.44 65.30 -82.79 23.53 64.04 -82.67 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 28.89 62.90 -80.66 28.35 62.99 -81.30 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 26.79 62.16 -76.74 28.45 60.97 -76.09 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA A 82 ALA^? 6.93 O MLY A 104 B 251 GLY A 83 GLY^? 7.64 CG MLY A 107 B 252 ASP A 86 ASP^? 4.13 CB MLY E 62 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 10.80 52.06 -74.41 9.44 51.94 -72.75 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA A 82 ALA^? 6.93 O MLY A 104 B 251 GLY A 83 GLY^? 7.64 CG MLY A 107 B 252 ASP A 88 ASP^? 3.30 CG MLY A 107 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 11.69 57.35 -71.43 12.09 58.76 -70.99 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 9.33 58.10 -74.38 9.18 57.50 -73.83 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 14.06 59.10 -75.34 13.56 59.34 -77.37 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA C 82 ALA^? 5.29 NZ MLY D 63 B 251 GLY C 83 GLY^? 6.95 NZ MLY D 63 B 252 ASP C 86 ASP^? 3.69 CB MLY D 63 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 13.78 99.19 -34.67 12.49 98.36 -36.08 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 5 3 # 5 B 250 ALA C 82 ALA^? 5.29 NZ MLY D 63 B 251 GLY C 83 GLY^? 6.95 NZ MLY D 63 B 252 ASP C 88 ASP^? 3.98 CA MLY C 107 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 13.04 94.08 -33.37 13.13 92.57 -33.04 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 10.63 95.21 -30.64 10.70 95.56 -31.41 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 14.72 94.17 -28.91 13.94 94.86 -27.07 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 5 hits 1tz3_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 5 ASP^? 11.56 CH1 MLY B 38 218 GLU C 31 GLU^? 4.33 CB MLY C 49 329 ASP B 15 ASP^? 3.54 CB MLY B 18 coo 49.16 35.16 15.19 51.08 34.43 15.65 29.67 45.39 -10.95 29.64 43.82 -9.50 coo 70.09 11.71 8.46 70.56 12.89 6.77 34.85 71.37 -25.71 32.93 70.57 -26.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.82 41.92 -21.37 29.40 40.51 -21.49 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 15 ASP^? 3.54 CB MLY B 18 218 GLU C 22 GLU^? 4.00 O MLY C 18 329 ASP B 5 ASP^? 11.56 CH1 MLY B 38 coo 49.16 35.16 15.19 51.08 34.43 15.65 27.82 41.92 -21.37 29.40 40.51 -21.49 coo 70.09 11.71 8.46 70.56 12.89 6.77 28.94 74.76 -12.36 27.80 76.47 -11.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 29.67 45.39 -10.95 29.64 43.82 -9.50 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 15 ASP^? 3.54 CB MLY B 18 218 GLU C 31 GLU^? 4.33 CB MLY C 49 329 ASP B 5 ASP^? 11.56 CH1 MLY B 38 coo 49.16 35.16 15.19 51.08 34.43 15.65 27.82 41.92 -21.37 29.40 40.51 -21.49 coo 70.09 11.71 8.46 70.56 12.89 6.77 34.85 71.37 -25.71 32.93 70.57 -26.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 29.67 45.39 -10.95 29.64 43.82 -9.50 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 86 ASP^? 8.21 CH2 MLY B 107 218 GLU C 90 GLU^? 4.76 CH2 MLY C 92 329 ASP B 88 ASP^? 3.13 NZ MLY B 107 coo 49.16 35.16 15.19 51.08 34.43 15.65 8.64 63.45 -11.70 8.10 61.49 -11.14 coo 70.09 11.71 8.46 70.56 12.89 6.77 14.69 87.71 -34.04 12.64 87.68 -34.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 11.27 60.93 -19.56 10.57 59.24 -18.48 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 86 ASP^? 8.21 CH2 MLY B 107 218 GLU C 100 GLU^? -7.78 O1 GOL C2126s 329 ASP B 88 ASP^? 3.13 NZ MLY B 107 coo 49.16 35.16 15.19 51.08 34.43 15.65 8.64 63.45 -11.70 8.10 61.49 -11.14 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 11.27 60.93 -19.56 10.57 59.24 -18.48 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP D 86 ASP^? 8.22 CH1 MLY A 63 218 GLU A 105 GLU^? 3.91 CD MLY A 107 329 ASP D 88 ASP^? 3.08 NZ MLY D 107 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.01 94.81 -68.58 5.43 92.90 -69.25 coo 70.09 11.71 8.46 70.56 12.89 6.77 13.30 64.14 -73.44 11.76 64.88 -74.71 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.64 92.96 -63.76 13.01 94.95 -63.51 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP D 86 ASP^? 8.22 CH1 MLY A 63 218 GLU C 100 GLU^? -7.78 O1 GOL C2126s 329 ASP D 88 ASP^? 3.08 NZ MLY D 107 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.01 94.81 -68.58 5.43 92.90 -69.25 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.64 92.96 -63.76 13.01 94.95 -63.51 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 7 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 111 ASP^? -3.93 O2 GOL A 126s 242 GLU A 22 GLU~? 4.93 O MLY A 18 329 ASP A 5 ASP~? 10.39 CH1 MLY A 117 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.79 62.16 -76.74 28.45 60.97 -76.09 coo 30.42 34.74 5.00 29.09 35.09 3.38 28.50 84.22 -77.57 26.73 84.40 -78.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 30.98 56.12 -81.35 30.72 54.26 -80.37 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 88 ASP^? 3.13 NZ MLY B 107 242 GLU E 80 GLU^? 3.80 CD MLY B 63 329 ASP B 86 ASP^? 8.21 CH2 MLY B 107 coo 49.16 35.16 15.19 51.08 34.43 15.65 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 30.42 34.74 5.00 29.09 35.09 3.38 12.20 46.96 -37.99 10.63 48.40 -38.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 8.64 63.45 -11.70 8.10 61.49 -11.14 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c05 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 66 TYR^? -4.01 O2 PEG D3127s A 40 ASP A 55 ASP^? 3.55 CH2 MLY A 104 A 103 LEU A 53 LEU^? 4.84 CE MLY A 104 coo 12.09 16.13 10.57 11.28 18.80 10.73 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 7.55 25.51 14.34 9.65 25.73 14.24 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.34 73.37 -66.58 20.50 71.46 -67.09 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 66 TYR^? 7.57 CH2 MLY B 56 A 40 ASP B 42 ASP^? 3.93 N MLY B 56 A 103 LEU B 53 LEU^? 4.65 CE MLY B 104 coo 12.09 16.13 10.57 11.28 18.80 10.73 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 7.55 25.51 14.34 9.65 25.73 14.24 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 11.83 18.73 16.99 10.99 19.71 15.26 19.31 53.68 -32.28 19.73 55.67 -31.49 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR C 66 TYR^? 7.67 C MLY C 63 A 40 ASP C 42 ASP^? 3.04 NZ MLY C 104 A 103 LEU C 53 LEU^? 4.82 CE MLY C 104 coo 12.09 16.13 10.57 11.28 18.80 10.73 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 7.55 25.51 14.34 9.65 25.73 14.24 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 11.83 18.73 16.99 10.99 19.71 15.26 22.19 77.26 -27.92 21.25 79.12 -28.44 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 3 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 66 TYR^? -4.01 O2 PEG D3127s B 40 ASP A 55 ASP^? 3.55 CH2 MLY A 104 B 103 LEU A 53 LEU^? 4.84 CE MLY A 104 coo 14.25 20.09 37.35 13.48 17.40 37.38 22.17 81.84 -68.52 22.05 83.01 -71.05 coo 9.39 10.77 34.53 11.50 10.63 34.41 16.41 75.18 -70.84 15.40 75.53 -68.95 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.34 73.37 -66.58 20.50 71.46 -67.09 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 66 TYR^? 7.57 CH2 MLY B 56 B 40 ASP B 42 ASP^? 3.93 N MLY B 56 B 103 LEU B 53 LEU^? 4.65 CE MLY B 104 coo 14.25 20.09 37.35 13.48 17.40 37.38 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 9.39 10.77 34.53 11.50 10.63 34.41 16.33 50.59 -26.42 14.26 50.43 -26.72 coo 12.89 17.60 31.13 12.34 16.51 32.90 19.31 53.68 -32.28 19.73 55.67 -31.49 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR C 66 TYR^? 7.67 C MLY C 63 B 40 ASP C 42 ASP^? 3.04 NZ MLY C 104 B 103 LEU C 53 LEU^? 4.82 CE MLY C 104 coo 14.25 20.09 37.35 13.48 17.40 37.38 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 9.39 10.77 34.53 11.50 10.63 34.41 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 12.89 17.60 31.13 12.34 16.51 32.90 22.19 77.26 -27.92 21.25 79.12 -28.44 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 3 hits 1vzz_c01 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA B 73 ALA^? 3.65 C MLY B 72 B 182 GLY C 97 GLY^? 7.40 O2 GOL C2126 B 183 GLY B 97 GLY^? 8.30 O MLY E 72 coo 38.36-101.47-135.52 39.62-101.29-136.35 26.25 62.56 -40.56 25.40 61.44 -41.11 coo 41.93-102.35-126.87 41.52-101.89-126.30 19.85 70.30 -42.97 19.72 71.05 -42.79 coo 38.37-101.99-128.11 38.63-102.24-127.37 20.42 66.45 -45.35 20.23 66.16 -44.64 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA C 73 ALA^? 3.70 C MLY C 72 B 182 GLY B 97 GLY^? 8.30 O MLY E 72 B 183 GLY C 97 GLY^? 7.40 O2 GOL C2126 coo 38.36-101.47-135.52 39.62-101.29-136.35 26.69 73.30 -38.88 25.98 72.46 -37.78 coo 41.93-102.35-126.87 41.52-101.89-126.30 20.42 66.45 -45.35 20.23 66.16 -44.64 coo 38.37-101.99-128.11 38.63-102.24-127.37 19.85 70.30 -42.97 19.72 71.05 -42.79 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA C 73 ALA^? 3.70 C MLY C 72 B 182 GLY C 97 GLY^? 7.40 O2 GOL C2126 B 183 GLY D 97 GLY^? 8.52 O1 GOL C2126 coo 38.36-101.47-135.52 39.62-101.29-136.35 26.69 73.30 -38.88 25.98 72.46 -37.78 coo 41.93-102.35-126.87 41.52-101.89-126.30 19.85 70.30 -42.97 19.72 71.05 -42.79 coo 38.37-101.99-128.11 38.63-102.24-127.37 19.87 75.56 -44.51 19.65 75.91 -45.18 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA C 73 ALA^? 3.70 C MLY C 72 B 182 GLY D 97 GLY^? 8.52 O1 GOL C2126 B 183 GLY C 97 GLY^? 7.40 O2 GOL C2126 coo 38.36-101.47-135.52 39.62-101.29-136.35 26.69 73.30 -38.88 25.98 72.46 -37.78 coo 41.93-102.35-126.87 41.52-101.89-126.30 19.87 75.56 -44.51 19.65 75.91 -45.18 coo 38.37-101.99-128.11 38.63-102.24-127.37 19.85 70.30 -42.97 19.72 71.05 -42.79 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA D 82 ALA^? 3.97 O2 GOL D3126 B 182 GLY A 61 GLY^? 2.44 N MLY A 62 B 183 GLY A 58 GLY^? 4.23 CG MLY A 63 coo 38.36-101.47-135.52 39.62-101.29-136.35 13.50 89.35 -68.66 13.62 90.83 -69.06 coo 41.93-102.35-126.87 41.52-101.89-126.30 9.20 80.72 -73.86 9.00 81.48 -73.88 coo 38.37-101.99-128.11 38.63-102.24-127.37 8.59 81.71 -69.27 8.46 80.93 -69.54 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA E 73 ALA^? 3.67 C MLY E 72 B 182 GLY B 97 GLY^? 8.30 O MLY E 72 B 183 GLY E 97 GLY^? 9.86 O MLY E 72 coo 38.36-101.47-135.52 39.62-101.29-136.35 24.59 60.71 -49.83 23.98 60.79 -51.22 coo 41.93-102.35-126.87 41.52-101.89-126.30 20.42 66.45 -45.35 20.23 66.16 -44.64 coo 38.37-101.99-128.11 38.63-102.24-127.37 17.65 65.64 -49.15 17.45 64.90 -48.93 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA E 73 ALA^? 3.67 C MLY E 72 B 182 GLY E 97 GLY^? 9.86 O MLY E 72 B 183 GLY B 97 GLY^? 8.30 O MLY E 72 coo 38.36-101.47-135.52 39.62-101.29-136.35 24.59 60.71 -49.83 23.98 60.79 -51.22 coo 41.93-102.35-126.87 41.52-101.89-126.30 17.65 65.64 -49.15 17.45 64.90 -48.93 coo 38.37-101.99-128.11 38.63-102.24-127.37 20.42 66.45 -45.35 20.23 66.16 -44.64 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA E 82 ALA^? 4.40 CG MLY B 63 B 182 GLY B 58 GLY^? 5.49 CB MLY B 63 B 183 GLY B 61 GLY^? 2.45 N MLY B 62 coo 38.36-101.47-135.52 39.62-101.29-136.35 9.76 41.30 -37.24 8.58 41.90 -37.96 coo 41.93-102.35-126.87 41.52-101.89-126.30 5.68 46.13 -30.22 6.16 46.29 -29.57 coo 38.37-101.99-128.11 38.63-102.24-127.37 9.36 43.37 -28.22 9.03 42.74 -28.65 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 8 hits 1xny_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 B 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 B 138 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 2.11 4.00 19.31 3.14 4.86 19.99 16.00 58.61 -71.58 17.49 58.35 -71.38 coo 2.45 5.53 11.28 3.59 7.56 13.29 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 6.10 2.00 25.24 6.12 1.84 23.13 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 B 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 B 138 GLU A 90 GLU^? 4.57 CE MLY A 92 coo 2.11 4.00 19.31 3.14 4.86 19.99 16.00 58.61 -71.58 17.49 58.35 -71.38 coo 2.45 5.53 11.28 3.59 7.56 13.29 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 6.10 2.00 25.24 6.12 1.84 23.13 13.22 61.52 -67.04 11.19 61.45 -66.51 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA C 89 ALA^? 6.02 N MLY C 107 B 126 ARG C 108 ARG^? 8.73 C MLY C 107 B 138 GLU C 80 GLU^? 4.30 CE MLY D 63 coo 2.11 4.00 19.31 3.14 4.86 19.99 17.41 92.58 -31.86 18.92 92.61 -31.93 coo 2.45 5.53 11.28 3.59 7.56 13.29 18.68 99.59 -26.36 18.80 102.03 -24.43 coo 6.10 2.00 25.24 6.12 1.84 23.13 15.56 92.60 -38.66 14.20 91.79 -40.09 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA C 89 ALA^? 6.02 N MLY C 107 B 126 ARG C 108 ARG^? 8.73 C MLY C 107 B 138 GLU C 90 GLU^? 4.76 CH2 MLY C 92 coo 2.11 4.00 19.31 3.14 4.86 19.99 17.41 92.58 -31.86 18.92 92.61 -31.93 coo 2.45 5.53 11.28 3.59 7.56 13.29 18.68 99.59 -26.36 18.80 102.03 -24.43 coo 6.10 2.00 25.24 6.12 1.84 23.13 14.69 87.71 -34.04 12.64 87.68 -34.52 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA C 89 ALA^? 6.02 N MLY C 107 B 126 ARG C 108 ARG^? 8.73 C MLY C 107 B 138 GLU C 105 GLU^? 4.13 CH1 MLY C 107 coo 2.11 4.00 19.31 3.14 4.86 19.99 17.41 92.58 -31.86 18.92 92.61 -31.93 coo 2.45 5.53 11.28 3.59 7.56 13.29 18.68 99.59 -26.36 18.80 102.03 -24.43 coo 6.10 2.00 25.24 6.12 1.84 23.13 13.07 87.54 -28.77 11.38 88.10 -27.56 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 B 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s B 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo 2.11 4.00 19.31 3.14 4.86 19.99 13.50 89.35 -68.66 13.62 90.83 -69.06 coo 2.45 5.53 11.28 3.59 7.56 13.29 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 6.10 2.00 25.24 6.12 1.84 23.13 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 B 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 B 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s B 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo 2.11 4.00 19.31 3.14 4.86 19.99 13.50 89.35 -68.66 13.62 90.83 -69.06 coo 2.45 5.53 11.28 3.59 7.56 13.29 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 6.10 2.00 25.24 6.12 1.84 23.13 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 B 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 B 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s B 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo 2.11 4.00 19.31 3.14 4.86 19.99 16.01 89.77 -65.40 17.43 89.97 -65.89 coo 2.45 5.53 11.28 3.59 7.56 13.29 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 6.10 2.00 25.24 6.12 1.84 23.13 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 B 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 B 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s B 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo 2.11 4.00 19.31 3.14 4.86 19.99 16.01 89.77 -65.40 17.43 89.97 -65.89 coo 2.45 5.53 11.28 3.59 7.56 13.29 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 6.10 2.00 25.24 6.12 1.84 23.13 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 B 124 ALA E 89 ALA^? 6.15 N MLY E 107 B 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 B 138 GLU E 80 GLU^? 3.80 CD MLY B 63 coo 2.11 4.00 19.31 3.14 4.86 19.99 13.32 41.94 -42.69 14.68 41.23 -42.73 coo 2.45 5.53 11.28 3.59 7.56 13.29 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 6.10 2.00 25.24 6.12 1.84 23.13 12.20 46.96 -37.99 10.63 48.40 -38.11 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 B 124 ALA E 89 ALA^? 6.15 N MLY E 107 B 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 B 138 GLU E 90 GLU^? 4.38 CE MLY E 92 coo 2.11 4.00 19.31 3.14 4.86 19.99 13.32 41.94 -42.69 14.68 41.23 -42.73 coo 2.45 5.53 11.28 3.59 7.56 13.29 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 6.10 2.00 25.24 6.12 1.84 23.13 11.64 47.22 -44.78 9.75 48.01 -44.25 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 C 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 C 138 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 16.00 58.61 -71.58 17.49 58.35 -71.38 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 18.06 54.88 -79.10 18.03 52.11 -77.78 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 C 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 C 138 GLU A 90 GLU^? 4.57 CE MLY A 92 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 16.00 58.61 -71.58 17.49 58.35 -71.38 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 18.06 54.88 -79.10 18.03 52.11 -77.78 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 13.22 61.52 -67.04 11.19 61.45 -66.51 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA C 89 ALA^? 6.02 N MLY C 107 C 126 ARG C 108 ARG^? 8.73 C MLY C 107 C 138 GLU C 80 GLU^? 4.30 CE MLY D 63 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 17.41 92.58 -31.86 18.92 92.61 -31.93 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 15.56 92.60 -38.66 14.20 91.79 -40.09 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA C 89 ALA^? 6.02 N MLY C 107 C 126 ARG C 108 ARG^? 8.73 C MLY C 107 C 138 GLU C 90 GLU^? 4.76 CH2 MLY C 92 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 17.41 92.58 -31.86 18.92 92.61 -31.93 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 14.69 87.71 -34.04 12.64 87.68 -34.52 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA C 89 ALA^? 6.02 N MLY C 107 C 126 ARG C 108 ARG^? 8.73 C MLY C 107 C 138 GLU C 105 GLU^? 4.13 CH1 MLY C 107 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 17.41 92.58 -31.86 18.92 92.61 -31.93 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 13.07 87.54 -28.77 11.38 88.10 -27.56 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 C 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s C 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 13.50 89.35 -68.66 13.62 90.83 -69.06 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 C 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s C 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 13.50 89.35 -68.66 13.62 90.83 -69.06 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 C 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s C 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 16.01 89.77 -65.40 17.43 89.97 -65.89 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 C 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 C 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s C 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 16.01 89.77 -65.40 17.43 89.97 -65.89 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 C 124 ALA E 89 ALA^? 6.15 N MLY E 107 C 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 C 138 GLU E 80 GLU^? 3.80 CD MLY B 63 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 13.32 41.94 -42.69 14.68 41.23 -42.73 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 10.12 34.27 -46.51 9.14 36.36 -44.43 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 12.20 46.96 -37.99 10.63 48.40 -38.11 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 C 124 ALA E 89 ALA^? 6.15 N MLY E 107 C 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 C 138 GLU E 90 GLU^? 4.38 CE MLY E 92 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 13.32 41.94 -42.69 14.68 41.23 -42.73 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 10.12 34.27 -46.51 9.14 36.36 -44.43 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 11.64 47.22 -44.78 9.75 48.01 -44.25 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 D 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 D 138 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 16.00 58.61 -71.58 17.49 58.35 -71.38 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 6.23 0.50 57.10 5.93 0.72 59.19 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 D 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 D 138 GLU A 90 GLU^? 4.57 CE MLY A 92 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 16.00 58.61 -71.58 17.49 58.35 -71.38 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 18.06 54.88 -79.10 18.03 52.11 -77.78 coo 6.23 0.50 57.10 5.93 0.72 59.19 13.22 61.52 -67.04 11.19 61.45 -66.51 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA C 89 ALA^? 6.02 N MLY C 107 D 126 ARG C 108 ARG^? 8.73 C MLY C 107 D 138 GLU C 80 GLU^? 4.30 CE MLY D 63 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 17.41 92.58 -31.86 18.92 92.61 -31.93 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 18.68 99.59 -26.36 18.80 102.03 -24.43 coo 6.23 0.50 57.10 5.93 0.72 59.19 15.56 92.60 -38.66 14.20 91.79 -40.09 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA C 89 ALA^? 6.02 N MLY C 107 D 126 ARG C 108 ARG^? 8.73 C MLY C 107 D 138 GLU C 90 GLU^? 4.76 CH2 MLY C 92 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 17.41 92.58 -31.86 18.92 92.61 -31.93 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 18.68 99.59 -26.36 18.80 102.03 -24.43 coo 6.23 0.50 57.10 5.93 0.72 59.19 14.69 87.71 -34.04 12.64 87.68 -34.52 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA C 89 ALA^? 6.02 N MLY C 107 D 126 ARG C 108 ARG^? 8.73 C MLY C 107 D 138 GLU C 105 GLU^? 4.13 CH1 MLY C 107 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 17.41 92.58 -31.86 18.92 92.61 -31.93 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 18.68 99.59 -26.36 18.80 102.03 -24.43 coo 6.23 0.50 57.10 5.93 0.72 59.19 13.07 87.54 -28.77 11.38 88.10 -27.56 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 D 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s D 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 13.50 89.35 -68.66 13.62 90.83 -69.06 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 6.23 0.50 57.10 5.93 0.72 59.19 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 D 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s D 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 13.50 89.35 -68.66 13.62 90.83 -69.06 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 6.23 0.50 57.10 5.93 0.72 59.19 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 D 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 D 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s D 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 16.01 89.77 -65.40 17.43 89.97 -65.89 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 6.23 0.50 57.10 5.93 0.72 59.19 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 D 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 D 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s D 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 16.01 89.77 -65.40 17.43 89.97 -65.89 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 15.31 96.96 -69.15 13.25 94.66 -68.95 coo 6.23 0.50 57.10 5.93 0.72 59.19 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 D 124 ALA E 89 ALA^? 6.15 N MLY E 107 D 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 D 138 GLU E 80 GLU^? 3.80 CD MLY B 63 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 13.32 41.94 -42.69 14.68 41.23 -42.73 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 6.23 0.50 57.10 5.93 0.72 59.19 12.20 46.96 -37.99 10.63 48.40 -38.11 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 D 124 ALA E 89 ALA^? 6.15 N MLY E 107 D 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 D 138 GLU E 90 GLU^? 4.38 CE MLY E 92 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 13.32 41.94 -42.69 14.68 41.23 -42.73 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 10.12 34.27 -46.51 9.14 36.36 -44.43 coo 6.23 0.50 57.10 5.93 0.72 59.19 11.64 47.22 -44.78 9.75 48.01 -44.25 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 E 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 E 138 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo -4.56 10.03 62.36 -4.38 11.31 61.55 16.00 58.61 -71.58 17.49 58.35 -71.38 coo -3.02 12.00 70.07 -1.94 13.84 67.82 18.06 54.88 -79.10 18.03 52.11 -77.78 coo -8.67 12.22 56.54 -8.68 12.09 58.65 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 E 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 E 138 GLU A 90 GLU^? 4.57 CE MLY A 92 coo -4.56 10.03 62.36 -4.38 11.31 61.55 16.00 58.61 -71.58 17.49 58.35 -71.38 coo -3.02 12.00 70.07 -1.94 13.84 67.82 18.06 54.88 -79.10 18.03 52.11 -77.78 coo -8.67 12.22 56.54 -8.68 12.09 58.65 13.22 61.52 -67.04 11.19 61.45 -66.51 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA C 89 ALA^? 6.02 N MLY C 107 E 126 ARG C 108 ARG^? 8.73 C MLY C 107 E 138 GLU C 80 GLU^? 4.30 CE MLY D 63 coo -4.56 10.03 62.36 -4.38 11.31 61.55 17.41 92.58 -31.86 18.92 92.61 -31.93 coo -3.02 12.00 70.07 -1.94 13.84 67.82 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -8.67 12.22 56.54 -8.68 12.09 58.65 15.56 92.60 -38.66 14.20 91.79 -40.09 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA C 89 ALA^? 6.02 N MLY C 107 E 126 ARG C 108 ARG^? 8.73 C MLY C 107 E 138 GLU C 90 GLU^? 4.76 CH2 MLY C 92 coo -4.56 10.03 62.36 -4.38 11.31 61.55 17.41 92.58 -31.86 18.92 92.61 -31.93 coo -3.02 12.00 70.07 -1.94 13.84 67.82 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -8.67 12.22 56.54 -8.68 12.09 58.65 14.69 87.71 -34.04 12.64 87.68 -34.52 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA C 89 ALA^? 6.02 N MLY C 107 E 126 ARG C 108 ARG^? 8.73 C MLY C 107 E 138 GLU C 105 GLU^? 4.13 CH1 MLY C 107 coo -4.56 10.03 62.36 -4.38 11.31 61.55 17.41 92.58 -31.86 18.92 92.61 -31.93 coo -3.02 12.00 70.07 -1.94 13.84 67.82 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -8.67 12.22 56.54 -8.68 12.09 58.65 13.07 87.54 -28.77 11.38 88.10 -27.56 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 E 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s E 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo -4.56 10.03 62.36 -4.38 11.31 61.55 13.50 89.35 -68.66 13.62 90.83 -69.06 coo -3.02 12.00 70.07 -1.94 13.84 67.82 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -8.67 12.22 56.54 -8.68 12.09 58.65 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 E 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 E 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s E 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo -4.56 10.03 62.36 -4.38 11.31 61.55 13.50 89.35 -68.66 13.62 90.83 -69.06 coo -3.02 12.00 70.07 -1.94 13.84 67.82 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -8.67 12.22 56.54 -8.68 12.09 58.65 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 E 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 E 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s E 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo -4.56 10.03 62.36 -4.38 11.31 61.55 16.01 89.77 -65.40 17.43 89.97 -65.89 coo -3.02 12.00 70.07 -1.94 13.84 67.82 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -8.67 12.22 56.54 -8.68 12.09 58.65 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 E 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 E 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s E 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo -4.56 10.03 62.36 -4.38 11.31 61.55 16.01 89.77 -65.40 17.43 89.97 -65.89 coo -3.02 12.00 70.07 -1.94 13.84 67.82 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -8.67 12.22 56.54 -8.68 12.09 58.65 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 E 124 ALA E 89 ALA^? 6.15 N MLY E 107 E 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 E 138 GLU E 80 GLU^? 3.80 CD MLY B 63 coo -4.56 10.03 62.36 -4.38 11.31 61.55 13.32 41.94 -42.69 14.68 41.23 -42.73 coo -3.02 12.00 70.07 -1.94 13.84 67.82 10.12 34.27 -46.51 9.14 36.36 -44.43 coo -8.67 12.22 56.54 -8.68 12.09 58.65 12.20 46.96 -37.99 10.63 48.40 -38.11 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 E 124 ALA E 89 ALA^? 6.15 N MLY E 107 E 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 E 138 GLU E 90 GLU^? 4.38 CE MLY E 92 coo -4.56 10.03 62.36 -4.38 11.31 61.55 13.32 41.94 -42.69 14.68 41.23 -42.73 coo -3.02 12.00 70.07 -1.94 13.84 67.82 10.12 34.27 -46.51 9.14 36.36 -44.43 coo -8.67 12.22 56.54 -8.68 12.09 58.65 11.64 47.22 -44.78 9.75 48.01 -44.25 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 F 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 F 138 GLU A 80 GLU^? 4.05 CH2 MLY A 92 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 16.00 58.61 -71.58 17.49 58.35 -71.38 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 18.06 54.88 -79.10 18.03 52.11 -77.78 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 13.22 55.53 -66.00 11.94 55.88 -64.34 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 89 ALA^? 4.05 O1 PEG E4126 F 126 ARG A 108 ARG^? 7.18 O1 PEG E4126 F 138 GLU A 90 GLU^? 4.57 CE MLY A 92 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 16.00 58.61 -71.58 17.49 58.35 -71.38 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 18.06 54.88 -79.10 18.03 52.11 -77.78 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 13.22 61.52 -67.04 11.19 61.45 -66.51 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA C 89 ALA^? 6.02 N MLY C 107 F 126 ARG C 108 ARG^? 8.73 C MLY C 107 F 138 GLU C 80 GLU^? 4.30 CE MLY D 63 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 17.41 92.58 -31.86 18.92 92.61 -31.93 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 15.56 92.60 -38.66 14.20 91.79 -40.09 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA C 89 ALA^? 6.02 N MLY C 107 F 126 ARG C 108 ARG^? 8.73 C MLY C 107 F 138 GLU C 90 GLU^? 4.76 CH2 MLY C 92 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 17.41 92.58 -31.86 18.92 92.61 -31.93 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 14.69 87.71 -34.04 12.64 87.68 -34.52 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA C 89 ALA^? 6.02 N MLY C 107 F 126 ARG C 108 ARG^? 8.73 C MLY C 107 F 138 GLU C 105 GLU^? 4.13 CH1 MLY C 107 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 17.41 92.58 -31.86 18.92 92.61 -31.93 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 18.68 99.59 -26.36 18.80 102.03 -24.43 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 13.07 87.54 -28.77 11.38 88.10 -27.56 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 F 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s F 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 13.50 89.35 -68.66 13.62 90.83 -69.06 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA D 82 ALA^? 3.97 O2 GOL D3126 F 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s F 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 13.50 89.35 -68.66 13.62 90.83 -69.06 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 F 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s F 138 GLU D 80 GLU^? 4.08 CH1 MLY D 92 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 16.01 89.77 -65.40 17.43 89.97 -65.89 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 15.29 82.50 -64.93 13.31 81.80 -64.63 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 F 124 ALA D 89 ALA^? 4.53 O4 PEG D3127 F 126 ARG D 108 ARG^? -4.43 O2 GOL D3126s F 138 GLU D 90 GLU^? 4.45 CE MLY D 92 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 16.01 89.77 -65.40 17.43 89.97 -65.89 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 15.31 96.96 -69.15 13.25 94.66 -68.95 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 14.28 86.95 -60.58 12.27 86.36 -60.48 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 F 124 ALA E 89 ALA^? 6.15 N MLY E 107 F 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 F 138 GLU E 80 GLU^? 3.80 CD MLY B 63 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 13.32 41.94 -42.69 14.68 41.23 -42.73 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 10.12 34.27 -46.51 9.14 36.36 -44.43 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 12.20 46.96 -37.99 10.63 48.40 -38.11 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 F 124 ALA E 89 ALA^? 6.15 N MLY E 107 F 126 ARG E 108 ARG^? 5.63 NZ MLY E 107 F 138 GLU E 90 GLU^? 4.38 CE MLY E 92 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 13.32 41.94 -42.69 14.68 41.23 -42.73 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 10.12 34.27 -46.51 9.14 36.36 -44.43 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 11.64 47.22 -44.78 9.75 48.01 -44.25 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY C 114 GLY^? 4.57 N MLY C 117 B 175 ARG C 121 ARG^? 5.28 O MLY C 117 B 242 TYR C 122 TYR^? 7.12 N MLY C 49 coo 99.45 58.28 3.33 99.57 58.61 4.10 29.63 90.90 -29.25 28.97 90.71 -29.70 coo 106.37 63.53 0.89 108.02 63.40 -1.62 35.65 87.14 -33.14 35.84 86.33 -30.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 33.60 80.42 -32.80 34.88 80.54 -30.34 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY D 125 GLY^? 4.51 CH2 MLY A 49 B 175 ARG A 50 ARG^? 6.59 CA MLY D 117 B 242 TYR A 71 TYR^? 4.26 O MLY A 49 coo 99.45 58.28 3.33 99.57 58.61 4.10 36.69 79.85 -56.14 36.32 79.74 -56.90 coo 106.37 63.53 0.89 108.02 63.40 -1.62 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 100.93 69.04 4.38 99.52 68.48 2.09 30.64 69.73 -60.98 30.99 70.47 -63.67 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY E 125 GLY^? 5.47 CH1 MLY B 72 B 175 ARG B 50 ARG^? 6.45 CA MLY E 117 B 242 TYR B 71 TYR^? 3.83 C MLY B 49 coo 99.45 58.28 3.33 99.57 58.61 4.10 34.30 54.36 -45.19 34.10 53.88 -44.54 coo 106.37 63.53 0.89 108.02 63.40 -1.62 27.11 51.81 -37.88 27.02 48.95 -39.10 coo 100.93 69.04 4.38 99.52 68.48 2.09 30.33 58.66 -35.11 30.25 56.72 -33.11 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 3 hits 1xva_c03 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 99 HIS^? 11.42 NZ MLY A 92 B 50 GLU B 100 GLU^? -7.17 O2 GOL B1126s B 113 GLN E 98 GLN^? 9.14 CD MLY A 92 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 15.60 61.89 -51.50 14.20 63.00 -52.67 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 99 HIS^? 8.19 O2 GOL C2126 B 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 B 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 18.15 63.11 -42.95 16.88 62.03 -44.28 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS D 67 HIS^? 7.34 O MLY C 92 B 50 GLU C 100 GLU^? -7.78 O1 GOL C2126s B 113 GLN C 78 GLN^? 4.49 CD MLY C 92 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 19.22 88.39 -40.34 17.47 88.29 -41.46 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS D 76 HIS^? 7.07 O MLY D 92 B 50 GLU D 100 GLU^? 8.65 CH2 MLY D 92 B 113 GLN A 98 GLN^? 8.94 CH2 MLY D 92 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 11.08 79.64 -49.38 10.05 78.59 -50.94 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 16.33 72.22 -55.12 14.93 73.71 -54.65 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS E 76 HIS^? -4.59 O1 GOL B1126s B 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 B 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 18.15 63.11 -42.95 16.88 62.03 -44.28 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 99 HIS^? 11.42 NZ MLY A 92 B 50 GLU B 100 GLU^? -7.17 O2 GOL B1126s B 113 GLN E 98 GLN^? 9.14 CD MLY A 92 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 15.60 61.89 -51.50 14.20 63.00 -52.67 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 99 HIS^? 8.19 O2 GOL C2126 B 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 B 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 18.15 63.11 -42.95 16.88 62.03 -44.28 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS D 67 HIS^? 7.34 O MLY C 92 B 50 GLU C 100 GLU^? -7.78 O1 GOL C2126s B 113 GLN C 78 GLN^? 4.49 CD MLY C 92 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 19.22 88.39 -40.34 17.47 88.29 -41.46 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS D 76 HIS^? 7.07 O MLY D 92 B 50 GLU D 100 GLU^? 8.65 CH2 MLY D 92 B 113 GLN A 98 GLN^? 8.94 CH2 MLY D 92 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 11.08 79.64 -49.38 10.05 78.59 -50.94 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 16.33 72.22 -55.12 14.93 73.71 -54.65 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS E 76 HIS^? -4.59 O1 GOL B1126s B 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 B 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 18.15 63.11 -42.95 16.88 62.03 -44.28 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 99 HIS^? 11.42 NZ MLY A 92 A 50 GLU B 100 GLU^? -7.17 O2 GOL B1126s A 113 GLN E 98 GLN^? 9.14 CD MLY A 92 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 15.60 61.89 -51.50 14.20 63.00 -52.67 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS B 99 HIS^? 8.19 O2 GOL C2126 A 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 A 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 73.37 -13.43 4.64 73.06 -11.77 3.39 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 18.15 63.11 -42.95 16.88 62.03 -44.28 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS D 67 HIS^? 7.34 O MLY C 92 A 50 GLU C 100 GLU^? -7.78 O1 GOL C2126s A 113 GLN C 78 GLN^? 4.49 CD MLY C 92 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 19.22 88.39 -40.34 17.47 88.29 -41.46 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 4 3 # 4 A 29 HIS D 76 HIS^? 7.07 O MLY D 92 A 50 GLU D 100 GLU^? 8.65 CH2 MLY D 92 A 113 GLN A 98 GLN^? 8.94 CH2 MLY D 92 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 11.08 79.64 -49.38 10.05 78.59 -50.94 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 16.33 72.22 -55.12 14.93 73.71 -54.65 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 5 3 # 5 A 29 HIS E 76 HIS^? -4.59 O1 GOL B1126s A 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 A 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 73.37 -13.43 4.64 73.06 -11.77 3.39 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 18.15 63.11 -42.95 16.88 62.03 -44.28 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 99 HIS^? 11.42 NZ MLY A 92 C 50 GLU B 100 GLU^? -7.17 O2 GOL B1126s C 113 GLN E 98 GLN^? 9.14 CD MLY A 92 coo 74.92 8.52 28.42 74.88 6.86 29.70 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 65.25 15.95 28.73 65.73 15.63 30.78 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 70.80 6.73 32.72 71.88 8.55 32.53 15.60 61.89 -51.50 14.20 63.00 -52.67 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS B 99 HIS^? 8.19 O2 GOL C2126 C 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 C 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 74.92 8.52 28.42 74.88 6.86 29.70 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 65.25 15.95 28.73 65.73 15.63 30.78 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 70.80 6.73 32.72 71.88 8.55 32.53 18.15 63.11 -42.95 16.88 62.03 -44.28 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS D 67 HIS^? 7.34 O MLY C 92 C 50 GLU C 100 GLU^? -7.78 O1 GOL C2126s C 113 GLN C 78 GLN^? 4.49 CD MLY C 92 coo 74.92 8.52 28.42 74.88 6.86 29.70 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 65.25 15.95 28.73 65.73 15.63 30.78 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 70.80 6.73 32.72 71.88 8.55 32.53 19.22 88.39 -40.34 17.47 88.29 -41.46 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 4 3 # 4 C 29 HIS D 76 HIS^? 7.07 O MLY D 92 C 50 GLU D 100 GLU^? 8.65 CH2 MLY D 92 C 113 GLN A 98 GLN^? 8.94 CH2 MLY D 92 coo 74.92 8.52 28.42 74.88 6.86 29.70 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 65.25 15.95 28.73 65.73 15.63 30.78 11.08 79.64 -49.38 10.05 78.59 -50.94 coo 70.80 6.73 32.72 71.88 8.55 32.53 16.33 72.22 -55.12 14.93 73.71 -54.65 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 5 3 # 5 C 29 HIS E 76 HIS^? -4.59 O1 GOL B1126s C 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 C 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 74.92 8.52 28.42 74.88 6.86 29.70 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 65.25 15.95 28.73 65.73 15.63 30.78 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 70.80 6.73 32.72 71.88 8.55 32.53 18.15 63.11 -42.95 16.88 62.03 -44.28 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 99 HIS^? 11.42 NZ MLY A 92 D 50 GLU B 100 GLU^? -7.17 O2 GOL B1126s D 113 GLN E 98 GLN^? 9.14 CD MLY A 92 coo 38.66 11.31 27.15 38.67 12.13 25.22 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 48.72 12.85 33.83 48.36 14.77 32.95 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 42.85 14.77 24.15 41.85 15.11 26.02 15.60 61.89 -51.50 14.20 63.00 -52.67 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS B 99 HIS^? 8.19 O2 GOL C2126 D 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 D 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 38.66 11.31 27.15 38.67 12.13 25.22 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 48.72 12.85 33.83 48.36 14.77 32.95 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 42.85 14.77 24.15 41.85 15.11 26.02 18.15 63.11 -42.95 16.88 62.03 -44.28 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS D 67 HIS^? 7.34 O MLY C 92 D 50 GLU C 100 GLU^? -7.78 O1 GOL C2126s D 113 GLN C 78 GLN^? 4.49 CD MLY C 92 coo 38.66 11.31 27.15 38.67 12.13 25.22 20.80 86.81 -44.45 20.29 84.80 -44.77 coo 48.72 12.85 33.83 48.36 14.77 32.95 11.61 77.43 -41.88 9.59 77.35 -41.33 coo 42.85 14.77 24.15 41.85 15.11 26.02 19.22 88.39 -40.34 17.47 88.29 -41.46 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 4 3 # 4 D 29 HIS D 76 HIS^? 7.07 O MLY D 92 D 50 GLU D 100 GLU^? 8.65 CH2 MLY D 92 D 113 GLN A 98 GLN^? 8.94 CH2 MLY D 92 coo 38.66 11.31 27.15 38.67 12.13 25.22 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 48.72 12.85 33.83 48.36 14.77 32.95 11.08 79.64 -49.38 10.05 78.59 -50.94 coo 42.85 14.77 24.15 41.85 15.11 26.02 16.33 72.22 -55.12 14.93 73.71 -54.65 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 5 3 # 5 D 29 HIS E 76 HIS^? -4.59 O1 GOL B1126s D 50 GLU E 100 GLU^? 7.50 CH1 MLY E 92 D 113 GLN B 98 GLN^? -4.27 O1 GOL B1126s coo 38.66 11.31 27.15 38.67 12.13 25.22 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 48.72 12.85 33.83 48.36 14.77 32.95 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 42.85 14.77 24.15 41.85 15.11 26.02 18.15 63.11 -42.95 16.88 62.03 -44.28 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 5 ASP^? 11.56 CH1 MLY B 38 219 GLU B 13 GLU^? 4.19 CD MLY B 38 294 ASP B 15 ASP^? 3.54 CB MLY B 18 coo 27.89 102.52 14.98 29.35 101.92 13.57 29.67 45.39 -10.95 29.64 43.82 -9.50 coo 25.84 105.87 9.06 27.86 105.55 8.74 23.91 48.46 -16.95 22.31 49.84 -16.69 coo 33.16 106.80 7.72 33.34 104.87 6.92 27.82 41.92 -21.37 29.40 40.51 -21.49 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 15 ASP^? 3.54 CB MLY B 18 219 GLU B 13 GLU^? 4.19 CD MLY B 38 294 ASP B 5 ASP^? 11.56 CH1 MLY B 38 coo 27.89 102.52 14.98 29.35 101.92 13.57 27.82 41.92 -21.37 29.40 40.51 -21.49 coo 25.84 105.87 9.06 27.86 105.55 8.74 23.91 48.46 -16.95 22.31 49.84 -16.69 coo 33.16 106.80 7.72 33.34 104.87 6.92 29.67 45.39 -10.95 29.64 43.82 -9.50 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 2 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 5 ASP^? 11.56 CH1 MLY B 38 231 ASP C 29 ASP^? 4.52 NZ MLY B 117 294 ASP B 15 ASP^? 3.54 CB MLY B 18 coo 27.89 102.52 14.98 29.35 101.92 13.57 29.67 45.39 -10.95 29.64 43.82 -9.50 coo 14.74 93.05 -1.00 14.30 94.22 0.73 39.03 64.91 -21.64 38.67 64.17 -19.68 coo 33.16 106.80 7.72 33.34 104.87 6.92 27.82 41.92 -21.37 29.40 40.51 -21.49 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 88 ASP^? 3.13 NZ MLY B 107 231 ASP C 42 ASP^? 3.04 NZ MLY C 104 294 ASP B 86 ASP^? 8.21 CH2 MLY B 107 coo 27.89 102.52 14.98 29.35 101.92 13.57 11.27 60.93 -19.56 10.57 59.24 -18.48 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.26 82.21 -24.59 17.46 81.65 -25.59 coo 33.16 106.80 7.72 33.34 104.87 6.92 8.64 63.45 -11.70 8.10 61.49 -11.14 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 2 hits 2amg_c06 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 76 HIS^? 7.10 O MLY A 92 B 163 ALA E 73 ALA^? 3.67 C MLY E 72 B 182 SER E 96 SER^? 5.86 O MLY E 72 coo 30.42 1.98 4.36 29.07 0.41 4.68 20.27 61.30 -55.15 18.31 61.65 -54.51 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 24.59 60.71 -49.83 23.98 60.79 -51.22 coo 24.00 -0.17 2.07 24.51 1.00 0.04 20.41 63.14 -48.27 21.90 65.05 -48.29 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS B 76 HIS^? -4.78 C3 GOL C2126s B 163 ALA C 73 ALA^? 3.70 C MLY C 72 B 182 SER C 96 SER^? 5.54 O MLY C 72 coo 30.42 1.98 4.36 29.07 0.41 4.68 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 26.69 73.30 -38.88 25.98 72.46 -37.78 coo 24.00 -0.17 2.07 24.51 1.00 0.04 22.75 72.50 -41.71 24.26 71.19 -43.03 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS C 76 HIS^? 7.27 O MLY C 92 B 163 ALA D 73 ALA^? 3.72 C MLY D 72 B 182 SER D 96 SER^? 5.96 O MLY D 72 coo 30.42 1.98 4.36 29.07 0.41 4.68 22.40 81.23 -44.05 20.46 80.64 -44.59 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 26.61 78.14 -48.04 26.03 78.99 -46.87 coo 24.00 -0.17 2.07 24.51 1.00 0.04 22.18 75.94 -47.53 23.49 74.14 -46.77 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS D 76 HIS^? 7.07 O MLY D 92 B 163 ALA A 73 ALA^? 3.70 C MLY A 72 B 182 SER A 96 SER^? 5.92 O MLY A 72 coo 30.42 1.98 4.36 29.07 0.41 4.68 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 25.53 70.37 -55.18 24.94 71.71 -55.64 coo 24.00 -0.17 2.07 24.51 1.00 0.04 21.16 70.03 -52.65 22.56 70.77 -50.83 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS E 76 HIS^? -4.59 O1 GOL B1126s B 163 ALA B 73 ALA^? 3.65 C MLY B 72 B 182 SER B 96 SER^? 5.90 O MLY B 72 coo 30.42 1.98 4.36 29.07 0.41 4.68 19.53 58.10 -41.26 17.57 58.86 -41.26 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 26.25 62.56 -40.56 25.40 61.44 -41.11 coo 24.00 -0.17 2.07 24.51 1.00 0.04 22.87 65.56 -42.63 24.42 65.74 -44.43 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 5 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 41 ARG^? 6.93 CH1 MLY A 107 A 161 ASP A 111 ASP^? -3.93 O2 GOL A 126s A 174 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 12.57 70.18 -72.86 9.93 70.06 -74.53 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 26.79 62.16 -76.74 28.45 60.97 -76.09 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG C 41 ARG^? 4.97 CH1 MLY C 104 A 161 ASP C 111 ASP^? 8.04 N MLY C 117 A 174 TYR C 37 TYR^? 5.94 N MLY C 38 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 13.30 82.18 -23.38 11.50 79.88 -24.41 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 26.96 91.49 -25.34 28.70 92.35 -26.18 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG E 41 ARG^? 3.76 O MLY E 56 A 161 ASP E 111 ASP^? 7.83 CB MLY E 117 A 174 TYR E 37 TYR^? 5.92 N MLY E 38 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 10.72 46.92 -56.99 8.84 48.23 -59.04 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 23.18 38.18 -49.05 24.84 37.79 -47.79 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 24.28 42.38 -52.54 26.48 42.21 -50.85 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 41 ARG^? 6.93 CH1 MLY A 107 B 161 ASP A 111 ASP^? -3.93 O2 GOL A 126s B 174 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 12.57 70.18 -72.86 9.93 70.06 -74.53 coo -14.86 10.19 8.14 -14.82 12.31 8.42 26.79 62.16 -76.74 28.45 60.97 -76.09 coo -21.46 12.70 8.53 -19.04 12.30 7.24 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG C 41 ARG^? 4.97 CH1 MLY C 104 B 161 ASP C 111 ASP^? 8.04 N MLY C 117 B 174 TYR C 37 TYR^? 5.94 N MLY C 38 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 13.30 82.18 -23.38 11.50 79.88 -24.41 coo -14.86 10.19 8.14 -14.82 12.31 8.42 26.96 91.49 -25.34 28.70 92.35 -26.18 coo -21.46 12.70 8.53 -19.04 12.30 7.24 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG E 41 ARG^? 3.76 O MLY E 56 B 161 ASP E 111 ASP^? 7.83 CB MLY E 117 B 174 TYR E 37 TYR^? 5.92 N MLY E 38 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 10.72 46.92 -56.99 8.84 48.23 -59.04 coo -14.86 10.19 8.14 -14.82 12.31 8.42 23.18 38.18 -49.05 24.84 37.79 -47.79 coo -21.46 12.70 8.53 -19.04 12.30 7.24 24.28 42.38 -52.54 26.48 42.21 -50.85 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 41 ARG^? 6.93 CH1 MLY A 107 C 161 ASP A 111 ASP^? -3.93 O2 GOL A 126s C 174 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo 2.84 19.43 40.34 1.59 20.35 37.65 12.57 70.18 -72.86 9.93 70.06 -74.53 coo -0.62 11.10 28.05 -0.65 13.15 27.46 26.79 62.16 -76.74 28.45 60.97 -76.09 coo 5.94 13.28 27.17 3.53 13.05 28.58 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG C 41 ARG^? 4.97 CH1 MLY C 104 C 161 ASP C 111 ASP^? 8.04 N MLY C 117 C 174 TYR C 37 TYR^? 5.94 N MLY C 38 coo 2.84 19.43 40.34 1.59 20.35 37.65 13.30 82.18 -23.38 11.50 79.88 -24.41 coo -0.62 11.10 28.05 -0.65 13.15 27.46 26.96 91.49 -25.34 28.70 92.35 -26.18 coo 5.94 13.28 27.17 3.53 13.05 28.58 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG E 41 ARG^? 3.76 O MLY E 56 C 161 ASP E 111 ASP^? 7.83 CB MLY E 117 C 174 TYR E 37 TYR^? 5.92 N MLY E 38 coo 2.84 19.43 40.34 1.59 20.35 37.65 10.72 46.92 -56.99 8.84 48.23 -59.04 coo -0.62 11.10 28.05 -0.65 13.15 27.46 23.18 38.18 -49.05 24.84 37.79 -47.79 coo 5.94 13.28 27.17 3.53 13.05 28.58 24.28 42.38 -52.54 26.48 42.21 -50.85 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 41 ARG^? 6.93 CH1 MLY A 107 D 161 ASP A 111 ASP^? -3.93 O2 GOL A 126s D 174 TYR A 37 TYR^? -3.91 C3 GOL A 126s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 12.57 70.18 -72.86 9.93 70.06 -74.53 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 26.79 62.16 -76.74 28.45 60.97 -76.09 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 26.61 66.73 -73.48 28.75 65.06 -72.74 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG C 41 ARG^? 4.97 CH1 MLY C 104 D 161 ASP C 111 ASP^? 8.04 N MLY C 117 D 174 TYR C 37 TYR^? 5.94 N MLY C 38 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 13.30 82.18 -23.38 11.50 79.88 -24.41 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 26.96 91.49 -25.34 28.70 92.35 -26.18 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 27.75 86.31 -25.30 29.95 87.22 -26.70 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG E 41 ARG^? 3.76 O MLY E 56 D 161 ASP E 111 ASP^? 7.83 CB MLY E 117 D 174 TYR E 37 TYR^? 5.92 N MLY E 38 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 10.72 46.92 -56.99 8.84 48.23 -59.04 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 23.18 38.18 -49.05 24.84 37.79 -47.79 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 24.28 42.38 -52.54 26.48 42.21 -50.85 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 15 ASP~? -3.42 O1 GOL A 128s A 233 GLU A 13 GLU.? 5.36 C1 GOL A 127s A 300 ASN A 10 ASN~? 7.93 O1 GOL A 126 coo 12.51 17.07 49.46 12.44 16.89 47.35 31.25 75.86 -81.75 33.13 76.66 -82.26 coo 6.52 19.14 48.16 7.77 18.42 46.61 30.21 69.38 -81.53 31.47 68.83 -83.15 coo 9.30 22.40 41.76 10.10 20.96 40.36 28.32 65.04 -85.07 30.35 64.74 -85.74 2cpu_c01 source 2cpu ALPHA-AMYLASE : 1 hits 2cpu_c01 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 99 HIS^? 11.42 NZ MLY A 92 A 341 GLU A 100 GLU^? 8.29 NZ MLY A 92 A 356 HIS A 76 HIS^? 7.10 O MLY A 92 coo 121.00 36.37 19.26 121.57 38.37 19.56 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 125.72 32.70 19.75 124.44 34.16 18.84 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 124.34 41.73 25.55 123.79 42.60 23.72 20.27 61.30 -55.15 18.31 61.65 -54.51 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS A 99 HIS^? 11.42 NZ MLY A 92 A 341 GLU A 100 GLU^? 8.29 NZ MLY A 92 A 356 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 121.00 36.37 19.26 121.57 38.37 19.56 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 125.72 32.70 19.75 124.44 34.16 18.84 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 124.34 41.73 25.55 123.79 42.60 23.72 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 A 311 HIS A 99 HIS^? 11.42 NZ MLY A 92 A 341 GLU A 100 GLU^? 8.29 NZ MLY A 92 A 356 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 121.00 36.37 19.26 121.57 38.37 19.56 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 125.72 32.70 19.75 124.44 34.16 18.84 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 124.34 41.73 25.55 123.79 42.60 23.72 10.43 63.28 -44.90 9.66 63.00 -42.97 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 A 311 HIS A 99 HIS^? 11.42 NZ MLY A 92 A 341 GLU E 100 GLU^? 7.50 CH1 MLY E 92 A 356 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 121.00 36.37 19.26 121.57 38.37 19.56 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 125.72 32.70 19.75 124.44 34.16 18.84 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 124.34 41.73 25.55 123.79 42.60 23.72 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 A 311 HIS B 99 HIS^? 8.19 O2 GOL C2126 A 341 GLU B 100 GLU^? -7.17 O2 GOL B1126s A 356 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 121.00 36.37 19.26 121.57 38.37 19.56 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 125.72 32.70 19.75 124.44 34.16 18.84 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 124.34 41.73 25.55 123.79 42.60 23.72 11.74 66.03 -51.26 10.97 64.13 -50.86 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 A 311 HIS B 99 HIS^? 8.19 O2 GOL C2126 A 341 GLU B 100 GLU^? -7.17 O2 GOL B1126s A 356 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 121.00 36.37 19.26 121.57 38.37 19.56 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 125.72 32.70 19.75 124.44 34.16 18.84 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 124.34 41.73 25.55 123.79 42.60 23.72 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 A 311 HIS D 99 HIS^? 11.73 CH2 MLY D 92 A 341 GLU D 100 GLU^? 8.65 CH2 MLY D 92 A 356 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 121.00 36.37 19.26 121.57 38.37 19.56 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 125.72 32.70 19.75 124.44 34.16 18.84 11.08 79.64 -49.38 10.05 78.59 -50.94 coo 124.34 41.73 25.55 123.79 42.60 23.72 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 8 3 # 8 A 311 HIS E 99 HIS^? 5.87 C1 GOL B1126 A 341 GLU B 100 GLU^? -7.17 O2 GOL B1126s A 356 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 121.00 36.37 19.26 121.57 38.37 19.56 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 125.72 32.70 19.75 124.44 34.16 18.84 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 124.34 41.73 25.55 123.79 42.60 23.72 11.74 66.03 -51.26 10.97 64.13 -50.86 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 8 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 99 HIS^? 11.42 NZ MLY A 92 B 341 GLU A 100 GLU^? 8.29 NZ MLY A 92 B 356 HIS A 76 HIS^? 7.10 O MLY A 92 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 20.27 61.30 -55.15 18.31 61.65 -54.51 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS A 99 HIS^? 11.42 NZ MLY A 92 B 341 GLU A 100 GLU^? 8.29 NZ MLY A 92 B 356 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 12.99 72.79 -44.62 12.72 70.82 -45.29 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 B 311 HIS A 99 HIS^? 11.42 NZ MLY A 92 B 341 GLU A 100 GLU^? 8.29 NZ MLY A 92 B 356 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 B 311 HIS A 99 HIS^? 11.42 NZ MLY A 92 B 341 GLU A 100 GLU^? 8.29 NZ MLY A 92 B 356 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 9.74 67.82 -56.04 9.26 65.81 -55.60 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 10.43 63.28 -44.90 9.66 63.00 -42.97 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 B 311 HIS A 99 HIS^? 11.42 NZ MLY A 92 B 341 GLU E 100 GLU^? 7.50 CH1 MLY E 92 B 356 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 8.93 59.60 -48.26 8.00 59.34 -46.39 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 B 311 HIS B 99 HIS^? 8.19 O2 GOL C2126 B 341 GLU B 100 GLU^? -7.17 O2 GOL B1126s B 356 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 11.74 66.03 -51.26 10.97 64.13 -50.86 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 B 311 HIS B 99 HIS^? 8.19 O2 GOL C2126 B 341 GLU B 100 GLU^? -7.17 O2 GOL B1126s B 356 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 8 3 # 8 B 311 HIS D 99 HIS^? 11.73 CH2 MLY D 92 B 341 GLU D 100 GLU^? 8.65 CH2 MLY D 92 B 356 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 11.08 79.64 -49.38 10.05 78.59 -50.94 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 9 3 # 9 B 311 HIS E 99 HIS^? 5.87 C1 GOL B1126 B 341 GLU B 100 GLU^? -7.17 O2 GOL B1126s B 356 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 10.96 66.18 -39.67 10.01 67.63 -38.45 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 11.74 66.03 -51.26 10.97 64.13 -50.86 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 9 hits 2isd_c01 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP C 55 ASP^? 3.93 N MLY C 56 A 35 SER C 65 SER^? 5.92 CH2 MLY C 104 A 215 ASP C 42 ASP^? 3.04 NZ MLY C 104 coo -14.00 61.45 43.99 -14.19 63.14 42.84 16.82 77.26 -24.21 14.93 78.15 -24.18 coo -13.21 66.21 45.84 -15.49 65.90 45.84 17.46 72.45 -23.42 17.18 72.60 -25.76 coo -10.72 64.19 37.77 -12.20 64.43 39.15 19.26 82.21 -24.59 17.46 81.65 -25.59 2jxr_c04 source 2jxr LIGAND CP-081282 : 1 hits 2jxr_c04 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 5 ASP~? 10.39 CH1 MLY A 117 166 GLY E 28 GLY^? 4.62 CE MLY A 117 169 GLU E 32 GLU^? 9.00 N MLY E 49 coo 8.28 6.87 1.62 10.08 5.77 1.34 30.98 56.12 -81.35 30.72 54.26 -80.37 coo -8.58 13.22 3.21 -8.90 13.15 4.05 33.91 56.81 -64.88 33.92 55.95 -65.02 coo -16.67 7.89 2.78 -17.65 6.56 1.49 36.93 48.99 -59.01 38.56 47.63 -58.62 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 29 ASP.? 3.50 CE MLY D 117 166 GLY A 17 GLY~? -2.40 N MLY A 18s 169 GLU A 13 GLU.? 5.36 C1 GOL A 127s coo 8.28 6.87 1.62 10.08 5.77 1.34 39.46 85.40 -64.07 38.37 87.19 -63.78 coo -8.58 13.22 3.21 -8.90 13.15 4.05 34.91 78.49 -78.73 34.09 78.39 -78.66 coo -16.67 7.89 2.78 -17.65 6.56 1.49 30.21 69.38 -81.53 31.47 68.83 -83.15 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 5 ASP^? 11.56 CH1 MLY B 38 166 GLY B 109 GLY^? -4.13 O MLY B 107s 169 GLU B 105 GLU^? 3.55 CD MLY B 107 coo 8.28 6.87 1.62 10.08 5.77 1.34 29.67 45.39 -10.95 29.64 43.82 -9.50 coo -8.58 13.22 3.21 -8.90 13.15 4.05 17.60 56.43 -14.69 17.67 56.82 -15.41 coo -16.67 7.89 2.78 -17.65 6.56 1.49 11.26 58.92 -23.27 9.32 58.09 -22.93 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 15 ASP^? 3.54 CB MLY B 18 166 GLY B 61 GLY^? 2.45 N MLY B 62 169 GLU E 80 GLU^? 3.80 CD MLY B 63 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.82 41.92 -21.37 29.40 40.51 -21.49 coo -8.58 13.22 3.21 -8.90 13.15 4.05 9.36 43.37 -28.22 9.03 42.74 -28.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 12.20 46.96 -37.99 10.63 48.40 -38.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 15 ASP^? 3.54 CB MLY B 18 166 GLY B 109 GLY^? -4.13 O MLY B 107s 169 GLU B 105 GLU^? 3.55 CD MLY B 107 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.82 41.92 -21.37 29.40 40.51 -21.49 coo -8.58 13.22 3.21 -8.90 13.15 4.05 17.60 56.43 -14.69 17.67 56.82 -15.41 coo -16.67 7.89 2.78 -17.65 6.56 1.49 11.26 58.92 -23.27 9.32 58.09 -22.93 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 88 ASP^? 3.13 NZ MLY B 107 166 GLY B 58 GLY^? 5.49 CB MLY B 63 169 GLU E 80 GLU^? 3.80 CD MLY B 63 coo 8.28 6.87 1.62 10.08 5.77 1.34 11.27 60.93 -19.56 10.57 59.24 -18.48 coo -8.58 13.22 3.21 -8.90 13.15 4.05 5.68 46.13 -30.22 6.16 46.29 -29.57 coo -16.67 7.89 2.78 -17.65 6.56 1.49 12.20 46.96 -37.99 10.63 48.40 -38.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 88 ASP^? 3.13 NZ MLY B 107 166 GLY B 61 GLY^? 2.45 N MLY B 62 169 GLU E 80 GLU^? 3.80 CD MLY B 63 coo 8.28 6.87 1.62 10.08 5.77 1.34 11.27 60.93 -19.56 10.57 59.24 -18.48 coo -8.58 13.22 3.21 -8.90 13.15 4.05 9.36 43.37 -28.22 9.03 42.74 -28.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 12.20 46.96 -37.99 10.63 48.40 -38.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP D 55 ASP^? 3.95 N MLY D 56 166 GLY D 17 GLY^? 2.44 N MLY D 18 169 GLU D 32 GLU^? 9.20 N MLY D 49 coo 8.28 6.87 1.62 10.08 5.77 1.34 17.25 94.50 -45.91 15.33 95.13 -46.57 coo -8.58 13.22 3.21 -8.90 13.15 4.05 34.42 103.09 -46.81 33.61 102.93 -46.92 coo -16.67 7.89 2.78 -17.65 6.56 1.49 40.33 93.18 -45.60 42.01 93.18 -46.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP E 15 ASP^? 3.80 N MLY E 18 166 GLY E 109 GLY^? 3.43 O MLY E 107 169 GLU E 105 GLU^? 4.83 CE MLY E 107 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.54 37.14 -63.49 29.27 36.92 -64.69 coo -8.58 13.22 3.21 -8.90 13.15 4.05 16.29 34.79 -50.75 16.46 35.35 -50.19 coo -16.67 7.89 2.78 -17.65 6.56 1.49 9.86 43.86 -48.83 8.13 42.90 -49.57 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP E 55 ASP^? 3.37 N MLY E 56 166 GLY E 97 GLY^? 9.86 O MLY E 72 169 GLU B 100 GLU^? -7.17 O2 GOL B1126s coo 8.28 6.87 1.62 10.08 5.77 1.34 14.69 49.71 -60.49 12.90 49.11 -59.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 17.65 65.64 -49.15 17.45 64.90 -48.93 coo -16.67 7.89 2.78 -17.65 6.56 1.49 10.96 66.18 -39.67 10.01 67.63 -38.45 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 10 hits 2tdt_c00 naa= 3 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 1 3 # 1 A 202 HIS A 99 HIS^? 11.42 NZ MLY A 92 A 295 HIS E 67 HIS^? 7.33 CH2 MLY E 104 A 296 HIS A 76 HIS^? 7.10 O MLY A 92 coo 65.34 65.04 50.22 63.95 63.70 51.06 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 63.46 53.34 50.98 63.08 55.39 51.17 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 64.71 54.80 47.28 63.92 56.57 48.06 20.27 61.30 -55.15 18.31 61.65 -54.51 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 2 3 # 2 A 202 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 295 HIS C 99 HIS^? 9.14 O1 GOL C2126 A 296 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 65.34 65.04 50.22 63.95 63.70 51.06 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 63.46 53.34 50.98 63.08 55.39 51.17 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 64.71 54.80 47.28 63.92 56.57 48.06 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 3 3 # 3 A 202 HIS C 76 HIS^? 7.27 O MLY C 92 A 295 HIS D 99 HIS^? 11.73 CH2 MLY D 92 A 296 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 65.34 65.04 50.22 63.95 63.70 51.06 22.40 81.23 -44.05 20.46 80.64 -44.59 coo 63.46 53.34 50.98 63.08 55.39 51.17 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 64.71 54.80 47.28 63.92 56.57 48.06 12.99 72.79 -44.62 12.72 70.82 -45.29 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 4 3 # 4 A 202 HIS E 99 HIS^? 5.87 C1 GOL B1126 A 295 HIS D 99 HIS^? 11.73 CH2 MLY D 92 A 296 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 65.34 65.04 50.22 63.95 63.70 51.06 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 63.46 53.34 50.98 63.08 55.39 51.17 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 64.71 54.80 47.28 63.92 56.57 48.06 12.99 72.79 -44.62 12.72 70.82 -45.29 4kbp_c00 source 4kbp PURPLE ACID PHOSPHATASE : 4 hits 4kbp_c00 naa= 3 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 1 3 # 1 B 202 HIS A 99 HIS^? 11.42 NZ MLY A 92 B 295 HIS E 67 HIS^? 7.33 CH2 MLY E 104 B 296 HIS A 76 HIS^? 7.10 O MLY A 92 coo 20.09 23.80 58.44 19.07 25.34 59.44 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 19.00 35.58 58.05 18.83 33.61 58.74 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 22.88 34.01 57.66 22.04 32.37 58.63 20.27 61.30 -55.15 18.31 61.65 -54.51 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 2 3 # 2 B 202 HIS B 76 HIS^? -4.78 C3 GOL C2126s B 295 HIS C 99 HIS^? 9.14 O1 GOL C2126 B 296 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 20.09 23.80 58.44 19.07 25.34 59.44 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 19.00 35.58 58.05 18.83 33.61 58.74 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 22.88 34.01 57.66 22.04 32.37 58.63 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 3 3 # 3 B 202 HIS E 99 HIS^? 5.87 C1 GOL B1126 B 295 HIS C 99 HIS^? 9.14 O1 GOL C2126 B 296 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 20.09 23.80 58.44 19.07 25.34 59.44 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 19.00 35.58 58.05 18.83 33.61 58.74 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 22.88 34.01 57.66 22.04 32.37 58.63 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 4 3 # 4 B 202 HIS E 99 HIS^? 5.87 C1 GOL B1126 B 295 HIS D 99 HIS^? 11.73 CH2 MLY D 92 B 296 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 20.09 23.80 58.44 19.07 25.34 59.44 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 19.00 35.58 58.05 18.83 33.61 58.74 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 22.88 34.01 57.66 22.04 32.37 58.63 12.99 72.79 -44.62 12.72 70.82 -45.29 4kbp_c01 source 4kbp PURPLE ACID PHOSPHATASE : 4 hits 4kbp_c01 naa= 3 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 1 3 # 1 C 202 HIS A 99 HIS^? 11.42 NZ MLY A 92 C 295 HIS E 67 HIS^? 7.33 CH2 MLY E 104 C 296 HIS A 76 HIS^? 7.10 O MLY A 92 coo 56.07 24.38 61.64 57.15 25.46 60.21 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 57.19 35.56 57.82 57.34 33.47 57.88 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 53.24 34.19 58.78 54.08 32.31 58.44 20.27 61.30 -55.15 18.31 61.65 -54.51 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 2 3 # 2 C 202 HIS B 76 HIS^? -4.78 C3 GOL C2126s C 295 HIS C 99 HIS^? 9.14 O1 GOL C2126 C 296 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 56.07 24.38 61.64 57.15 25.46 60.21 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 57.19 35.56 57.82 57.34 33.47 57.88 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 53.24 34.19 58.78 54.08 32.31 58.44 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 3 3 # 3 C 202 HIS E 99 HIS^? 5.87 C1 GOL B1126 C 295 HIS D 99 HIS^? 11.73 CH2 MLY D 92 C 296 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 56.07 24.38 61.64 57.15 25.46 60.21 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 57.19 35.56 57.82 57.34 33.47 57.88 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 53.24 34.19 58.78 54.08 32.31 58.44 12.99 72.79 -44.62 12.72 70.82 -45.29 4kbp_c02 source 4kbp PURPLE ACID PHOSPHATASE : 3 hits 4kbp_c02 naa= 3 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 1 3 # 1 D 202 HIS A 99 HIS^? 11.42 NZ MLY A 92 D 295 HIS E 67 HIS^? 7.33 CH2 MLY E 104 D 296 HIS A 76 HIS^? 7.10 O MLY A 92 coo 61.78 113.98 49.61 62.80 115.33 50.85 11.74 66.03 -51.26 10.97 64.13 -50.86 coo 63.27 125.61 50.94 63.59 123.54 51.16 18.54 56.25 -57.78 18.20 57.67 -56.27 coo 63.24 124.12 46.99 63.79 122.40 48.02 20.27 61.30 -55.15 18.31 61.65 -54.51 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 2 3 # 2 D 202 HIS B 76 HIS^? -4.78 C3 GOL C2126s D 295 HIS C 99 HIS^? 9.14 O1 GOL C2126 D 296 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 61.78 113.98 49.61 62.80 115.33 50.85 22.13 70.54 -35.03 20.24 71.08 -35.76 coo 63.27 125.61 50.94 63.59 123.54 51.16 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 63.24 124.12 46.99 63.79 122.40 48.02 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 3 3 # 3 D 202 HIS E 99 HIS^? 5.87 C1 GOL B1126 D 295 HIS C 99 HIS^? 9.14 O1 GOL C2126 D 296 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 61.78 113.98 49.61 62.80 115.33 50.85 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 63.27 125.61 50.94 63.59 123.54 51.16 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 63.24 124.12 46.99 63.79 122.40 48.02 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 4 3 # 4 D 202 HIS E 99 HIS^? 5.87 C1 GOL B1126 D 295 HIS D 99 HIS^? 11.73 CH2 MLY D 92 D 296 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 61.78 113.98 49.61 62.80 115.33 50.85 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 63.27 125.61 50.94 63.59 123.54 51.16 12.57 74.67 -48.82 11.85 73.34 -50.27 coo 63.24 124.12 46.99 63.79 122.40 48.02 12.99 72.79 -44.62 12.72 70.82 -45.29 4kbp_c03 source 4kbp PURPLE ACID PHOSPHATASE : 4 hits 4kbp_c03 naa= 3 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 1 3 # 1 83 GLN A 57 GLN^? 5.22 O MLY A 56 94 HIS D 76 HIS^? 7.07 O MLY D 92 96 HIS A 67 HIS^? 6.87 CH2 MLY A 104 coo 12.06 13.83 19.61 9.96 13.82 20.00 13.11 78.06 -68.28 13.58 77.51 -66.25 coo 15.69 26.32 19.80 17.39 27.17 20.68 21.19 75.42 -56.78 19.17 75.05 -56.40 coo 14.38 20.59 22.16 12.49 20.21 21.35 19.88 76.04 -62.54 19.35 75.17 -60.71 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 2 3 # 2 83 GLN A 98 GLN^? 8.94 CH2 MLY D 92 94 HIS C 99 HIS^? 9.14 O1 GOL C2126 96 HIS D 99 HIS^? 11.73 CH2 MLY D 92 coo 12.06 13.83 19.61 9.96 13.82 20.00 16.33 72.22 -55.12 14.93 73.71 -54.65 coo 15.69 26.32 19.80 17.39 27.17 20.68 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 14.38 20.59 22.16 12.49 20.21 21.35 12.57 74.67 -48.82 11.85 73.34 -50.27 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 3 3 # 3 83 GLN A 98 GLN^? 8.94 CH2 MLY D 92 94 HIS E 99 HIS^? 5.87 C1 GOL B1126 96 HIS A 99 HIS^? 11.42 NZ MLY A 92 coo 12.06 13.83 19.61 9.96 13.82 20.00 16.33 72.22 -55.12 14.93 73.71 -54.65 coo 15.69 26.32 19.80 17.39 27.17 20.68 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 14.38 20.59 22.16 12.49 20.21 21.35 11.74 66.03 -51.26 10.97 64.13 -50.86 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 4 3 # 4 83 GLN B 98 GLN^? -4.27 O1 GOL B1126s 94 HIS C 99 HIS^? 9.14 O1 GOL C2126 96 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 12.06 13.83 19.61 9.96 13.82 20.00 18.15 63.11 -42.95 16.88 62.03 -44.28 coo 15.69 26.32 19.80 17.39 27.17 20.68 12.99 72.79 -44.62 12.72 70.82 -45.29 coo 14.38 20.59 22.16 12.49 20.21 21.35 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 5 3 # 5 83 GLN C 98 GLN^? -3.27 O2 GOL C2126s 94 HIS E 99 HIS^? 5.87 C1 GOL B1126 96 HIS B 99 HIS^? 8.19 O2 GOL C2126 coo 12.06 13.83 19.61 9.96 13.82 20.00 17.44 72.80 -39.41 16.11 71.18 -39.17 coo 15.69 26.32 19.80 17.39 27.17 20.68 10.43 63.28 -44.90 9.66 63.00 -42.97 coo 14.38 20.59 22.16 12.49 20.21 21.35 12.56 69.06 -42.37 11.08 70.30 -41.55 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 6 3 # 6 83 GLN D 98 GLN^? 7.57 CH2 MLY D 104 94 HIS B 99 HIS^? 8.19 O2 GOL C2126 96 HIS C 99 HIS^? 9.14 O1 GOL C2126 coo 12.06 13.83 19.61 9.96 13.82 20.00 16.59 80.12 -46.90 17.21 82.12 -47.27 coo 15.69 26.32 19.80 17.39 27.17 20.68 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 14.38 20.59 22.16 12.49 20.21 21.35 12.99 72.79 -44.62 12.72 70.82 -45.29 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 7 3 # 7 83 GLN E 98 GLN^? 9.14 CD MLY A 92 94 HIS B 99 HIS^? 8.19 O2 GOL C2126 96 HIS E 99 HIS^? 5.87 C1 GOL B1126 coo 12.06 13.83 19.61 9.96 13.82 20.00 15.60 61.89 -51.50 14.20 63.00 -52.67 coo 15.69 26.32 19.80 17.39 27.17 20.68 12.56 69.06 -42.37 11.08 70.30 -41.55 coo 14.38 20.59 22.16 12.49 20.21 21.35 10.43 63.28 -44.90 9.66 63.00 -42.97 5fit_c00 source 5fit FRAGILE HISTIDINE TRIAD PROTEIN : 7 hits 5fit_c00 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 111 ASP^? -3.93 O2 GOL A 126s A 99 GLY A 9 GLY~? -3.63 O2 GOL A 126s A 125 ASN A 10 ASN~? 7.93 O1 GOL A 126 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 26.79 62.16 -76.74 28.45 60.97 -76.09 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 28.89 62.90 -80.66 28.35 62.99 -81.30 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 28.32 65.04 -85.07 30.35 64.74 -85.74 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 1 hits 1hkd_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 10 ASN~? 7.93 O1 GOL A 126 coo 5.80 63.03 55.85 5.52 65.03 56.45 28.32 65.04 -85.07 30.35 64.74 -85.74 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 30 ASN.? 5.83 CH1 MLY A 49 coo 5.80 63.03 55.85 5.52 65.03 56.45 40.27 80.58 -61.87 41.65 82.00 -61.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN B 30 ASN^? 4.18 CH2 MLY B 49 coo 5.80 63.03 55.85 5.52 65.03 56.45 37.76 48.70 -41.25 36.04 49.71 -42.04 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN C 30 ASN^? 5.09 CE MLY C 49 coo 5.80 63.03 55.85 5.52 65.03 56.45 40.70 67.40 -25.79 39.20 66.57 -27.10 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN D 30 ASN^? 7.01 CH2 MLY D 49 coo 5.80 63.03 55.85 5.52 65.03 56.45 42.16 89.18 -40.82 43.17 89.06 -38.94 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN E 30 ASN^? 6.67 NZ MLY E 49 coo 5.80 63.03 55.85 5.52 65.03 56.45 39.79 55.85 -62.13 41.36 56.60 -63.37 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 6 hits 1kbk_p00 naa= 1 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 50 ARG^? 6.59 CA MLY D 117 A 188 TYR A 122 TYR^? 6.96 N MLY A 49 A 190 SER A 48 SER^? 3.36 N MLY A 49 coo 37.69 7.64 13.51 38.82 8.84 16.11 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 47.14 12.10 13.73 48.75 12.33 16.01 32.33 67.18 -64.12 33.76 68.27 -66.26 coo 43.77 6.93 15.46 45.49 7.21 17.11 35.82 73.21 -64.61 36.98 75.34 -64.56 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG B 50 ARG^? 6.45 CA MLY E 117 A 188 TYR B 66 TYR^? 7.57 CH2 MLY B 56 A 190 SER B 68 SER^? 8.39 O MLY E 92 coo 37.69 7.64 13.51 38.82 8.84 16.11 27.11 51.81 -37.88 27.02 48.95 -39.10 coo 47.14 12.10 13.73 48.75 12.33 16.01 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 43.77 6.93 15.46 45.49 7.21 17.11 22.79 53.21 -37.95 23.70 50.99 -38.49 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG C 50 ARG^? 6.37 CA MLY B 117 A 188 TYR C 122 TYR^? 7.12 N MLY C 49 A 190 SER C 48 SER^? 3.29 N MLY C 49 coo 37.69 7.64 13.51 38.82 8.84 16.11 29.38 71.17 -28.15 29.46 68.99 -25.90 coo 47.14 12.10 13.73 48.75 12.33 16.01 33.60 80.42 -32.80 34.88 80.54 -30.34 coo 43.77 6.93 15.46 45.49 7.21 17.11 36.60 75.26 -28.91 37.65 73.40 -27.84 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG D 50 ARG^? 6.49 CA MLY C 117 A 188 TYR D 66 TYR^? 6.79 CE MLY D 56 A 190 SER D 68 SER^? 8.33 C MLY D 49 coo 37.69 7.64 13.51 38.82 8.84 16.11 29.95 87.67 -43.01 30.32 89.04 -40.28 coo 47.14 12.10 13.73 48.75 12.33 16.01 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 43.77 6.93 15.46 45.49 7.21 17.11 25.58 86.91 -43.38 26.68 88.19 -41.66 ULMN 3 2p3i_p00 VP4 user 5 3 # 5 A 101 ARG E 50 ARG^? 6.44 CA MLY A 117 A 188 TYR E 66 TYR^? -3.37 C3 PEG E4126s A 190 SER E 68 SER^? 8.34 C MLY E 49 coo 37.69 7.64 13.51 38.82 8.84 16.11 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 47.14 12.10 13.73 48.75 12.33 16.01 20.78 52.34 -65.13 20.44 50.34 -67.07 coo 43.77 6.93 15.46 45.49 7.21 17.11 23.32 56.54 -58.94 24.53 56.34 -61.01 ULMN 3 2p3i_p00 VP4 user 6 3 # 6 A 101 ARG E 50 ARG^? 6.44 CA MLY A 117 A 188 TYR E 122 TYR^? 6.86 N MLY E 49 A 190 SER E 48 SER^? 3.44 N MLY E 49 coo 37.69 7.64 13.51 38.82 8.84 16.11 27.70 55.94 -59.52 28.04 56.21 -62.59 coo 47.14 12.10 13.73 48.75 12.33 16.01 30.84 50.71 -50.24 32.10 48.91 -51.93 coo 43.77 6.93 15.46 45.49 7.21 17.11 34.26 52.12 -55.96 35.52 52.85 -57.90 2p3i_p00 source 2p3i VP4 : 6 hits 2p3i_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 30 ASN.? 5.83 CH1 MLY A 49 A 384 ASN D 30 ASN^? 7.01 CH2 MLY D 49 A 385 GLU D 31 GLU^? 4.34 CB MLY D 49 coo 22.28 63.17 110.61 22.47 65.06 111.53 40.27 80.58 -61.87 41.65 82.00 -61.12 coo 7.06 50.07 96.17 8.50 48.54 96.31 42.16 89.18 -40.82 43.17 89.06 -38.94 coo 11.59 49.83 99.41 10.92 47.97 100.16 35.32 90.11 -43.10 33.53 89.40 -42.25 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 30 ASN.? 5.83 CH1 MLY A 49 A 384 ASN D 30 ASN^? 7.01 CH2 MLY D 49 A 385 GLU D 32 GLU^? 9.20 N MLY D 49 coo 22.28 63.17 110.61 22.47 65.06 111.53 40.27 80.58 -61.87 41.65 82.00 -61.12 coo 7.06 50.07 96.17 8.50 48.54 96.31 42.16 89.18 -40.82 43.17 89.06 -38.94 coo 11.59 49.83 99.41 10.92 47.97 100.16 40.33 93.18 -45.60 42.01 93.18 -46.89 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 2 hits 2v3r_p00 naa= 3 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 1 3 # 1 A 82 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 166 SER A 68 SER^? 8.30 O MLY D 92 A 168 HIS D 76 HIS^? 7.07 O MLY D 92 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 24.61 77.27 -62.31 25.74 79.33 -62.97 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 21.19 75.42 -56.78 19.17 75.05 -56.40 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 2 3 # 2 A 82 HIS A 76 HIS^? 7.10 O MLY A 92 A 166 SER E 68 SER^? 8.34 C MLY E 49 A 168 HIS E 67 HIS^? 7.33 CH2 MLY E 104 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 20.27 61.30 -55.15 18.31 61.65 -54.51 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 23.32 56.54 -58.94 24.53 56.34 -61.01 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 18.54 56.25 -57.78 18.20 57.67 -56.27 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 3 3 # 3 A 82 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 166 SER B 68 SER^? 8.39 O MLY E 92 A 168 HIS E 76 HIS^? -4.59 O1 GOL B1126s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 18.03 54.22 -37.13 17.47 55.93 -38.18 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 22.79 53.21 -37.95 23.70 50.99 -38.49 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 19.53 58.10 -41.26 17.57 58.86 -41.26 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 4 3 # 4 A 82 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 166 SER C 68 SER^? 8.27 C MLY C 49 A 168 HIS C 67 HIS^? -4.41 O3 GOL C2126s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 22.13 70.54 -35.03 20.24 71.08 -35.76 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 25.14 71.48 -29.19 26.05 70.14 -27.42 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 20.47 72.89 -29.97 19.97 72.66 -31.99 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 5 3 # 5 A 82 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 166 SER C 68 SER^? 8.27 C MLY C 49 A 168 HIS B 76 HIS^? -4.78 C3 GOL C2126s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 25.14 71.48 -29.19 26.05 70.14 -27.42 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 22.13 70.54 -35.03 20.24 71.08 -35.76 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 6 3 # 6 A 82 HIS C 76 HIS^? 7.27 O MLY C 92 A 166 SER D 68 SER^? 8.33 C MLY D 49 A 168 HIS D 67 HIS^? 7.34 O MLY C 92 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 22.40 81.23 -44.05 20.46 80.64 -44.59 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 25.58 86.91 -43.38 26.68 88.19 -41.66 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 20.80 86.81 -44.45 20.29 84.80 -44.77 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 7 3 # 7 A 82 HIS D 67 HIS^? 7.34 O MLY C 92 A 166 SER D 68 SER^? 8.33 C MLY D 49 A 168 HIS C 76 HIS^? 7.27 O MLY C 92 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 25.58 86.91 -43.38 26.68 88.19 -41.66 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 22.40 81.23 -44.05 20.46 80.64 -44.59 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 8 3 # 8 A 82 HIS D 76 HIS^? 7.07 O MLY D 92 A 166 SER A 68 SER^? 8.30 O MLY D 92 A 168 HIS A 67 HIS^? 6.87 CH2 MLY A 104 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 21.19 75.42 -56.78 19.17 75.05 -56.40 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 24.61 77.27 -62.31 25.74 79.33 -62.97 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 19.88 76.04 -62.54 19.35 75.17 -60.71 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 9 3 # 9 A 82 HIS E 67 HIS^? 7.33 CH2 MLY E 104 A 166 SER E 68 SER^? 8.34 C MLY E 49 A 168 HIS A 76 HIS^? 7.10 O MLY A 92 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 18.54 56.25 -57.78 18.20 57.67 -56.27 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 23.32 56.54 -58.94 24.53 56.34 -61.01 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 20.27 61.30 -55.15 18.31 61.65 -54.51 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 10 3 # 10 A 82 HIS E 76 HIS^? -4.59 O1 GOL B1126s A 166 SER B 68 SER^? 8.39 O MLY E 92 A 168 HIS B 67 HIS^? -4.73 O3 GOL B1126s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 19.53 58.10 -41.26 17.57 58.86 -41.26 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 22.79 53.21 -37.95 23.70 50.99 -38.49 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 18.03 54.22 -37.13 17.47 55.93 -38.18 2vmg_p00 source 2vmg FIBRONECTIN TYPE III DOMAIN PROTEIN : 10 hits 2vmg_p00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR B 66 TYR^? 7.57 CH2 MLY B 56 I 306 VAL E 79 VAL^? 5.55 N MLY E 92 I 308 VAL E 112 VAL^? 6.27 O MLY E 107 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.82 45.97 -35.59 19.43 43.56 -34.25 coo 23.55 29.53 9.81 23.15 27.39 10.24 17.47 47.07 -40.87 18.60 45.42 -41.80 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.47 39.84 -45.28 18.74 39.43 -44.04 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR C 66 TYR^? 7.67 C MLY C 63 I 306 VAL B 79 VAL^? 5.59 N MLY B 92 I 308 VAL B 112 VAL^? 6.57 O MLY B 107 coo 26.18 35.24 6.87 24.33 35.18 8.97 21.79 71.25 -21.62 21.33 71.81 -18.88 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.17 66.93 -24.77 20.03 65.35 -23.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 22.00 60.69 -20.06 20.18 61.66 -19.32 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR D 66 TYR^? 6.79 CE MLY D 56 I 306 VAL C 79 VAL^? 5.51 N MLY C 92 I 308 VAL C 112 VAL^? 6.15 O MLY C 107 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.81 93.85 -40.58 24.25 96.59 -40.12 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.68 89.85 -36.88 21.99 90.21 -35.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.25 92.00 -29.51 22.31 92.82 -30.22 1cqt_d00 source 1cqt GENE REGULATION/DNA : 3 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 25 PRO~? 5.09 CH2 MLY D 117 A 272 LEU A 23 LEU~? 5.84 C1 PEG D3127 A 276 ARG A 50 ARG^? 6.59 CA MLY D 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 30.37 88.27 -71.28 31.36 87.19 -69.57 coo 10.97 0.43 16.73 11.31 2.11 18.06 29.38 81.56 -71.39 27.58 80.36 -71.41 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 28.95 77.70 -62.89 29.34 80.69 -63.51 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 25 PRO~? 5.09 CH2 MLY D 117 A 272 LEU A 27 LEU~? 5.81 CH1 MLY D 117 A 276 ARG A 50 ARG^? 6.59 CA MLY D 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 30.37 88.27 -71.28 31.36 87.19 -69.57 coo 10.97 0.43 16.73 11.31 2.11 18.06 33.10 82.19 -67.15 32.12 80.67 -68.35 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 28.95 77.70 -62.89 29.34 80.69 -63.51 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 25 PRO~? 5.09 CH2 MLY D 117 A 272 LEU A 27 LEU~? 5.81 CH1 MLY D 117 A 276 ARG D 121 ARG^? 4.29 CG MLY D 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 30.37 88.27 -71.28 31.36 87.19 -69.57 coo 10.97 0.43 16.73 11.31 2.11 18.06 33.10 82.19 -67.15 32.12 80.67 -68.35 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 36.09 87.23 -59.47 34.81 89.98 -60.22 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 25 PRO^? 5.54 CH1 MLY E 117 A 272 LEU B 23 LEU^? 6.92 O MLY B 18 A 276 ARG B 50 ARG^? 6.45 CA MLY E 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 27.08 38.09 -37.34 28.19 39.97 -37.93 coo 10.97 0.43 16.73 11.31 2.11 18.06 26.88 43.70 -33.15 25.23 44.79 -32.23 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 27.11 51.81 -37.88 27.02 48.95 -39.10 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO B 25 PRO^? 5.54 CH1 MLY E 117 A 272 LEU B 27 LEU^? 6.96 CH1 MLY E 117 A 276 ARG B 50 ARG^? 6.45 CA MLY E 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 27.08 38.09 -37.34 28.19 39.97 -37.93 coo 10.97 0.43 16.73 11.31 2.11 18.06 30.61 45.15 -37.03 29.85 45.97 -35.10 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 27.11 51.81 -37.88 27.02 48.95 -39.10 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO B 70 PRO^? 4.88 O MLY B 49 A 272 LEU E 124 LEU^? 3.79 CB MLY B 49 A 276 ARG E 121 ARG^? 4.47 O MLY E 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 26.41 57.10 -41.39 26.67 57.40 -39.18 coo 10.97 0.43 16.73 11.31 2.11 18.06 31.07 53.61 -41.98 29.33 53.08 -40.79 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 33.54 46.74 -47.77 31.94 44.02 -47.62 ULMN 3 1emh_d00 HYDROLASE/DNA user 7 3 # 7 A 271 PRO C 25 PRO^? 6.28 NZ MLY B 117 A 272 LEU C 23 LEU^? 7.03 O MLY C 18 A 276 ARG C 50 ARG^? 6.37 CA MLY B 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 29.19 67.20 -15.26 30.45 67.07 -17.12 coo 10.97 0.43 16.73 11.31 2.11 18.06 29.50 72.84 -18.94 27.98 74.02 -19.88 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 29.38 71.17 -28.15 29.46 68.99 -25.90 ULMN 3 1emh_d00 HYDROLASE/DNA user 8 3 # 8 A 271 PRO C 25 PRO^? 6.28 NZ MLY B 117 A 272 LEU C 27 LEU^? 7.14 NZ MLY B 117 A 276 ARG C 50 ARG^? 6.37 CA MLY B 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 29.19 67.20 -15.26 30.45 67.07 -17.12 coo 10.97 0.43 16.73 11.31 2.11 18.06 32.97 69.63 -21.68 32.40 71.70 -21.70 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 29.38 71.17 -28.15 29.46 68.99 -25.90 ULMN 3 1emh_d00 HYDROLASE/DNA user 9 3 # 9 A 271 PRO D 25 PRO^? 5.46 CH1 MLY C 117 A 272 LEU D 23 LEU^? 6.81 O MLY D 18 A 276 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 30.75 98.34 -34.99 32.04 96.64 -35.70 coo 10.97 0.43 16.73 11.31 2.11 18.06 30.10 96.37 -41.69 28.48 95.76 -42.96 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1emh_d00 HYDROLASE/DNA user 10 3 # 10 A 271 PRO D 25 PRO^? 5.46 CH1 MLY C 117 A 272 LEU D 27 LEU^? 6.28 CH1 MLY C 117 A 276 ARG C 121 ARG^? 5.28 O MLY C 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 30.75 98.34 -34.99 32.04 96.64 -35.70 coo 10.97 0.43 16.73 11.31 2.11 18.06 34.07 93.11 -39.75 33.39 93.79 -41.71 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 35.65 87.14 -33.14 35.84 86.33 -30.16 ULMN 3 1emh_d00 HYDROLASE/DNA user 11 3 # 11 A 271 PRO D 25 PRO^? 5.46 CH1 MLY C 117 A 272 LEU D 27 LEU^? 6.28 CH1 MLY C 117 A 276 ARG D 50 ARG^? 6.49 CA MLY C 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 30.75 98.34 -34.99 32.04 96.64 -35.70 coo 10.97 0.43 16.73 11.31 2.11 18.06 34.07 93.11 -39.75 33.39 93.79 -41.71 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 29.95 87.67 -43.01 30.32 89.04 -40.28 ULMN 3 1emh_d00 HYDROLASE/DNA user 12 3 # 12 A 271 PRO D 70 PRO^? 4.30 CH2 MLY D 72 A 272 LEU C 124 LEU^? 4.10 CB MLY D 49 A 276 ARG C 121 ARG^? 5.28 O MLY C 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 28.80 81.54 -43.64 28.77 82.59 -45.63 coo 10.97 0.43 16.73 11.31 2.11 18.06 33.54 83.48 -41.21 31.81 84.76 -41.61 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 35.65 87.14 -33.14 35.84 86.33 -30.16 ULMN 3 1emh_d00 HYDROLASE/DNA user 13 3 # 13 A 271 PRO E 25 PRO^? 6.17 CH2 MLY A 117 A 272 LEU E 23 LEU^? 6.48 C4 PEG E4126 A 276 ARG E 50 ARG^? 6.44 CA MLY A 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 29.04 51.34 -72.30 30.02 52.43 -70.61 coo 10.97 0.43 16.73 11.31 2.11 18.06 27.72 49.13 -65.79 26.02 48.99 -64.52 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 27.70 55.94 -59.52 28.04 56.21 -62.59 ULMN 3 1emh_d00 HYDROLASE/DNA user 14 3 # 14 A 271 PRO E 25 PRO^? 6.17 CH2 MLY A 117 A 272 LEU E 27 LEU^? 6.44 CH2 MLY A 117 A 276 ARG E 50 ARG^? 6.44 CA MLY A 117 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 29.04 51.34 -72.30 30.02 52.43 -70.61 coo 10.97 0.43 16.73 11.31 2.11 18.06 31.73 52.98 -65.25 30.70 51.36 -64.16 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 27.70 55.94 -59.52 28.04 56.21 -62.59 1emh_d00 source 1emh HYDROLASE/DNA : 14 hits 1emh_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 50 ARG^? 6.59 CA MLY D 117 E 41 TYR A 71 TYR^? 4.26 O MLY A 49 E 83 ARG B 108 ARG^? 7.66 C MLY B 107s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 28.95 77.70 -62.89 29.34 80.69 -63.51 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 30.64 69.73 -60.98 30.99 70.47 -63.67 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 14.28 61.53 -14.52 14.41 61.31 -11.40 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 1 hits 1id3_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 65 SER^? 6.25 CH2 MLY A 104 A 20 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 22 LEU A 51 LEU^? 8.07 C MLY A 49 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 17.55 80.47 -67.90 17.09 78.92 -66.03 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -14.55 2.62 13.63 -14.94 2.66 11.50 26.34 71.44 -64.43 24.92 70.62 -65.84 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 65 SER^? 6.25 CH2 MLY A 104 A 20 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 22 LEU A 93 LEU^? 4.15 C MLY A 92 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 17.55 80.47 -67.90 17.09 78.92 -66.03 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -14.55 2.62 13.63 -14.94 2.66 11.50 20.10 66.50 -61.78 21.88 66.65 -63.04 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER A 65 SER^? 6.25 CH2 MLY A 104 A 20 HIS A 67 HIS^? 6.87 CH2 MLY A 104 A 22 LEU A 102 LEU^? 4.62 CE MLY A 104 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 17.55 80.47 -67.90 17.09 78.92 -66.03 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 19.88 76.04 -62.54 19.35 75.17 -60.71 coo -14.55 2.62 13.63 -14.94 2.66 11.50 16.70 69.27 -62.41 17.14 71.36 -62.38 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER A 96 SER^? 5.92 O MLY A 72 A 20 HIS D 76 HIS^? 7.07 O MLY D 92 A 22 LEU D 93 LEU^? 4.28 C MLY D 92 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 21.16 70.03 -52.65 22.56 70.77 -50.83 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 21.19 75.42 -56.78 19.17 75.05 -56.40 coo -14.55 2.62 13.63 -14.94 2.66 11.50 21.13 83.43 -54.40 23.21 83.73 -54.02 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER B 65 SER^? 5.68 N MLY B 56 A 20 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 22 LEU B 51 LEU^? 8.04 C MLY B 49 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 15.33 47.83 -35.47 14.54 49.92 -34.62 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 18.03 54.22 -37.13 17.47 55.93 -38.18 coo -14.55 2.62 13.63 -14.94 2.66 11.50 25.15 56.38 -33.02 23.84 56.48 -31.26 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER B 65 SER^? 5.68 N MLY B 56 A 20 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 22 LEU B 93 LEU^? 3.98 C MLY B 92 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 15.33 47.83 -35.47 14.54 49.92 -34.62 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 18.03 54.22 -37.13 17.47 55.93 -38.18 coo -14.55 2.62 13.63 -14.94 2.66 11.50 20.41 62.54 -33.36 21.67 61.34 -32.01 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 A 18 SER B 65 SER^? 5.68 N MLY B 56 A 20 HIS B 67 HIS^? -4.73 O3 GOL B1126s A 22 LEU B 102 LEU^? 4.07 C3 GOL B1126 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 15.33 47.83 -35.47 14.54 49.92 -34.62 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 18.03 54.22 -37.13 17.47 55.93 -38.18 coo -14.55 2.62 13.63 -14.94 2.66 11.50 16.84 60.57 -35.04 16.60 58.42 -34.76 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 A 18 SER B 96 SER^? 5.90 O MLY B 72 A 20 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 22 LEU C 93 LEU^? 4.02 C MLY C 92 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 22.87 65.56 -42.63 24.42 65.74 -44.43 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 22.13 70.54 -35.03 20.24 71.08 -35.76 coo -14.55 2.62 13.63 -14.94 2.66 11.50 21.43 80.24 -35.74 23.11 80.90 -34.51 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 A 18 SER B 96 SER^? 5.90 O MLY B 72 A 20 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 22 LEU C 102 LEU^? -4.12 C1 GOL C2126s coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 22.87 65.56 -42.63 24.42 65.74 -44.43 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 22.13 70.54 -35.03 20.24 71.08 -35.76 coo -14.55 2.62 13.63 -14.94 2.66 11.50 17.90 78.41 -34.22 18.01 77.13 -32.55 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 A 18 SER B 96 SER^? 5.90 O MLY B 72 A 20 HIS E 76 HIS^? -4.59 O1 GOL B1126s A 22 LEU E 93 LEU^? 4.01 C MLY E 92 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 22.87 65.56 -42.63 24.42 65.74 -44.43 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 19.53 58.10 -41.26 17.57 58.86 -41.26 coo -14.55 2.62 13.63 -14.94 2.66 11.50 19.00 53.28 -48.08 20.46 51.77 -48.55 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 A 18 SER C 65 SER^? 5.92 CH2 MLY C 104 A 20 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 22 LEU C 51 LEU^? 8.16 C MLY C 49 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 17.46 72.45 -23.42 17.18 72.60 -25.76 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -14.55 2.62 13.63 -14.94 2.66 11.50 27.32 77.36 -30.42 25.97 78.99 -29.81 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 A 18 SER C 65 SER^? 5.92 CH2 MLY C 104 A 20 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 22 LEU C 93 LEU^? 4.02 C MLY C 92 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 17.46 72.45 -23.42 17.18 72.60 -25.76 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -14.55 2.62 13.63 -14.94 2.66 11.50 21.43 80.24 -35.74 23.11 80.90 -34.51 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 A 18 SER C 65 SER^? 5.92 CH2 MLY C 104 A 20 HIS C 67 HIS^? -4.41 O3 GOL C2126s A 22 LEU C 102 LEU^? -4.12 C1 GOL C2126s coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 17.46 72.45 -23.42 17.18 72.60 -25.76 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 20.47 72.89 -29.97 19.97 72.66 -31.99 coo -14.55 2.62 13.63 -14.94 2.66 11.50 17.90 78.41 -34.22 18.01 77.13 -32.55 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 14 3 # 14 A 18 SER C 96 SER^? 5.54 O MLY C 72 A 20 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 22 LEU B 93 LEU^? 3.98 C MLY B 92 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 22.75 72.50 -41.71 24.26 71.19 -43.03 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 22.13 70.54 -35.03 20.24 71.08 -35.76 coo -14.55 2.62 13.63 -14.94 2.66 11.50 20.41 62.54 -33.36 21.67 61.34 -32.01 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 15 3 # 15 A 18 SER C 96 SER^? 5.54 O MLY C 72 A 20 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 22 LEU C 51 LEU^? 8.16 C MLY C 49 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 22.75 72.50 -41.71 24.26 71.19 -43.03 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 22.13 70.54 -35.03 20.24 71.08 -35.76 coo -14.55 2.62 13.63 -14.94 2.66 11.50 27.32 77.36 -30.42 25.97 78.99 -29.81 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 16 3 # 16 A 18 SER C 96 SER^? 5.54 O MLY C 72 A 20 HIS B 76 HIS^? -4.78 C3 GOL C2126s A 22 LEU C 53 LEU^? 4.82 CE MLY C 104 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 22.75 72.50 -41.71 24.26 71.19 -43.03 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 22.13 70.54 -35.03 20.24 71.08 -35.76 coo -14.55 2.62 13.63 -14.94 2.66 11.50 22.19 77.26 -27.92 21.25 79.12 -28.44 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 17 3 # 17 A 18 SER D 65 SER^? 5.84 N MLY D 56 A 20 HIS D 67 HIS^? 7.34 O MLY C 92 A 22 LEU D 51 LEU^? 7.98 C MLY D 49 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 18.90 93.40 -41.01 17.66 92.55 -42.90 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -14.55 2.62 13.63 -14.94 2.66 11.50 27.34 87.17 -49.56 25.98 88.11 -50.97 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 18 3 # 18 A 18 SER D 65 SER^? 5.84 N MLY D 56 A 20 HIS D 67 HIS^? 7.34 O MLY C 92 A 22 LEU D 102 LEU^? 4.45 CH2 MLY D 104 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 18.90 93.40 -41.01 17.66 92.55 -42.90 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 20.80 86.81 -44.45 20.29 84.80 -44.77 coo -14.55 2.62 13.63 -14.94 2.66 11.50 18.13 85.04 -51.90 18.99 85.25 -49.89 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 19 3 # 19 A 18 SER D 96 SER^? 5.96 O MLY D 72 A 20 HIS C 76 HIS^? 7.27 O MLY C 92 A 22 LEU C 93 LEU^? 4.02 C MLY C 92 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 22.18 75.94 -47.53 23.49 74.14 -46.77 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 22.40 81.23 -44.05 20.46 80.64 -44.59 coo -14.55 2.62 13.63 -14.94 2.66 11.50 21.43 80.24 -35.74 23.11 80.90 -34.51 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 20 3 # 20 A 18 SER D 96 SER^? 5.96 O MLY D 72 A 20 HIS C 76 HIS^? 7.27 O MLY C 92 A 22 LEU D 51 LEU^? 7.98 C MLY D 49 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 22.18 75.94 -47.53 23.49 74.14 -46.77